<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery: an overview of systematic reviews - Lewis, SR - 2023 | Cochrane Library</title> <meta content="Interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery: an overview of systematic reviews - Lewis, SR - 2023 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013737.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery: an overview of systematic reviews - Lewis, SR - 2023 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013737.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013737.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery: an overview of systematic reviews" name="citation_title"/> <meta content="Sharon R Lewis" name="citation_author"/> <meta content="Queen Mary University of London" name="citation_author_institution"/> <meta content="sharonrlewis@googlemail.com" name="citation_author_email"/> <meta content="Michael W Pritchard" name="citation_author"/> <meta content="Queen Mary University of London" name="citation_author_institution"/> <meta content="Lise J Estcourt" name="citation_author"/> <meta content="NHS Blood and Transplant" name="citation_author_institution"/> <meta content="Simon J Stanworth" name="citation_author"/> <meta content="Oxford University Hospitals NHS Foundation Trust and University of Oxford" name="citation_author_institution"/> <meta content="Xavier L Griffin" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD013737.pub2" name="citation_doi"/> <meta content="2023" name="citation_date"/> <meta content="2023/06/08" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013737.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013737.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013737.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Anemia [therapy]; *Emergence Delirium; Erythrocyte Transfusion; Hemorrhage; *Hip Fractures [surgery]; Iron; Systematic Reviews as Topic; *Tranexamic Acid [therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013737.pub2&amp;doi=10.1002/14651858.CD013737.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="18M35a5z";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013737\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013737\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013737\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013737\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","zh_HANT","th","ms","fa","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013737.pub2",title:"Interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery: an overview of systematic reviews",firstPublishedDate:"Jun 8, 2023 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Bone, Joint and Muscle Trauma Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013737.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013737.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013737.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013737.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013737.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013737.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013737.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013737.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013737.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013737.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2943 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013737.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-sec-0079"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-sec-0006"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-sec-0013"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-sec-0014"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-sec-0033"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-sec-0071"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/appendices#CD013737-sec-0083"> Search strategies </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/supinfo/CD013737-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/supinfo/CD013737-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Overview</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery: an overview of systematic reviews </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/information#CD013737-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Sharon R Lewis</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/information#CD013737-cr-0005">Michael W Pritchard</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/information#CD013737-cr-0006">Lise J Estcourt</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/information#CD013737-cr-0007">Simon J Stanworth</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013737.pub2/information#CD013737-cr-0008">Xavier L Griffin</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/information/en#CD013737-sec-0100">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 08 June 2023 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013737.pub2">https://doi.org/10.1002/14651858.CD013737.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013737-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013737-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013737-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013737-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013737-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD013737-abs-0007">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013737-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013737-abs-0001" lang="en"> <section id="CD013737-sec-0001"> <h3 class="title" id="CD013737-sec-0001">Background</h3> <p>Following hip fracture, people sustain an acute blood loss caused by the injury and subsequent surgery. Because the majority of hip fractures occur in older adults, blood loss may be compounded by pre‐existing anaemia. Allogenic blood transfusions (ABT) may be given before, during, and after surgery to correct chronic anaemia or acute blood loss. However, there is uncertainty about the benefit‐risk ratio for ABT. This is a potentially scarce resource, with availability of blood products sometimes uncertain. Other strategies from Patient Blood Management may prevent or minimise blood loss and avoid administration of ABT. </p> </section> <section id="CD013737-sec-0002"> <h3 class="title" id="CD013737-sec-0002">Objectives</h3> <p>To summarise the evidence from Cochrane Reviews and other systematic reviews of randomised or quasi‐randomised trials evaluating the effects of pharmacological and non‐pharmacological interventions, administered perioperatively, on reducing blood loss, anaemia, and the need for ABT in adults undergoing hip fracture surgery. </p> </section> <section id="CD013737-sec-0003"> <h3 class="title" id="CD013737-sec-0003">Methods</h3> <p>In January 2022, we searched the Cochrane Library, MEDLINE, Embase, and five other databases for systematic reviews of randomised controlled trials (RCTs) of interventions given to prevent or minimise blood loss, treat the effects of anaemia, and reduce the need for ABT, in adults undergoing hip fracture surgery. We searched for pharmacological interventions (fibrinogen, factor VIIa and factor XIII, desmopressin, antifibrinolytics, fibrin and non‐fibrin sealants and glue, agents to reverse the effects of anticoagulants, erythropoiesis agents, iron, vitamin B12, and folate replacement therapy) and non‐pharmacological interventions (surgical approaches to reduce or manage blood loss, intraoperative cell salvage and autologous blood transfusion, temperature management, and oxygen therapy). </p> <p>We used Cochrane methodology, and assessed the methodological quality of included reviews using AMSTAR 2. We assessed the degree of overlap of RCTs between reviews. Because overlap was very high, we used a hierarchical approach to select reviews from which to report data; we compared the findings of selected reviews with findings from the other reviews. Outcomes were: number of people requiring ABT, volume of transfused blood (measured as units of packed red blood cells (PRC)), postoperative delirium, adverse events, activities of daily living (ADL), health‐related quality of life (HRQoL), and mortality. </p> </section> <section id="CD013737-sec-0004"> <h3 class="title" id="CD013737-sec-0004">Main results</h3> <p>We found 26 systematic reviews including 36 RCTs (3923 participants), which only evaluated tranexamic acid and iron. We found no reviews of other pharmacological interventions or any non‐pharmacological interventions. </p> <p><b>Tranexamic acid (17 reviews, 29 eligible RCTs)</b> </p> <p>We selected reviews with the most recent search date, and which included data for the most outcomes. The methodological quality of these reviews was low. However, the findings were largely consistent across reviews. </p> <p>One review included 24 RCTs, with participants who had internal fixation or arthroplasty for different types of hip fracture. Tranexamic acid was given intravenously or topically during the perioperative period. In this review, based on a control group risk of 451 people per 1000, 194 fewer people per 1000 probably require ABT after receiving tranexamic acid (risk ratio (RR) 0.56, 95% confidence interval (CI) 0.46 to 0.68; 21 studies, 2148 participants; moderate‐certainty evidence). We downgraded the certainty for possible publication bias. </p> <p>Review authors found that there was probably little or no difference in the risks of adverse events, reported as deep vein thrombosis (RR 1.16, 95% CI 0.74 to 1.81; 22 studies), pulmonary embolism (RR 1.01, 95% CI 0.36 to 2.86; 9 studies), myocardial infarction (RR 1.00, 95% CI 0.23 to 4.33; 8 studies), cerebrovascular accident (RR 1.45, 95% CI 0.56 to 3.70; 8 studies), or death (RR 1.01, 95% CI 0.70 to 1.46; 10 studies). We judged evidence from these outcomes to be moderate certainty, downgraded for imprecision. </p> <p>Another review, with a similarly broad inclusion criteria, included 10 studies, and found that tranexamic acid probably reduces the volume of transfused PRC (0.53 fewer units, 95% CI 0.27 to 0.80; 7 studies, 813 participants; moderate‐certainty evidence). We downgraded the certainty because of unexplained high levels of statistical heterogeneity. </p> <p>No reviews reported outcomes of postoperative delirium, ADL, or HRQoL.</p> <p><b>Iron (9 reviews, 7 eligible RCTs)</b> </p> <p>Whilst all reviews included studies in hip fracture populations, most also included other surgical populations. The most current, direct evidence was reported in two RCTs, with 403 participants with hip fracture; iron was given intravenously, starting preoperatively. This review did not include evidence for iron with erythropoietin. The methodological quality of this review was low. </p> <p>In this review, there was low‐certainty evidence from two studies (403 participants) that there may be little or no difference according to whether intravenous iron was given in: the number of people who required ABT (RR 0.90, 95% CI 0.73 to 1.11), the volume of transfused blood (MD ‐0.07 units of PRC, 95% CI ‐0.31 to 0.17), infection (RR 0.99, 95% CI 0.55 to 1.80), or mortality within 30 days (RR 1.06, 95% CI 0.53 to 2.13). There may be little or no difference in delirium (25 events in the iron group compared to 26 events in control group; 1 study, 303 participants; low‐certainty evidence). We are very unsure whether there was any difference in HRQoL, since it was reported without an effect estimate. The findings were largely consistent across reviews. We downgraded the evidence for imprecision, because studies included few participants, and the wide CIs indicated possible benefit and harm. </p> <p>No reviews reported outcomes of cognitive dysfunction, ADL, or HRQoL.</p> </section> <section id="CD013737-sec-0005"> <h3 class="title" id="CD013737-sec-0005">Authors' conclusions</h3> <p>Tranexamic acid probably reduces the need for ABT in adults undergoing hip fracture surgery, and there is probably little or no difference in adverse events. For iron, there may be little or no difference in overall clinical effects, but this finding is limited by evidence from only a few small studies. Reviews of these treatments did not adequately include patient‐reported outcome measures (PROMS), and evidence for their effectiveness remains incomplete. We were unable to effectively explore the impact of timing and route of administration between reviews. </p> <p>A lack of systematic reviews for other types of pharmacological or any non‐pharmacological interventions to reduce the need for ABT indicates a need for further evidence syntheses to explore this. Methodologically sound evidence syntheses should include PROMS within four months of surgery. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013737-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013737-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD013737-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD013737-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013737-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013737-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013737-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD013737-abs-0014">Polski</a> </li> <li class="section-language"> <a class="" href="full/th#CD013737-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013737-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD013737-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013737-abs-0002" lang="en"> <h3>What treatments reduce the need for a blood transfusion in adults who have broken their hip? </h3> <p><b>Key messages</b> </p> <p>‐ Using a medicine called tranexamic acid before, during, or after surgery for a broken hip probably reduces the need for a blood transfusion. </p> <p>‐ Treatment with iron may make little to no difference to whether people need a blood transfusion after they have broken their hip. </p> <p><b>What is the condition?</b> </p> <p>A broken hip (a break at the top of the leg bone) is common in older adults whose bones may have weakened because of a condition called osteoporosis. People can lose large amounts of blood with this injury, and they will also lose blood while the bone is fixed in an operation. Many of these older people also have anaemia, with fewer red blood cells to help carry oxygen around the body. Often people will need to be given a blood transfusion (donated from another person) as part of their treatment. There are some risks with this, such as infections, a longer stay in hospital, or becoming confused after surgery. </p> <p><b>What did we want to find out?</b> </p> <p>We wanted to find out whether there were any treatments that could reduce the need for a blood transfusion. We were interested in any medicine, or any other method that reduces additional blood loss. We also wanted to know if these treatments improved people's quality of life after surgery, or caused any unwanted effects. </p> <p><b>What did we do?</b> </p> <p>We searched for systematic reviews that looked at treatments to reduce blood loss in people with a broken hip. These reviews collect all the available evidence for a treatment from published studies and analyse their results. In this overview, we summarised the results of reviews and rated our confidence in the evidence that they reported. We based our judgements about our confidence on factors such as study methods and sizes. </p> <p><b>What did we find?</b> </p> <p>We found 17 reviews about tranexamic acid and nine reviews about iron, which included 36 studies with 3923 participants. These reviews included many of the same studies; we summarised evidence from three reviews that provided the most relevant information. </p> <p>For tranexamic acid, one review included 24 studies with 2148 people with a broken hip, and another included 10 studies with 1123 people. In these studies, people were given tranexamic acid before, during, or after surgery (or at all three times); it was given either directly into a person's vein, or applied onto open wounds. </p> <p>For iron, one review included two studies with 403 people. The treatment was given directly into a vein either before surgery, or before and after surgery. </p> <p>We found no reviews for any other types of treatment.</p> <p><b>Main results</b> </p> <p>Compared to no treatment (or a 'dummy' treatment that does not contain a medicine), tranexamic acid: </p> <p>‐ probably reduces the need for a blood transfusion. For every 1000 people who have a hip fracture, 257 people might need a blood transfusion after receiving tranexamic acid, compared to 451 people who did not receive it; </p> <p>‐ probably reduces the amount of transfused blood that a person is given;</p> <p>‐ probably makes little to no difference to the number of people who have side effects from treatment (such as blood clots that develop in a deep vein), or the number of people who die within a month of breaking their hip. </p> <p>Compared to no treatment (or a 'dummy' treatment), iron may make little to no difference to: </p> <p>‐ the number of people who need to have a blood transfusion;</p> <p>‐ the amount of transfused blood, confusion after surgery, infections, or deaths within one month. </p> <p>We were not sure if receiving iron would affect people's health‐related quality of life four months after surgery. </p> <p>No reviews reported whether these treatments affected people's ability to carry out daily activities four months after surgery. No reviews about tranexamic acid reported information about confusion or health‐related quality of life. </p> <p><b>What are the limitations of the evidence?</b> </p> <p>We are only moderately confident in the evidence that tranexamic acid reduces the need for blood transfusion. The studies that provided results in our selected review may not represent all of the evidence, and this may have exaggerated the benefits of this treatment. For other outcomes, some studies were too small, reported wide differences in their results, and we could not be certain if all the studies were well‐designed to give a reliable result. </p> <p>We have little confidence in our findings for iron treatment, because the studies were too small to produce reliable results. </p> <p>There were some flaws in the way all of the reviews came to their final conclusions, meaning that they may not have been conducted to the highest possible standard. However, the results in each review were all similar, and this meant that we were more confident that their results were accurately collected from study reports. </p> <p><b>How up to date is this evidence?</b> </p> <p>This overview is up to date to January 2022.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013737-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013737-sec-0079"></div> <h3 class="title" id="CD013737-sec-0080">Implications for practice</h3> <section id="CD013737-sec-0080"> <p>Based on evidence from systematic reviews of tranexamic acid, this treatment likely reduces the need for allogeneic blood transfusion in adults undergoing hip fracture surgery. It likely also reduces the volume of transfused packed red blood cells. It probably does not impact the risks of adverse events, such as thromboembolic events or mortality. There were no data to support an estimate of the effect of tranexamic acid on postoperative delirium, health‐related quality of life, or activities of daily living four months after surgery. </p> <p>Based on evidence from systematic reviews of iron, this treatment may make little or no difference to the risk of allogenic blood transfusion, the volume of transfused PRC, the incidence of infection, or mortality. It is very uncertain whether the treatment affected health‐related quality of life four months after surgery. There were no data to support an estimate of the effect of iron on postoperative delirium or activities of daily living after four months. </p> </section> <h3 class="title" id="CD013737-sec-0081">Implications for research</h3> <section id="CD013737-sec-0081"> <p>This overview lacks evidence of the effectiveness of many pharmacological interventions (such as fibrinogen, factor VIIa and factor XIII, desmopressin, fibrin and non‐fibrin sealants and glues, and agents to reverse the effect of anticoagulants), and of all non‐pharmacological interventions (such as surgical approaches or temperature management). Whilst the effectiveness of these treatments may have been evaluated in systematic reviews with other objectives, it is apparent that they were not evaluated in systematic reviews for their impact on minimising the need for allogenic blood transfusion in adults undergoing hip fracture. Therefore, we recommend the production of systematic reviews to evaluate these treatments. Whilst it was beyond the scope of this overview to systematically search for randomised trials for each of these interventions, we are aware of ongoing trials (for example, an evaluation of cell salvage (<a href="./references#CD013737-bbs2-0073" title="GriffinX , AchtenJ , AthwalA , AppelbeD . WHiTE 9: World Hip Trauma Evaluation 9 - Blood Cell Salvage Trial. A multi centre randomised controlled trial comparing intra operative cell salvage with standard care in the treatment of hip fractures. www.ndorms.ox.ac.uk/research/clinical-trials/current-trials-and-studies/WHITE-9 (accessed 7 October 2022).">Griffin 2022</a>)). We are also aware of ongoing trials evaluating the interventions included in this review (for example, an evaluation of iron and erythropoietin, with a target sample size of 2400 participants (<a href="./references#CD013737-bbs2-0112" title="MoppettI , AchesonA , ShahA , KarantanaA , SugavanamA , PartlettC , et al. The clinical benefits and cost-effectiveness and safety of haematopoietic interventions for patients with anaemia following major emergency surgery: a phase IV, multicentre, multi-arm randomised controlled trial: Peri-op Iron and EPO Intervention Study - POP-I. fundingawards.nihr.ac.uk/award/NIHR133467 (accessed 24 October 2022).">Moppett 2020</a>)). We cannot say with certainty whether future systematic reviews would provide a sufficiently comprehensive evaluation to inform clinical practice, or act as a means to identify significant gaps in the primary research. </p> <p>The evidence in this overview for tranexamic acid shows that it is likely an effective treatment for reducing the need for blood transfusion, and it is possible to infer that the evidence is sufficient, and no further systematic reviews are required. However, there remains uncertainty about the route of administration for tranexamic acid. Further work is needed to understand the relative effectiveness of intravenous and topical tranexamic acid, as well as intramuscular administration, which was missing from this overview. For iron use, it is also necessary to explore whether there is any role for oral iron, as well as establishing the optimal timing for iron. </p> <p>We were unable to determine the impact of tranexamic acid or iron on self‐reported outcome measures. We did not check if primary studies reported these outcomes, and we cannot state with confidence whether the lack of reporting by review authors was influenced by lack of reporting in the primary studies. We encourage future review authors to include these outcomes alongside an evaluation of any treatment; outcomes should be based on the core outcome set for this surgical population (<a href="./references#CD013737-bbs2-0078" title="HaywoodKL , GriffinXL , AchtenJ , CostaML . Developing a core outcome set for hip fracture trials. Bone &amp; Joint Journal2014;96-B(8):1016-23. [PMID: 25086115]">Haywood 2014</a>). </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013737-sec-0006" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013737-sec-0006"></div> <section id="CD013737-sec-0007"> <h3 class="title" id="CD013737-sec-0007">Description of the condition</h3> <p>A hip fracture, or proximal femoral fracture, is a break in the upper region of the femur (thigh bone) between the subcapital region (the area just under the femoral head) and 5 cm below the lesser trochanter (a bony projection of the upper femur). The incidence of hip fractures rises with age. The overwhelming majority occur in adults aged over 65 years, with greater numbers in women (<a href="./references#CD013737-bbs2-0058" title="Court-BrownCM , ClementND , DuckworthAD , BiantLC , McQueenMM . The changing epidemiology of fall-related fractures in adults. Injury2017;48(4):819-24. [PMID: 28283181]">Court‐Brown 2017</a>; <a href="./references#CD013737-bbs2-0086" title="KanisJA , OdenA , JohnellO , JönssonB , deLaetC , DawsonA . The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporosis International2001;12(5):417-27. [PMID: 11444092]">Kanis 2001</a>). For example, in the UK, the mean age of a person with a hip fracture is 83 years; approximately two‐thirds occur in women (<a href="./references#CD013737-bbs2-0117" title="Royal College of Physicians. National Hip Fracture Database (NHFD) annual report 2017. nhfd.co.uk/files/2017ReportFiles/NHFD-AnnualReport2017.pdf (accessed 2 January 2020).">NHFD 2017</a>). However, incidence rates for hip fracture and characteristics of the people affected, vary around the world; these variations mainly reflect differences in population demographics (<a href="./references#CD013737-bbs2-0063" title="DhanwalDK , DennisonEM , HarveyNC , CooperC . Epidemiology of hip fracture: worldwide geographic variation. Indian Journal of Orthopaedics2011;45(1):15-22.">Dhanwal 2011</a>). Most hip fractures in older adults are fragility fractures associated with osteoporosis. The World Health Organization defines fragility fractures as those sustained from injuries equivalent to a fall from a standing height or less (<a href="./references#CD013737-bbs2-0087" title="KanisJA , OdenA , McCloskeyEV , JohanssonH , WahlDA , CooperC , et al. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporosis International2012;23(9):2239-56. [PMID: 22419370]">Kanis 2012</a>). Such fractures are caused by mechanical forces that would not ordinarily result in fracture. Hip fractures in younger adults are usually associated with poor bone health (<a href="./references#CD013737-bbs2-0089" title="KarantanaA , BoultonC , BouliotisG , ShuKS , ScammellBE , MoranCG . Epidemiology and outcome of fracture of the hip in women aged 65 years and under: a cohort study. Journal of Bone and Joint Surgery. British Volume2011;93(5):658-64. [PMID: 21511933]">Karantana 2011</a>; <a href="./references#CD013737-bbs2-0134" title="RogmarkC , KristensenMT , VibergB , RönnquistSS , OvergaardS , PalmH . Hip fractures in the non-elderly - who, why and whither?Injury2018;49(8):1445-50. [PMID: 29983171]">Rogmark 2018</a>). High‐energy traumas, such as road traffic collisions, industrial injuries, and sports injuries cause a very small proportion of hip fractures in younger adults (<a href="./references#CD013737-bbs2-0058" title="Court-BrownCM , ClementND , DuckworthAD , BiantLC , McQueenMM . The changing epidemiology of fall-related fractures in adults. Injury2017;48(4):819-24. [PMID: 28283181]">Court‐Brown 2017</a>). </p> <p>Hip fracture is typically treated with an operation. Whilst hip fracture surgery is considered urgent worldwide, different healthcare systems are able to respond in different ways. For example, in the UK, 98% of people with a fractured hip undergo surgery, with 71% having surgery by the day following their presentation (<a href="./references#CD013737-bbs2-0117" title="Royal College of Physicians. National Hip Fracture Database (NHFD) annual report 2017. nhfd.co.uk/files/2017ReportFiles/NHFD-AnnualReport2017.pdf (accessed 2 January 2020).">NHFD 2017</a>). In India, 95% of people with a fractured hip undergo surgery, but 21% experience delays exceeding two weeks (<a href="./references#CD013737-bbs2-0131" title="RathS , YadavL , TewariA , ChantlerT , WoodwardM , KotwalP , et al. Management of older adults with hip fractures in India: a mixed methods study of current practice, barriers and facilitators, with recommendations to improve care pathways. Archives of Osteoporosis2017;12(1):55.">Rath 2017</a>). The type of surgery is guided by the type of fracture. Intracapsular fractures are usually fixed with screws, or the hip is replaced with an arthroplasty, whereas extracapsular fractures are usually treated with an intramedullary nail or a sliding hip screw. The results of a Cochrane network meta‐analyses examining the relative effectiveness of different implants for these two subgroups of hip fracture are reported in <a href="./references#CD013737-bbs2-0098" title="LewisSR , MaceyR , LewisJ , StokesJ , GillJR , CookJA , et al. Surgical interventions for treating extracapsular hip fractures in older adults: a network meta‐analysis. Cochrane Database of Systematic Reviews2022, Issue 2. Art. No: CD013405. [DOI: 10.1002/14651858.CD013405.pub2]">Lewis 2022b</a> and <a href="./references#CD013737-bbs2-0100" title="LewisSR , MaceyR , StokesJ , CookJA , EardleyWGP , GriffinXL . Surgical interventions for treating intracapsular hip fractures in older adults: a network meta‐analysis. Cochrane Database of Systematic Reviews2022, Issue 2. Art. No: CD013404. [DOI: 10.1002/14651858.CD013404.pub2]">Lewis 2022d</a>. Hip fracture surgeries are substantial and invasive operations. Most people with these fractures are frail, have multiple comorbidities associated with age, including chronic anaemia, and there is a high risk of death in the perioperative and early postoperative period (<a href="./references#CD013737-bbs2-0088" title="KannegaardPN , van derMarkS , EikenP , AbrahamsenB . Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age and Ageing2010;39(2):203-9. [PMID: 20075035]">Kannegaard 2010</a>; <a href="./references#CD013737-bbs2-0091" title="KenzoraJE , McCarthyRE , LowellJD , SledgeCB . Hip fracture mortality. Relation to age, treatment, preoperative illness, time of surgery, and complications. Clinical Orthopaedics and Related Research1984;186:45-56. [PMID: 6723159]">Kenzora 1984</a>; <a href="./references#CD013737-bbs2-0103" title="LloydR , BakerG , MacdonaldJ , ThompsonNW . Co-morbidities in patients with a hip fracture. Ulster Medical Journal2019;88(3):162-6. [PMID: 31619850]">Lloyd 2019</a>; <a href="./references#CD013737-bbs2-0126" title="PenninxBW , PahorM , WoodmanRC , GuralnikJM . Anemia in old age is associated with increased mortality and hospitalization. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences2006;61(5):474-9. [PMID: 16720744]">Penninx 2006</a>; <a href="./references#CD013737-bbs2-0133" title="RocheJJ , WennRT , SahotaO , MoranCG . Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ2005;331(7529):1374. [PMID: 16299013]">Roche 2005</a>). For example, in England, Wales, and Northern Ireland in 2016, the 30‐day mortality rate was 6.7%, which rose to 30% at one year (<a href="./references#CD013737-bbs2-0117" title="Royal College of Physicians. National Hip Fracture Database (NHFD) annual report 2017. nhfd.co.uk/files/2017ReportFiles/NHFD-AnnualReport2017.pdf (accessed 2 January 2020).">NHFD 2017</a>). However, fewer than half of those deaths were attributable to the fracture itself, which reflects the frailty of this population, and the associated high prevalence of comorbidities and complications. The impact of morbidity associated with hip fractures is similar to that of stroke, and entails a substantial loss of healthy life‐years in older adults (<a href="./references#CD013737-bbs2-0072" title="GriffinXL , ParsonsN , AchtenJ , FernandezM , CostaML . Recovery of health-related quality of life in a United Kingdom hip fracture population: the Warwick Hip Trauma Evaluation - a prospective cohort study. Bone &amp; Joint Journal2015;97-B(3):372-82. [PMID: 25737522]">Griffin 2015</a>). </p> <p>As a consequence of both the fracture and the urgent surgery required, people with a hip fracture sustain an acute blood loss, compounding any pre‐existing anaemia (<a href="./references#CD013737-bbs2-0068" title="FossNB , KehletH . Hidden blood loss after surgery for hip fracture. Journal of Bone and Joint Surgery. British Volume2006;88(8):1053-9. [PMID: 16877605]">Foss 2006</a>). Postoperative anaemia is associated with increased disability and delirium, reduced muscle strength, and reduced physical performance (<a href="./references#CD013737-bbs2-0069" title="FossNB , KristensenMT , KehletH . Anaemia impedes functional mobility after hip fracture surgery. Age and Ageing2008;37(2):173-8. [PMID: 18349013]">Foss 2008</a>; <a href="./references#CD013737-bbs2-0126" title="PenninxBW , PahorM , WoodmanRC , GuralnikJM . Anemia in old age is associated with increased mortality and hospitalization. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences2006;61(5):474-9. [PMID: 16720744]">Penninx 2006</a>; <a href="./references#CD013737-bbs2-0152" title="van derZandenV , BeishuizenSJ , ScholtensRM , deJongheA , deRooijSE , vanMunsterBC . The effects of blood transfusion on delirium incidence. Journal of the American Medical Directors Association2016;17(8):748-53. [PMID: 27233490]">van der Zanden 2016</a>). Beyond the perioperative period, anaemia is associated with an increased risk of falls, hospitalisation, and mortality (<a href="./references#CD013737-bbs2-0125" title="PenninxBW , PluijmSM , LipsP , WoodmanR , MiedemaK , GuralnikJM , et al. Late-life anemia is associated with increased risk of recurrent falls. Journal of the Amercian Geriatrics Society2005;53(12):2106-11. [PMID: 16398894]">Penninx 2005</a>; <a href="./references#CD013737-bbs2-0126" title="PenninxBW , PahorM , WoodmanRC , GuralnikJM . Anemia in old age is associated with increased mortality and hospitalization. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences2006;61(5):474-9. [PMID: 16720744]">Penninx 2006</a>). In this elderly, frail, and anaemic population, perioperative allogeneic blood transfusion (ABT) — meaning blood from an unrelated donor — is often required to correct anaemia and to improve the oxygen‐carrying capacity of the blood. Blood from a donor is a costly and potentially scarce resource (<a href="./references#CD013737-bbs2-0114" title="MurphyMF , WatersJH , WoodEM , YazerMH . Transfusing blood safely and appropriately. BMJ (Clinical Research ed.)2013;347:f4303. [PMID: 23861410]">Murphy 2013</a>; <a href="./references#CD013737-bbs2-0161" title="World Health Organisation (WHO). The urgent need to implement patient blood management: policy brief. www.who.int/publications/i/item/9789240035744 (accessed 22 February 2023).">WHO 2021</a>). At the time of writing this overview, NHS Blood and Transport issued a four‐week 'amber alert' to hospitals in the UK to put in place management plans to protect blood stocks because of uncertainty in the supply and availability of donated blood. </p> <p>There is uncertainty about the benefit‐risk ratio for ABT (<a href="./references#CD013737-bbs2-0028" title="BrunskillSJ , MilletteSL , ShokoohiA , PulfordEC , DoreeC , MurphyMF , et al. Red blood cell transfusion for people undergoing hip fracture surgery. Cochrane Database of Systematic Reviews2015, Issue 4. Art. No: CD009699. [DOI: 10.1002/14651858.CD009699.pub2]">Brunskill 2015</a>). As documented by UK haemovigilance systems, risks of ABT include transfusion‐transmitted infections, transfusion reactions, circulatory overload, and errors in the transfusion process (<a href="http://www.shotuk.org/shot-reports/" target="_blank">Serious Hazards of Transfusion</a>). ABTs may increase rates of local (e.g. wound) and systemic (e.g. pneumonia) infections in those who are postoperative, which may be attributable to the immunomodulatory effect of allogeneic blood on the recipient (<a href="./references#CD013737-bbs2-0135" title="RohdeJM , DimcheffDE , BlumbergN , SaintS , LangaKM , KuhnL , et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA2014;311(13):1317-26. [PMID: 24691607]">Rohde 2014</a>), though this has not been reported in later reviews (<a href="./references#CD013737-bbs2-0055" title="CarsonJL , StanworthSJ , DennisJA , TrivellaM , RoubinianN , FergussonDA , et al. Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database of Systematic Reviews2021, Issue 12. Art. No: CD002042. [DOI: 10.1002/14651858.CD002042.pub5]">Carson 2021</a>). Allogeneic blood use within 30 days of surgery has been shown to cause deep wound infections in people following hip fracture surgery (<a href="./references#CD013737-bbs2-0082" title="HolleymanR , KhanS , MarshM , TyasB , KalsonN , BakerP , et al. Risk factors for the development of deep infection following hip fracture surgery: analysis of 2822 consecutive patients. British Editorial Society of Bone &amp; Joint Surgery2016;98(23):12.">Holleyman 2016</a>). In people with a fractured hip, a severe complication, such as a deep infection, can be fatal. Notably, a World Health Organization priority is to reduce perioperative infections (<a href="./references#CD013737-bbs2-0047" title="AllegranziB , ZayedB , BischoffP , KubilayNZ , deJongeS , deVriesF , et al. New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infectious Diseases2016;16(12):e288-303. [PMID: 27816414]">Allegranzi 2016</a>). In people with a hip fracture, postoperative transfusion is also associated with a higher risk of delirium (<a href="./references#CD013737-bbs2-0158" title="WangCG , QinYF , WanX , SongLC , LiZJ , LiH . Incidence and risk factors of postoperative delirium in the elderly patients with hip fracture. Journal of Orthopaedic Surgery and Research2018;13(1):186. [PMID: 30049276]">Wang 2018b</a>), and is independently associated with increased length of hospital stay in orthopaedic surgery (<a href="./references#CD013737-bbs2-0110" title="Bou MonsefJ , BoettnerF . Blood management may have an impact on length of stay after total hip arthroplasty. HSS Journal2014;10(2):124-30. [PMID: 25050095]">Monsef 2014</a>). </p> <p>Delirium is a common complication after a hip fracture, or its surgical treatment (<a href="./references#CD013737-bbs2-0083" title="InouyeSK , WestendorpRG , SaczynskiJS . Delirium in elderly people. Lancet2014;383(9920):911-22. [PMID: 23992774]">Inouye 2014</a>). Delirium is an acute confusional state that is under recognised, but can have a serious impact on outcomes for a person, including increased mortality (<a href="./references#CD013737-bbs2-0083" title="InouyeSK , WestendorpRG , SaczynskiJS . Delirium in elderly people. Lancet2014;383(9920):911-22. [PMID: 23992774]">Inouye 2014</a>; <a href="./references#CD013737-bbs2-0106" title="MarcantonioER . Delirium in hospitalized older adults. New England Journal of Medicine2017;377(15):1456-66. [PMID: 29020579]">Marcantonio 2017</a>). Anaemia and a restrictive blood transfusion have been associated with an increased risk of delirium, however, these factors are not included in validated risk‐factor models for delirium (<a href="./references#CD013737-bbs2-0052" title="BlandfortS , GregersenM , BorrisLC , DamsgaardEM . Blood transfusion strategy and risk of postoperative delirium in nursing homes residents with hip fracture. A post hoc analysis based on the TRIFE randomized controlled trial. Aging Clinical and Experimental Resesearch2017;29(3):459-66. [PMID: 27251666]">Blandford 2016</a>; <a href="./references#CD013737-bbs2-0083" title="InouyeSK , WestendorpRG , SaczynskiJS . Delirium in elderly people. Lancet2014;383(9920):911-22. [PMID: 23992774]">Inouye 2014</a>; <a href="./references#CD013737-bbs2-0152" title="van derZandenV , BeishuizenSJ , ScholtensRM , deJongheA , deRooijSE , vanMunsterBC . The effects of blood transfusion on delirium incidence. Journal of the American Medical Directors Association2016;17(8):748-53. [PMID: 27233490]">van der Zanden 2016</a>). </p> </section> <section id="CD013737-sec-0008"> <h3 class="title" id="CD013737-sec-0008">Description of the interventions</h3> <p>Patient Blood Management (PBM) refers to an international, evidence‐based approach that aims to optimise the care of people who might need a blood transfusion. The strategies in PBM include optimal use of transfusion therapy that aims to avoid inappropriate use of blood or blood components (<a href="./references#CD013737-bbs2-0116" title="National Blood Transfusion Committee. Patient Blood Management. An evidence-based approach to patient care. www.transfusionguidelines.org.uk/uk-transfusion-committees/national-blood-transfusion-committee/patient-blood-management (accessed 20 January 2020).">National Blood Transfusion Committee 2014</a>). </p> <p>Practitioners have advocated alternative interventions that aim to prevent or minimise blood loss, the tendency to administer inappropriate transfusions, or both (<a href="./references#CD013737-bbs2-0147" title="StanworthSJ , Grant-CaseyJ , LoweD , LaffanM , NewH , MurphyMF , et al. The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children. Transfusion2011;51(1):62-70. [PMID: 20804532]">Stanworth 2011</a>). This overview considers these alternatives delivered during the perioperative period. Examples of pharmacological interventions include antifibrinolytics, desmopressin, fibrinogen, and fibrin and non‐fibrin sealants, which all support blood clotting or the strengthening of blood clots, and therefore, may reduce bleeding (<a href="./references#CD013737-bbs2-0061" title="DesboroughMJ , SmethurstPA , EstcourtLJ , StanworthSJ . Alternatives to allogeneic platelet transfusion. British Journal of Haematology2016;175(3):381-92. [PMID: 27650431]">Desborough 2016</a>). Non‐pharmacological interventions are wide‐ranging, and include methods to minimise blood loss (such as surgical approaches that are less invasive), alternative surgical positioning of the person undergoing surgery, intraoperative temperature control, and methods to improve the oxygen‐carrying potential of the blood, such as oxygen therapy. </p> </section> <section id="CD013737-sec-0009"> <h3 class="title" id="CD013737-sec-0009">How the intervention might work</h3> <p>The varied strategies for PBM that may reduce or avoid red blood cell transfusion work by minimising blood loss, and reversing anaemia. Each intervention has multiple and different mechanisms of action. </p> <section id="CD013737-sec-0010"> <h4 class="title">Pharmacological interventions</h4> <p>We will include pharmacological agents that minimise blood loss by modifying the stages of blood coagulation. </p> <p> <ul id="CD013737-list-0001"> <li> <p>Fibrinogen. This is a glycoprotein complex that is cleaved to produce the fibrin monomers that are essential to clot formation. This agent is given to replace fibrinogen that may be lost during acute bleeding (with insufficient time to reproduce further fibrinogen in the liver). It is converted by thrombin to fibrin and then to a fibrin‐based blood clot (<a href="./references#CD013737-bbs2-0115" title="NajafiA , ShariatMR , OrandiAA , EtezadiF , SanatkarM , KhajaviMR , et al. Prophylactic administration of fibrinogen concentrate in perioperative period of total hip arthroplasty: a randomized clinical trial study. Acta Medica Iranica2014;52(11):804-10. [PMID: 25415811]">Najafi 2014</a>). </p> </li> <li> <p>Factor XIII and factor VIIa. Factor XIII enables the cross‐linking of fibrin monomers to the fibrin matrix, which makes the clot more stable (<a href="./references#CD013737-bbs2-0076" title="GödjeO , GallmeierU , SchelianM , GrünewaldM , MairH . Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thoracic and Cardiovascular Surgeon2006;54(1):26-33. [PMID: 16485185]">Gödje 2006</a>). Factor VIIa is also a protein in the coagulation matrix that works in conjunction with tissue factor found on the outside of blood vessels, and may improve haemostasis at the site of injury (<a href="./references#CD013737-bbs2-0144" title="SimpsonE , LinY , StanworthS , BirchallJ , DoreeC , HydeC . Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database of Systematic Reviews2012, Issue 3. Art. No: CD005011. [DOI: 10.1002/14651858.CD005011.pub4]">Simpson 2012</a>). </p> </li> <li> <p>Desmopressin. This synthetic vasopressin stimulates the release of factor VIII and von Willebrand factor, promotes platelet adhesiveness to the vascular endothelium, and also works to improve clot stability (<a href="./references#CD013737-bbs2-0094" title="LeinoKA , PälveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiologica Scandinavica2010;54(7):863-70. [PMID: 20546209]">Leino 2010</a>). </p> </li> <li> <p>Antifibrinolytics. These include tranexamic acid, aprotinin, and epsilon‐aminocaproic acid. These agents inhibit the natural enzymatic breakdown of fibrin clots (fibrinolysis), making the clots longer lasting and more stable (<a href="./references#CD013737-bbs2-0163" title="YuanL , ZengY , Chen Z-Q, Zhang X-L, MaiS , SongP , et al. Efficacy and safety of antifibrinolytic agents in spinal surgery: a network meta-analysis. Chinese Medical Journal2019;132(5):577-88. [PMID: 30807356]">Yuan 2019</a>). </p> </li> <li> <p>Fibrin sealants/glue. These are used as a topical application, containing fibrinogen and thrombin; they act to bind the damaged tissue through clot formation when applied directly to the site of the tissue damage (<a href="./references#CD013737-bbs2-0130" title="RandelliF , BanciL , RagoneV , PavesiM , RandelliG . Effectiveness of fibrin sealant after cementless total hip replacement: a double-blind randomized controlled trial. International Journal of Immunopathology and Pharmacology2013;26(1):189-97. [PMID: 23527721]">Randelli 2013</a>). </p> </li> <li> <p>Non‐fibrin sealants. These use components other than fibrin, with the same intention to seal a wound without sutures through clot formation (<a href="./references#CD013737-bbs2-0140" title="ScognamiglioF , TravanA , RustighiI , TarchiP , PalmisanoS , MarsichE , et al. Adhesive and sealant interfaces for general surgery applications. Journal of Biomedical Materials Research. Part B, Appl Biomaterials2016;104(3):626-39. [PMID: 25891348]">Scognamiglio 2016</a>). </p> </li> </ul> </p> <p>We will also include other pharmacological agents given to reverse the effect of anticoagulants. To manage comorbidities, people may take anticoagulants, which are given to thin the blood by reducing coagulation and increasing the time to clot formation. Specific reversal agents are given depending on the anticoagulant agent (e.g. protamine sulfate for heparin and enoxaparin; 4F‐PCC for warfarin and fondaparinux; activated charcoal for apixaban; idarucizumab for dabigatran (<a href="./references#CD013737-bbs2-0057" title="ChristosS , NaplesR . Anticoagulation reversal and treatment strategies in major bleeding: update 2016. Western Journal of Emergency Medicine2016;17(3):264-70. [PMID: 27330657]">Christos 2016</a>)). </p> <p>In addition, we will include agents given to restore normal blood composition.</p> <p> <ul id="CD013737-list-0002"> <li> <p>Erythropoiesis‐stimulating agents, such as erythropoietin, may be used to stimulate the bone marrow to make red blood cells (<a href="./references#CD013737-bbs2-0048" title="AlsalehK , AlotaibiGS , AlmodaimeghHS , AleemAA , KouroukisCT . The use of preoperative erythropoiesis-stimulating agents (ESAs) in patients who underwent knee or hip arthroplasty: a meta-analysis of randomized clinical trials. Journal of Arthroplasty2013;28(9):1463-72. [PMID: 23528548]">Alsaleh 2013</a>). </p> </li> <li> <p>Iron, vitamin B12, and folate replacement therapy. Essential for the development of red blood cells, these haematonics may be given perioperatively to address the management of anaemia directly, by stimulating the production of red blood cells through erythropoiesis (<a href="./references#CD013737-bbs2-0060" title="CuencaJ , García-ErceJA , MartínezF , CardonaR , Pérez-SerranoL , MuñozM . Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement. International Journal of Surgery2007;5(2):89-94. [PMID: 17448971]">Cuenca 2007</a>; <a href="./references#CD013737-bbs2-0136" title="RowlandsM , ForwardDP , SahotaO , MoppettIK . The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients: study protocol for a randomized controlled trial. Trials2013;14:288. [PMID: 24015990]">Rowlands 2013</a>). </p> </li> </ul> </p> </section> <section id="CD013737-sec-0011"> <h4 class="title">Non‐pharmacological interventions</h4> <p> <ul id="CD013737-list-0003"> <li> <p>Approaches used during and after surgery to reduce or manage intraoperative or postoperative blood loss, including secondary haemorrhage. These approaches are wide‐ranging. Examples include: electrocautery or diathermy during surgery to cauterise (seal) damaged tissue to reduce excessive bleeding; positioning of the person undergoing surgery, which may influence blood loss by changes in local tissue blood pressure and hydrostatic blood pressure at the wound site (<a href="./references#CD013737-bbs2-0121" title="PaceA , YousefA . The effect of patient position on blood loss in primary cemented total hip arthroplasty. Archives of Orthopaedic and Trauma Surgery2008;128(10):1209-12. [PMID: 18214504]">Pace 2008</a>); internal fixation implants, which may reduce blood loss by improving the stabilisation of the bone (<a href="./references#CD013737-bbs2-0122" title="ParkerMJ , GurusamyKS . Internal fixation implants for intracapsular hip fractures in adults. Cochrane Database of Systematic Reviews2001, Issue 4. Art. No: CD001467. [DOI: 10.1002/14651858.CD001467]">Parker 2001</a>); surgical procedures, such as osteotomy of the femur, which may stabilise the fracture before surgery or reduce the risk of further collapse of the fracture site; or cement augmentation, which may improve the stabilisation of the internal fixations at the fracture site (<a href="./references#CD013737-bbs2-0123" title="ParkerMJ , HandollHHG . Osteotomy, compression and other modifications of surgical techniques for internal fixation of extracapsular hip fractures. Cochrane Database of Systematic Reviews2009, Issue 2. Art. No: CD000522. [DOI: 10.1002/14651858.CD000522.pub2]">Parker 2009</a>); dressings, such as compression bandages, which may reduce blood loss after surgery by increasing external pressure and allowing for clot formation (<a href="./references#CD013737-bbs2-0149" title="TanM , WuT , GuoJ , ZhangC , FanZ , GuoX . Hemostasis effect of compression dressing therapy after total hip arthroplasty. Chinese Journal of Reparative and Reconstructive Surgery2016;30(4):416‐20.">Tan 2016</a>); perioperative fluid therapy and optimisation methods for volume expansion, using alternative products to blood, such as colloids or saline solutions (<a href="./references#CD013737-bbs2-0036" title="LewisSR , ButlerAR , BrammarA , NicholsonA , SmithAF . Perioperative fluid volume optimization following proximal femoral fracture. Cochrane Database of Systematic Reviews2016, Issue 3. Art. No: CD003004. [DOI: 10.1002/14651858.CD003004.pub4]">Lewis 2016</a>; <a href="./references#CD013737-bbs2-0095" title="LewisSR , PritchardMW , EvansDJW , ButlerAR , AldersonP , SmithAF , et al. Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database of Systematic Reviews2018, Issue 8. Art. No: CD000567. [DOI: 10.1002/14651858.CD000567.pub7]">Lewis 2018</a>). </p> </li> <li> <p>Intraoperative cell salvage and autologous blood transfusion. This intervention involves the collection of blood lost during or after surgery (or collected from the person before planned surgery), which is then re‐infused into the person in order to replace the lost volume of blood (<a href="./references#CD013737-bbs2-0067" title="EsperSA , WatersJH . Intra-operative cell salvage: a fresh look at the indications and contraindications. Blood Transfusion2011;9(2):139-47. [PMID: 21251468]">Esper 2011</a>). </p> </li> <li> <p>Temperature management during surgery. As hypothermia may slow down the enzymatic reactions and impair blood coagulation, active warming or methods to maintain normothermia may reduce blood loss (<a href="./references#CD013737-bbs2-0162" title="YiJ , LiangH , SongR , XiaH , HuangY . Maintaining intraoperative normothermia reduces blood loss in patients undergoing major operations: a pilot randomized controlled clinical trial. BMC Anesthesiology2018;18(1):126. [PMID: 30193571]">Yi 2018</a>). </p> </li> <li> <p>Oxygen therapy. Increasing the partial pressure of oxygen in the lungs will increase oxygen saturation of the blood, and may reduce the need for ABT. </p> </li> </ul> </p> <p>Whilst interventions may help to restore or maintain blood composition, or both, these interventions may increase other risks to the person. For example, hypotension may be more frequent with desmopressins (<a href="./references#CD013737-bbs2-0062" title="DesboroughMJ , OaklandK , BrierleyC , BennettS , DoreeC , TrivellaM , et al. Desmopressin use for minimising perioperative blood transfusion. Cochrane Database of Systematic Reviews2017, Issue 7. Art. No: CD001884. [DOI: 10.1002/14651858.CD001884.pub3]">Desborough 2017</a>); the effect of antifibrinolytics on the risk of thromboembolytic events is uncertain (<a href="./references#CD013737-bbs2-0092" title="KerK , EdwardsP , PerelP , ShakurH , RobertsI . Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ2012;344:e3054. [PMID: 22611164]">Ker 2012</a>); and it is uncertain whether some colloids increase the risk of allergic skin reactions (<a href="./references#CD013737-bbs2-0095" title="LewisSR , PritchardMW , EvansDJW , ButlerAR , AldersonP , SmithAF , et al. Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database of Systematic Reviews2018, Issue 8. Art. No: CD000567. [DOI: 10.1002/14651858.CD000567.pub7]">Lewis 2018</a>). </p> </section> </section> <section id="CD013737-sec-0012"> <h3 class="title" id="CD013737-sec-0012">Why it is important to do this overview</h3> <p>A variety of pharmacological and non‐pharmacological interventions are available in addition to ABT, and these could be used in a PBM approach for people who present for hip fracture surgery. However, blood transfusion and alternative interventions, delivered independently or as part of bundles of care, have varying degrees of benefit, risk, and cost‐effectiveness. Cochrane and non‐Cochrane systematic reviews, international guidelines for red blood cell transfusion therapy, and a recent international initiative on PBM have all evaluated the evidence for these interventions (<a href="./references#CD013737-bbs2-0055" title="CarsonJL , StanworthSJ , DennisJA , TrivellaM , RoubinianN , FergussonDA , et al. Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database of Systematic Reviews2021, Issue 12. Art. No: CD002042. [DOI: 10.1002/14651858.CD002042.pub5]">Carson 2021</a>; <a href="./references#CD013737-bbs2-0054" title="CarsonJL , GuyattG , HeddleNM , GrossmanB , CohnCS , FungMK , et al. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA2016;316(19):2025-35. [PMID: 27732721]">Carson 2016b</a>; <a href="./references#CD013737-bbs2-0113" title="MuellerMM , Van RemoortelH , MeybohmP , ArankoK , AubronC , BurgerR , et al. Patient blood management: recommendations from the 2018 Frankfurt consensus conference. JAMA2019;321(10):983-97. [PMID: 30860564]">Mueller 2019</a>; <a href="./references#CD013737-bbs2-0118" title="National Institute for Health and Care Excellence (NICE). Blood transfusion. NICE guideline (NG 24). www.nice.org.uk/guidance/ng24 (accessed 20 January 2020).">NICE 2015</a>). Given the diversity of interventions, an overview provides the best opportunity to evaluate these treatment options.This overview aims to identify existing evidence from systematic reviews, and to describe the effectiveness of any intervention that has been applied to people with hip fracture, as an alternative to ABT. This overview is written at a time when supply and availability of blood is uncertain in the UK; therefore, it is an important and timely evaluation. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013737-sec-0013" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013737-sec-0013"></div> <p>To summarise the evidence from Cochrane Reviews and other systematic reviews of randomised or quasi‐randomised trials evaluating the effects of pharmacological and non‐pharmacological interventions, administered perioperatively, on reducing blood loss, anaemia, and the need for allogeneic blood transfusion in adults undergoing hip fracture surgery. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013737-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013737-sec-0014"></div> <section id="CD013737-sec-0015"> <h3 class="title">Criteria for considering reviews for inclusion</h3> <section id="CD013737-sec-0016"> <h4 class="title">Types of reviews</h4> <p>We included systematic reviews of randomised controlled trials (RCTs) and quasi‐RCTs; we included Cochrane Reviews and non‐Cochrane systematic reviews. We included a systematic review if it reported a comprehensive search strategy, clear study inclusion criteria, and a narrative or quantitative synthesis of included studies. </p> <p>Some systematic reviews included studies with non‐randomised study designs. We only included systematic reviews if it was possible to extract data separately for RCTs and quasi‐RCTs. This was reported in systematic reviews as sensitivity analyses, or data for individual RCTs were available from forest plots. </p> </section> <section id="CD013737-sec-0017"> <h4 class="title">Types of participants</h4> <p>We included systematic reviews that selected studies with the following participant group. </p> <p> <ul id="CD013737-list-0004"> <li> <p>Adults with a fragility hip fracture, from a low‐energy trauma, undergoing surgery.</p> </li> <li> <p>Fractures may be intracapsular (displaced and undisplaced) or extracapsular (trochanteric or subtrochanteric), and may be stable or unstable. </p> </li> </ul> </p> <p>We excluded systematic reviews that selected only studies of participants undergoing elective hip arthroplasty, who had not sustained a fragility fracture; unless clearly stated, we assumed that reviews of arthroplasty surgery were for elective indications and not the result of hip fracture. </p> <p>We would have preferred to include only reviews that included RCTs of participants with hip fracture, as this would provide the most direct evidence for our overview. However, as anticipated, some systematic reviews included studies with mixed populations, some of which were not directly eligible for inclusion in the overview, such as hip arthroplasty without fracture, or hip and knee arthroplasty studies (which may include some participants with hip fracture). We took a pragmatic approach to such reviews. Therefore, we included systematic reviews of mixed populations in the overview in the absence of direct evidence for each intervention. If we reported findings from these reviews, we planned to ensure that this evidence was clearly highlighted for likely indirectness. </p> </section> <section id="CD013737-sec-0018"> <h4 class="title">Types of interventions</h4> <p>We included systematic reviews of studies that evaluated the effects of pharmacological or non‐pharmacological interventions for preventing or minimising blood loss, for treating the effects of anaemia by improving the oxygen‐carrying potential of the blood, and for reducing the need for allogeneic blood transfusion. We included interventions that were given during the perioperative period. </p> <p>Comparisons were between categories of intervention (e.g. pharmacological versus non‐pharmacological), or within‐category (e.g. two different types of surgery), or an active treatment against a control (standard of care or placebo). If systematic reviews had included multiple interventions, we planned to only include data from the interventions that were relevant to this review. </p> <p>In our overview, we categorised pharmacological interventions and non‐pharmacological interventions as two separate comparison groups. </p> <section id="CD013737-sec-0019"> <h5 class="title">Pharmacological interventions</h5> <p>We included the following types of interventions.</p> <p> <ul id="CD013737-list-0005"> <li> <p>Fibrinogen</p> </li> <li> <p>Factor VIIa and factor XIII</p> </li> <li> <p>Desmopressin</p> </li> <li> <p>Antifibrinolytics (tranexamic acid; aprotinin; epsilon‐aminocaproic acid)</p> </li> <li> <p>Fibrin and non‐fibrin sealants and glue (excluding surface dressings)</p> </li> <li> <p>Agents to reverse the effect of anticoagulants (e.g. protamine sulfate; 4F‐PCC; activated charcoal) </p> </li> <li> <p>Erythropoiesis‐stimulating agents</p> </li> <li> <p>Iron, vitamin B12, folate replacement therapy</p> </li> </ul> </p> </section> <section id="CD013737-sec-0020"> <h5 class="title">Non‐pharmacological interventions</h5> <p>We included the following types of interventions.</p> <p> <ul id="CD013737-list-0006"> <li> <p>Approaches used during and after surgery to reduce or manage intraoperative or postoperative blood loss, including secondary haemorrhage: e.g. surgical procedures, implants, use of diathermy or electrocautery, dressings, perioperative fluid management, positioning of the person during surgery </p> </li> <li> <p>Intraoperative cell salvage and autologous blood transfusion</p> </li> <li> <p>Temperature management: e.g. normothermia versus hypothermia, different types of intraoperative warming devices </p> </li> <li> <p>Oxygen therapy</p> </li> </ul> </p> <p>We anticipated that some interventions could be used concomitantly as part of an individualised package (e.g. goal‐directed management). We included a systematic review if the intervention was evaluated separately, rather than as part of a package. We collected information on these concomitant treatments along with other descriptive information about the reviews. </p> </section> </section> <section id="CD013737-sec-0021"> <h4 class="title">Type of outcome measures</h4> <p>We planned to collect measures that were plausibly linked to the interventions of interest in this overview, and those that people who had suffered a hip fracture had prioritised in the published hip fracture core outcome set (<a href="./references#CD013737-bbs2-0078" title="HaywoodKL , GriffinXL , AchtenJ , CostaML . Developing a core outcome set for hip fracture trials. Bone &amp; Joint Journal2014;96-B(8):1016-23. [PMID: 25086115]">Haywood 2014</a>). </p> <section id="CD013737-sec-0022"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD013737-list-0007"> <li> <p>Number of people requiring allogeneic blood transfusion (ABT)</p> </li> <li> <p>Volume of transfused allogeneic blood (packed red blood cells; in units or millilitres)</p> </li> </ul> </p> </section> <section id="CD013737-sec-0023"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD013737-list-0008"> <li> <p>Postoperative delirium. We accepted validated measurement tools, such as the Confusion Assessment Method or Diagnostic and Statistical Manual of Mental Disorders, measured in the early postoperative period (up to 72 hours). </p> </li> <li> <p>Postoperative cognitive dysfunction. We accepted validated measurement tools, such as the Mini‐Mental State Examination or the Digit Symbol Substitution Test, measured in the postoperative period (up to 30 days). </p> </li> <li> <p>Adverse events experienced by participants within 30 days of surgery, such as postoperative infection, acute respiratory distress syndrome, and thromboembolism </p> </li> <li> <p>Activities of daily living (ADL) at four months postoperatively. We used validated measurement tools, such as the Barthel Index or Functional Independence Measure. </p> </li> <li> <p>Health‐related quality of life (HRQoL) at four months postoperatively. We used validated measurement tools, such as the SF‐36 or EQ‐5D. </p> </li> <li> <p>All‐cause mortality at one month postoperatively.</p> </li> <li> <p>All‐cause mortality at four months postoperatively.</p> </li> </ul> </p> <p>In addition, we proposed to collect data for ADL, HRQoL, and mortality measured at a longer follow‐up, after four months and up to one year postoperatively. We anticipated that some outcomes would be reported at different time points or using different measurement tools to those specified above. We included all data for these specified outcomes and reported where time points differed. If non‐validated measurement tools had been used, we planned to report the findings, but would have considered downgrading the certainty of the evidence. </p> </section> </section> </section> <section id="CD013737-sec-0024"> <h3 class="title">Search methods for identification of reviews</h3> <p>We searched the following databases for relevant systematic reviews.</p> <p> <ul id="CD013737-list-0009"> <li> <p>Cochrane Database of Systematic Reviews (CDSR; 2022, Issue 1) in the Cochrane Library (searched 14 January 2022) </p> </li> <li> <p>MEDLINE OvidSP (1946 to 5 January 2022)</p> </li> <li> <p>PubMed (for e‐publications ahead of print only; searched 6 January 2022)</p> </li> <li> <p>Embase OvidSP (1974 to 5 January 2022)</p> </li> <li> <p>Epistemonikos (searched 18 January 2022)</p> </li> <li> <p>PROSPERO (searched 6 January 2022)</p> </li> <li> <p>Transfusion Evidence Library (<a href="http://www.transfusionevidencelibrary.com/" target="_blank">transfusionevidencelibrary.com</a>; 1950 to 7 January 2022) </p> </li> <li> <p>Web of Science Core Collection (Science Citation Index Expanded (SCI‐EXPANDED); 1945 to 7 January 2022; Conference Proceedings Citation Index ‐ Science (CPCI‐S; 1990 to 7 January 2022); Book Citation Index – Science (BKCI‐S 2005 to 2007; searched 7 January 2022) </p> </li> </ul> </p> <p>We developed a subject‐specific search strategy, with terms for the participant group combined with a study design filter for systematic reviews (see <a href="./appendices#CD013737-sec-0084">Appendix 1</a>). For searches in MEDLINE and Embase, strategies were combined with adaptations of the Scottish Intercollegiate Guidelines Network (SIGN) Systematic Review filters (<a href="https://www.sign.ac.uk/search-filters" target="_blank">www.sign.ac.uk/search-filters</a>); we adapted these filters for other databases. We did not restrict our search by language or publication date. We also conducted backward‐citation searches (by looking through reference lists of eligible reviews). </p> </section> <section id="CD013737-sec-0025"> <h3 class="title" id="CD013737-sec-0025">Data collection and analysis</h3> <p>We based the methods for data collection and analysis on those described by <a href="./references#CD013737-bbs2-0128" title="PollockM , FernandesRM , BeckerLA , PieperD , HartlingL . Chapter V: Overviews of Reviews. In: Higgins JPT, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.">Pollock 2022</a>. </p> <section id="CD013737-sec-0026"> <h4 class="title">Selection of reviews</h4> <p>We used reference management software to collate the results of searches and to remove duplicates (<a href="./references#CD013737-bbs2-0066" title="Endnote X9. ThomsonR . Philadelphia (PA): Thomson Reuters, 2018.">Endnote</a>). We used <a href="./references#CD013737-bbs2-0059" title="Covidence. Version accessed 27 November 2019. Melbourne, Australia: Veritas Health Innovation. Available at www.covidence.org.">Covidence</a> software to screen results of the search of titles and abstracts, and to identify potentially relevant studies. We used standard Cochrane methods, using two overview authors (SL and MP) to independently screen titles and abstracts, and source full‐texts (<a href="./references#CD013737-bbs2-0081" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.">Higgins 2022</a>). We selected systematic reviews for inclusion in the overview that met the review design, participant, and intervention criteria above. We resolved disagreements through discussion, or if necessary, through input from a third author. We recorded the number of papers retrieved at each stage and reported this information using a PRISMA flow chart. In the overview, we reported brief details of closely related but excluded reviews. </p> </section> <section id="CD013737-sec-0027"> <h4 class="title">Data extraction and management</h4> <p>We collected and reported the following descriptive information and quantitative data reported by the systematic review authors. </p> <p> <ul id="CD013737-list-0010"> <li> <p>Review criteria (primary aim or objectives of the review; types of study designs; types of participants; types of interventions and comparisons; types of outcomes) </p> </li> <li> <p>Review search details (date of last search; date range of searches; number and names of databases searched; restrictions or limitations on searches, such as language of publication) </p> </li> <li> <p>Characteristics of primary studies in reviews (primary study objectives; number of studies; types of study designs, details of participants, and details of interventions and comparisons; methods of risk of bias assessments and risk of bias judgements on included studies; judgements on the certainty of the evidence) </p> </li> <li> <p>Outcomes measured and reported in the review (methods and units of measurement; time points of measurement; effect estimates for dichotomous and continuous outcome data) </p> </li> <li> <p>Other information (review protocol; methodology to select studies and extract data; tools used to assess risk of bias, or certainty of the evidence, or both; methodology or decisions related to meta‐analysis; sources of funding and conflicts of interest) </p> </li> </ul> </p> <p>Two overview authors (SL and MP) independently extracted data and compared results, using a data extraction form in <a href="./references#CD013737-bbs2-0059" title="Covidence. Version accessed 27 November 2019. Melbourne, Australia: Veritas Health Innovation. Available at www.covidence.org.">Covidence</a>. We resolved disagreements through discussion, or if necessary, through input from a third author. In the event of missing information in reviews regarding primary study characteristics or outcome data, we referred to the primary study reports. In the event that important information was missing, we attempted to contact review authors. We noted any outstanding gaps in coverage of data. </p> <p>Using <a href="./references#CD013737-bbs2-0132" title="Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.">Review Manager 2020</a>, we presented tables to summarise characteristics of included systematic reviews, and tables to summarise characteristics of primary studies in the included reviews. </p> <p>We acknowledge the risk of overlapping systematic reviews when conducting overviews. Therefore, we mapped which primary studies were included in which systematic review(s). Because primary studies may be reported using different references in each systematic review, we considered study characteristics to help determine whether primary studies were the same. We used a table specifically to present overlap, and described the number and size of overlapping studies, and the amount of weight they contributed to the analyses. We were guided by the work of <a href="./references#CD013737-bbs2-0127" title="PieperD , AntoineS , MathesT , NeugebauerE , EikermannM . Systematic review finds overlapping reviews were not mentioned in every other overview. Journal of Clinical Epidemiology2014;67:7. [PMID: 24581293]">Pieper 2014</a> to calculate a numerical measure of any overlap. </p> </section> <section id="CD013737-sec-0028"> <h4 class="title">Assessment of methodological quality of included reviews</h4> <p>We assessed risk of bias in systematic reviews using the AMSTAR 2 critical appraisal tool for systematic reviews and its related guidance tools (<a href="./references#CD013737-bbs2-0142" title="SheaBJ , ReevesBC , WellsG , ThukuM , HamelC , MoranJ , et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ (Clinical Research ed.)2017;358:j4008. [PMID: 28935701]">Shea 2017</a>). Two overview authors (SL and MP) independently considered the 16 questions of the appraisal tool for each included systematic review (<a href="./appendices#CD013737-sec-0085">Appendix 2</a>). We resolved disagreements through discussion, or if necessary, through input from a third author. We presented a table that provided a judgement for each item in the assessment tool, to explain how we rated our confidence in the results in each systematic review. </p> <p>AMSTAR 2 is not designed to generate an overall score. A high score may disguise critical weaknesses in specific domains, such as an inadequate literature search or a failure to assess risk of bias in individual studies (<a href="./references#CD013737-bbs2-0142" title="SheaBJ , ReevesBC , WellsG , ThukuM , HamelC , MoranJ , et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ (Clinical Research ed.)2017;358:j4008. [PMID: 28935701]">Shea 2017</a>). Therefore, we took account of the potential impact of an inadequate rating for each item, as these inadequacies may weaken the confidence that we can have in a systematic review's findings. Using our assessments from AMSTAR 2, we rated our overall confidence in the results of each systematic review as follows: </p> <p> <ul id="CD013737-list-0011"> <li> <p>High (no, or one non‐critical weakness) — the systematic review provides an accurate and comprehensive summary of the results of the available studies that address the question of interest; </p> </li> <li> <p>Moderate (no critical flaws, and more than one non‐critical weakness) — the systematic review has more than one weakness but no critical flaws. It may provide an accurate summary of the results of the available studies that address the question of interest; </p> </li> <li> <p>Low (one critical flaw, with or without non‐critical weaknesses) — the review has a critical flaw and may not provide an accurate and comprehensive summary of the available studies that address the question of interest; </p> </li> <li> <p>Very low (more than one critical flaw, with or without non‐critical weaknesses) — the review has more than one critical flaw and should not be relied on to provide an accurate and comprehensive summary of the available studies that address the question of interest.  </p> </li> </ul> </p> </section> <section id="CD013737-sec-0029"> <h4 class="title">Data synthesis</h4> <p>We planned to present outcome data separately for pharmacological interventions and non‐pharmacological interventions. Based on the findings, we then grouped systematic reviews by appropriate groups of interventions (e.g. agents with the same mode of action, such as antifibrinolytics). </p> <p>We presented narrative summaries according to the type of intervention and following the order of our outcomes. We extracted outcome data as they were presented in each systematic review, to include effect estimates (and 95% confidence intervals). It was not our intention to make inferences about effects using indirect comparisons from more than one systematic review; therefore, where relevant, we reported summaries separately for each systematic review. We enhanced the presentation of our findings using tables and figures, as necessary, and we adhered to the methods of narrative synthesis, developed from the work of <a href="./references#CD013737-bbs2-0053" title="CampbellM , McKenzieJE , SowdenA , KatikireddiSV , BrennanSE , EllisS , et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ Open2020;368:l6890. [PMID: 31948937]">Campbell 2020</a>. </p> <p>In the narrative summaries, we planned to take account of our prespecified subgroups (as below). We took account of studies with a mixed population (such as those that included participants who had knee arthroplasty, as well as participants who had hip arthroplasty; or those that included participants who had intramedullary nailing for humeral shaft fractures, as well as participants who had intramedullary nailing for intertrochanteric fractures), or those that included RCTs and non‐randomised studies. If reviews included studies with a mixed population or both types of study design, we aimed primarily to report data only for the types of participants consistent with the overview criteria; if data were not reported separately, we highlighted when the evidence was indirect. </p> <p>In the event we found multiple overlapping reviews with a large measure of overlap, we planned to adopt a hierarchy to prioritise from which systematic review we reported data: to prioritise Cochrane systematic reviews, followed by the most recent systematic review, the systematic review with the highest methodological quality, the most relevant systematic review, and the most comprehensive systematic review. However, whilst still considering all of these criteria, we adopted a pragmatic approach in order to ensure that we selected the most relevant review. We acknowledge that any approach, whilst avoiding double‐counting, included the potential for missing data. We explored the effects of our approach in sensitivity analyses. </p> <p>We planned to consider re‐analysis of outcome data only in these prespecified circumstances:</p> <p> <ul id="CD013737-list-0012"> <li> <p>If re‐analysis allowed for the inclusion of a specific subgroup; or</p> </li> <li> <p>To ensure that effect estimates were reported in a consistent manner that was easily understood by the end‐user of the overview. </p> </li> </ul> </p> <p>If re‐analysis of outcome data had been necessary, we would have adhered to standard meta‐analytic principles, according to <a href="./references#CD013737-bbs2-0081" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.">Higgins 2022</a>. </p> <section id="CD013737-sec-0030"> <h5 class="title">Subgroup analysis and investigation of heterogeneity</h5> <p>We collected information from review reports for the following prespecified subgroups.</p> <p> <ul id="CD013737-list-0013"> <li> <p>Time of administration of the intervention (preoperatively, intraoperatively, postoperatively)</p> </li> <li> <p>Age of participants (to include 'elderly', according to specified age cut‐offs, ‘frail elderly’) </p> </li> <li> <p>Baseline comorbidities (using validated scales or scoring systems that measure comorbidities to indicate physical status, such as the American Society of Anesthesiologists (ASA) physical status classification system, or the Charlson Comorbidity Index </p> </li> <li> <p>People at higher risk of bleeding</p> </li> </ul> </p> <p>We also collected information on an additional subgroup.</p> <p> <ul id="CD013737-list-0014"> <li> <p>Route of administration (intravenous or topical)</p> </li> </ul> </p> <p>Firstly, we noted whether any of the systematic reviews included interventions or participants from only one subgroup (for example, only frail elderly participants); for this, we assessed both the review inclusion criteria and the characteristics of studies included in each review. Secondly, we noted whether the reviews conducted subgroup analyses for any of our prespecified subgroups. We described differences in review characteristics between systematic reviews (e.g. such as study design eligibility) in <a href="#CD013737-sec-0034">Description of included reviews</a>. In the event of differences in subgroup categories between systematic reviews, we used a narrative approach to describe the outcome data according to these subgroups (in <a href="#CD013737-sec-0042">Effects of interventions</a>); we reported these findings for all outcomes relevant to this overview. We reported effect estimates, alongside a narrative description, in the event that review authors noted differences between subgroups. </p> </section> <section id="CD013737-sec-0031"> <h5 class="title">Sensitivity analysis</h5> <p>We used sensitivity analyses to explore the effects of decisions made during the overview process. In particular, we examined and reported the effects of presenting data according to a hierarchical approach. We compared the effect estimates of systematic reviews which we prioritised using the hierarchical approach, with the effect estimates of the other systematic review(s). Where we observed important differences in effect estimates such that our interpretation of the findings differed (for example, when the direction of an effect estimate differed between reviews), we observed possible reasons for this, such as the dates of searches in the systematic reviews and the number of included studies, to establish whether the prioritisation of reviews in the hierarchy led to missing data. </p> </section> </section> <section id="CD013737-sec-0032"> <h4 class="title">Summary of findings table and GRADE</h4> <p>Two overview authors independently assessed the certainty of the body of evidence associated with the following outcomes (<a href="./references#CD013737-bbs2-0075" title='GuyattGH , OxmanAD , KunzR , VistGE , Falck-YtterY , SchünemannHJ . What is "quality of evidence" and why is it important to clinicians?BMJ (Clinical Research ed.)2008;336(7651):995-8. [PMID: 18456631]'>Guyatt 2008</a>). </p> <p> <ul id="CD013737-list-0015"> <li> <p>Number of people requiring allogeneic blood transfusion (ABT)</p> </li> <li> <p>Volume of transfused allogeneic blood</p> </li> <li> <p>Postoperative delirium</p> </li> <li> <p>Adverse events experienced by participants within 30 days of surgery</p> </li> <li> <p>Activities of daily living (ADL) at four months postoperatively</p> </li> <li> <p>Health‐related quality of life (HRQoL) at four months postoperatively</p> </li> <li> <p>All‐cause mortality at one month postoperatively</p> </li> </ul> </p> <p>If data were only available at later time points, we planned to assess the certainty of the evidence for ADL, HRQoL, and all‐cause mortality at available time points, up to one year postoperatively. For adverse events, we reported absolute effects for the type of adverse event that included the most participants. We used the comments section of the summary of findings table to report the effect estimates of other adverse events. </p> <p>The GRADE approach appraises the certainty of a body of evidence based on the extent to which we can be confident that an estimate of effect or association reflects the item being assessed. Evaluation of the certainty of a body of evidence considers risk of bias, directness of the evidence, heterogeneity of the data, precision of the effect estimates, and risk of publication bias. </p> <p>Because we identified overlapping reviews, we only reported data from prioritised reviews in the summary of findings table. We used more than one review to report data for as many of our selected outcomes as possible. Our prioritised reviews did not report summary of findings tables or conduct their own GRADE assessments, therefore, we made GRADE judgements based on the information reported in these reviews. We were also guided by the checklist in <a href="./references#CD013737-bbs2-0107" title="MeaderN , KingK , LlewellynA , NormanG , BrownJ , RodgersM , et al. A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation. Systematic Reviews2014;3:82. [PMID: 25056145]">Meader 2014</a> when assessing GRADE in published reviews. We used risk of bias tables reported in the review, as well as the results of any reported sensitivity analyses, when considering limitations owing to risk of bias. For directness of the evidence, we considered whether to downgrade the certainty of the evidence for indirectness if reviews included studies with a mixed surgical population (such as participants having other types of orthopaedic surgery). </p> <p>The GRADE system rates the certainty of the evidence according to the following categories.</p> <p> <ul id="CD013737-list-0016"> <li> <p>High ‐ further research is very unlikely to change confidence in the estimate of effect</p> </li> <li> <p>Moderate ‐ further research is likely to have an important impact on the confidence in the estimate of effect, and may change the estimate </p> </li> <li> <p>Low ‐ further research is very likely to have an important impact on confidence in the estimate of effect, and is likely to change the estimate </p> </li> <li> <p>Very low ‐ any estimate of effect is very uncertain</p> </li> </ul> </p> <p>We constructed summary of findings tables using the GRADE GDT software (<a href="https://gradepro.org/" target="_blank">GRADEpro GDT</a>). Because reviews were unavailable for non‐pharmacological interventions, we constructed tables only for the following comparison. </p> <p> <ul id="CD013737-list-0017"> <li> <p>Pharmacological interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery </p> </li> </ul> </p> <p>Rather than separately presenting the data within the same summary of findings table for each group of interventions (e.g. agents with the same mode of action such as antifibrinolytics), we constructed separate summary of findings table for each group of pharmacological interventions. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013737-sec-0033" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013737-sec-0033"></div> <p>For this overview of reviews, we searched for Cochrane and non‐Cochrane systematic reviews of randomised controlled trials (RCTs) of interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery. In total, we identified 8109 records from the following databases: Cochrane Database of Systematic Reviews (172), MEDLINE (1372), PubMed (94), Embase (2263), Epistemonikos (1652), PROSPERO (1114), Transfusion Evidence Library (20), and the Web of Science (1422). After removing 2575 duplicates, we screened 5534 titles and abstracts. We excluded 5483 records at this stage, and screened 51 full texts against our inclusion and exclusion criteria (see <a href="#CD013737-sec-0015">Criteria for considering reviews for inclusion</a>). We excluded 19 records that did not meet the inclusion criteria following closer inspection; we summarise these 19 reviews, with reasons for their exclusion, in <a href="./appendices#CD013737-sec-0086">Appendix 3</a>. The selection process is shown in <a href="./full#CD013737-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD013737-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="original image" data-id="CD013737-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/image_n/nCD013737-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> <p>During the search process, we contacted 10 review authors identified in PROSPERO to ask if their reviews were completed. We received replies from six review authors (<a href="./references#CD013737-bbs2-0001" title="AgiusC , ColeE , MifsudMG , VasireddyA . The use of tranexamic acid (TXA) in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Trauma2022;36(12):e442-8. [DOI: 10.1097/BOT.0000000000002440]">Agius 2022</a>; <a href="./references#CD013737-bbs2-0029" title="CharityJ , FergusonB , CoonJT , RogersM , UkoumunneO , WhitehouseS , et al. The use of intravenous tranexamic acid in hip fracture surgery. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420150245192015.">Charity 2015</a>; <a href="./references#CD013737-bbs2-0030" title="ChawlaA , DickensonE , GriffinD . Cell salvage and auto-transfusion in patients undergoing surgical treatment for fractured neck of femur: a systematic review. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420180766412018. [CRD: 42018076641]">Chawla 2018</a>; <a href="./references#CD013737-bbs2-0071" title="GibbsV , ChampaneriaR , NovakA , DoreeC , PalmerA , EstcourtL . Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation of hip, pelvic and long bone fractures: a systematic review and network meta-analysis. www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020169402 (first received 14 February 2020).">Gibbs 2020</a>; <a href="./references#CD013737-bbs2-0108" title="MiangulS , OluwaremiT , El HaddadJ , PinnawalaN , NakanishiH , MatarR , et al. Update on the efficacy and safety of intravenous tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021289850 (first received 7 December 2021).">Miangul 2021</a>; <a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a>); of these, two were able to supply either published or unpublished review information that we could use in the overview (<a href="./references#CD013737-bbs2-0001" title="AgiusC , ColeE , MifsudMG , VasireddyA . The use of tranexamic acid (TXA) in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Trauma2022;36(12):e442-8. [DOI: 10.1097/BOT.0000000000002440]">Agius 2022</a>; <a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a>). We received no reply from four review authors. </p> <section id="CD013737-sec-0034"> <h3 class="title" id="CD013737-sec-0034">Description of included reviews</h3> <p>Overall, we found 26 systematic reviews. Three ongoing reviews are described in <a href="./appendices#CD013737-sec-0087">Appendix 4</a>, and three reviews awaiting classification are described in <a href="./appendices#CD013737-sec-0088">Appendix 5</a>. We found no reviews for non‐pharmacological interventions, and only two types of pharmacological interventions (tranexamic acid and iron). Here, we summarise the characteristics of reviews for these different intervention types. </p> <section id="CD013737-sec-0035"> <h4 class="title">Tranexamic acid</h4> <p>We included 17 reviews of tranexamic acid (<a href="./references#CD013737-bbs2-0001" title="AgiusC , ColeE , MifsudMG , VasireddyA . The use of tranexamic acid (TXA) in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Trauma2022;36(12):e442-8. [DOI: 10.1097/BOT.0000000000002440]">Agius 2022</a>; <a href="./references#CD013737-bbs2-0002" title="BaskaranD , RahmanS , SalmasiY , FroghiS , BerberO , GeorgeM . Effect of tranexamic acid use on blood loss and thromboembolic risk in hip fracture surgery: systematic review and meta-analysis. Hip International2018;28(1):3-10.">Baskaran 2018</a>; <a href="./references#CD013737-bbs2-0004" title="FarrowLS , SmithTO , AshcroftGP , MyintPK . A systematic review of tranexamic acid in hip fracture surgery. British Journal of Clinical Pharmacology2016;82:1458-70.">Farrow 2016</a>; <a href="./references#CD013737-bbs2-0006" title="Haj-YounesB , SivakumarBS , WangM , AnVV , LorentzosP , AdieS . Tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Surgery2020;28(1):1-6.">Haj‐Younes 2020</a>; <a href="./references#CD013737-bbs2-0007" title="JiangW , ShangL . Tranexamic acid can reduce blood loss in patients undergoing intertrochanteric fracture surgery: a meta-analysis. Medicine (Baltimore)2019;98(11):e14564.">Jiang 2019</a>; <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>; <a href="./references#CD013737-bbs2-0010" title="LuoX , HuangH , TangX . Efficacy and safety of tranexamic acid for reducing blood loss in elderly patients with intertrochanteric fracture treated with intramedullary fixation surgery: a meta-analysis of randomized controlled trials. Acta Orthopaedica et Traumatologica Turcica2020;54(1):4-14.">Luo 2020</a>; <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>; <a href="./references#CD013737-bbs2-0012" title="QiYM , WangHP , LiYJ , MaBB , XieT , WangC , et al. The efficacy and safety of intravenous tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Translation2019;19:1-11.">Qi 2019</a>; <a href="./references#CD013737-bbs2-0018" title="WangW , YuJ . Tranexamic acid reduces blood loss in intertrochanteric fractures: a meta-analysis from randomized controlled trials. Medicine (Baltimore)2017;96(52):e9396.">Wang 2017a</a>; <a href="./references#CD013737-bbs2-0019" title="XiaoC , ZhangS , LongN , YuW , JiangY . Is intravenous tranexamic acid effective and safe during hip fracture surgery? An updated meta-analysis of randomized controlled trials. Archives of Orthopaedic and Trauma Surgery2019;139:893-902.">Xiao 2019</a>; <a href="./references#CD013737-bbs2-0020" title="XingF , ChenW , LongC , HuangFG , WangGL , XiangZ . Postoperative outcomes of tranexamic acid use in geriatric trauma patients treated with proximal femoral intramedullary nails: a systematic review and meta-analysis. Orthopaedics &amp; Traumatology: Surgery &amp; Research2020;106(1):117-26.">Xing 2020</a>; <a href="./references#CD013737-bbs2-0022" title="YuXB , WangJW , WangXY , XieLZ , ChenCH , ZhengWH . The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials. Journal of Thrombosis and Thrombolysis2020;50(2):243-57.">Yu 2020</a>; <a href="./references#CD013737-bbs2-0023" title="ZhangP , HeJS , FangYC , ChenPT , LiangY , WangJC . Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis. A meta-analysis. Medicine2017;96(21):1-8.">Zhang 2017</a>; <a href="./references#CD013737-bbs2-0024" title="ZhangP , BaiJ , HeJ , LiangY , ChenP , WangJ . A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery. Clinical Interventions in Aging2018;13:1579-91.">Zhang 2018</a>; <a href="./references#CD013737-bbs2-0025" title="ZhouXD , LiJ , FanGM , HuangY , XuNW . Efficacy and safety of tranexamic acid in elderly patients with intertrochanteric fracture: an updated meta-analysis. World Journal of Clinical Cases2019;7(11):1302-14.">Zhou 2019a</a>; <a href="./references#CD013737-bbs2-0026" title="ZhuQ , YuC , ChenX , XuX , ChenY , LiuC , et al. Efficacy and safety of tranexamic acid for blood salvage in intertrochanteric fracture surgery: a meta-analysis. Clinical and Applied Thrombosis/Hemostasis2018;24(8):1189-98.">Zhu 2018</a>). The earliest search was conducted in June 2016 (<a href="./references#CD013737-bbs2-0004" title="FarrowLS , SmithTO , AshcroftGP , MyintPK . A systematic review of tranexamic acid in hip fracture surgery. British Journal of Clinical Pharmacology2016;82:1458-70.">Farrow 2016</a>); the latest in February 2021 (<a href="./references#CD013737-bbs2-0001" title="AgiusC , ColeE , MifsudMG , VasireddyA . The use of tranexamic acid (TXA) in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Trauma2022;36(12):e442-8. [DOI: 10.1097/BOT.0000000000002440]">Agius 2022</a>; <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>; <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>). Characteristics of these reviews are summarised in <a href="#CD013737-tbl-0001">Table 1</a>; more detailed information is in <a href="./appendices#CD013737-sec-0089">Appendix 6</a>. </p> <div class="table" id="CD013737-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of systematic review characteristics evaluating tranexamic acid</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Review</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Date of search</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study designs</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number of RCTs (participants)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participants</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention/</b> </p> <p><b>comparison</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Relevant outcomes</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk of bias assessment</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Certainty of evidence assessment</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0001" title="AgiusC , ColeE , MifsudMG , VasireddyA . The use of tranexamic acid (TXA) in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Trauma2022;36(12):e442-8. [DOI: 10.1097/BOT.0000000000002440]">Agius 2022</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>February 2021</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13 (1194)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip fracture surgery (type of fracture specified)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV TXA/ control (placebo or no treatment)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (thomboembolic events)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane risk of bias tool (<a href="./references#CD013737-bbs2-0148" title="SterneJA , SavovićJ , PageMJ , ElbersRG , BlencoweNS , BoutronI , et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ (Clinical Research ed.)2019;366:14898.">Sterne 2019</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GRADE</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0002" title="BaskaranD , RahmanS , SalmasiY , FroghiS , BerberO , GeorgeM . Effect of tranexamic acid use on blood loss and thromboembolic risk in hip fracture surgery: systematic review and meta-analysis. Hip International2018;28(1):3-10.">Baskaran 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>July 2016</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> <p>NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 (479)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip fracture surgery (any type)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV TXA/ control (placebo or no treatment)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (thomboembolic events)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0004" title="FarrowLS , SmithTO , AshcroftGP , MyintPK . A systematic review of tranexamic acid in hip fracture surgery. British Journal of Clinical Pharmacology2016;82:1458-70.">Farrow 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>June 2016</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> <p>NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 (499)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip fracture surgery (any type)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV and topical TXA/ control (type not specified)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (thomboembolic events, CVA, PE, DVT); mortality</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GRADE</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0006" title="Haj-YounesB , SivakumarBS , WangM , AnVV , LorentzosP , AdieS . Tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Surgery2020;28(1):1-6.">Haj‐Younes 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>March 2019</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 (842)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip/proximal femoral fractures (AO types 31‐A and 31‐B)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV TXA/ placebo or no control</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (DVT, PE, acute coronary syndrome, CVA, wound complications)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane risk of bias tool<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0007" title="JiangW , ShangL . Tranexamic acid can reduce blood loss in patients undergoing intertrochanteric fracture surgery: a meta-analysis. Medicine (Baltimore)2019;98(11):e14564.">Jiang 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>October 2017</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (584)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intertrochanteric hip fractures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV and topical TXA/ placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (DVT, PE, infection, haematoma)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>February 2021</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> <p>NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 (2340)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip fractures (type not specified)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV, topical, or combined IV and topical TXA/ placebo or no treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (DVT, PE, MI, CVA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0010" title="LuoX , HuangH , TangX . Efficacy and safety of tranexamic acid for reducing blood loss in elderly patients with intertrochanteric fracture treated with intramedullary fixation surgery: a meta-analysis of randomized controlled trials. Acta Orthopaedica et Traumatologica Turcica2020;54(1):4-14.">Luo 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>December 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (552)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intertrochanteric fractures treated with intramedullary fixation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV and topical TXA/ placebo or no treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (number of people, and volume); adverse events (thrombotic events); mortality </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane risk of bias tool<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>February 2021</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 (1123)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intra‐or extracapsular hip fractures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV TXA/ placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (number of people, and volume); adverse events (thrombotic events)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane risk of bias tool<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0012" title="QiYM , WangHP , LiYJ , MaBB , XieT , WangC , et al. The efficacy and safety of intravenous tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Translation2019;19:1-11.">Qi 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>March 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 (854)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip fracture</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV TXA/ placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (thromboembolic events)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane risk of bias tool (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0018" title="WangW , YuJ . Tranexamic acid reduces blood loss in intertrochanteric fractures: a meta-analysis from randomized controlled trials. Medicine (Baltimore)2017;96(52):e9396.">Wang 2017a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>September 2017</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (514)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intertrochanteric fractures with internal fixation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV and topical TXA/ placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; Adaerse events (DVT, PE, infection)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GRADE</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0019" title="XiaoC , ZhangS , LongN , YuW , JiangY . Is intravenous tranexamic acid effective and safe during hip fracture surgery? An updated meta-analysis of randomized controlled trials. Archives of Orthopaedic and Trauma Surgery2019;139:893-902.">Xiao 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>May 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 (892)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip fractures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV TXA/ control (placebo, saline, or no treatment)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (DVT, total thromboembolic events)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane risk of bias tool and Jadad<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0020" title="XingF , ChenW , LongC , HuangFG , WangGL , XiangZ . Postoperative outcomes of tranexamic acid use in geriatric trauma patients treated with proximal femoral intramedullary nails: a systematic review and meta-analysis. Orthopaedics &amp; Traumatology: Surgery &amp; Research2020;106(1):117-26.">Xing 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>April 2019</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (539)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intertrochanteric fractures with intramedullary nailing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV and topical TXA/ control (placebo, saline, or no treatment)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (DVT, PE, haematoma, wound infection, respiratory infection, renal failure, CVA); mortality </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0022" title="YuXB , WangJW , WangXY , XieLZ , ChenCH , ZhengWH . The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials. Journal of Thrombosis and Thrombolysis2020;50(2):243-57.">Yu 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>October 2019</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 (1202)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intertrochanteric fractures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV and topical TXA/ control (placebo, saline, or no treatment)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (DVT, PE, CVA, MI, wound complications); mortality</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0023" title="ZhangP , HeJS , FangYC , ChenPT , LiangY , WangJC . Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis. A meta-analysis. Medicine2017;96(21):1-8.">Zhang 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>December 2016</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 (598)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip fracture</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV TXA/ control (placebo or saline)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (thromboembolic events)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12‐item tool (<a href="./references#CD013737-bbs2-0070" title="FurlanAD , PennickV , BombardierC , vanTulderM , Editorial Board Cochrane Back Group. Updated method guideline for systematic reviews in the Cochrane Back Group. Spine2009;34:1929-41. [PMID: 19680101]">Furlan 2009</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GRADE</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0024" title="ZhangP , BaiJ , HeJ , LiangY , ChenP , WangJ . A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery. Clinical Interventions in Aging2018;13:1579-91.">Zhang 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> <p>NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 (1129)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip fracture</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV and topical TXA/ control (placebo or saline)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (thromboembolic events); mortality (3 months)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12‐item tool (<a href="./references#CD013737-bbs2-0070" title="FurlanAD , PennickV , BombardierC , vanTulderM , Editorial Board Cochrane Back Group. Updated method guideline for systematic reviews in the Cochrane Back Group. Spine2009;34:1929-41. [PMID: 19680101]">Furlan 2009</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0025" title="ZhouXD , LiJ , FanGM , HuangY , XuNW . Efficacy and safety of tranexamic acid in elderly patients with intertrochanteric fracture: an updated meta-analysis. World Journal of Clinical Cases2019;7(11):1302-14.">Zhou 2019a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>October 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 (836)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intertrochanteric fractures with internal fixation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV and topical TXA/ control (placebo, saline, or no treatment)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (DVT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GRADE</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0026" title="ZhuQ , YuC , ChenX , XuX , ChenY , LiuC , et al. Efficacy and safety of tranexamic acid for blood salvage in intertrochanteric fracture surgery: a meta-analysis. Clinical and Applied Thrombosis/Hemostasis2018;24(8):1189-98.">Zhu 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>February 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 (746)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intertrochanteric fractures with internal fixation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV and topical TXA/ control (placebo, saline, or no treatment)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (DVT, PE)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane risk of bias tool<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GRADE</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>review reported no citation for the Cochrane risk of bias tool and we could not be certain which version of the tool was used in the review </p> <p>CVA: cerebrovascular accident; DVT: deep vein thrombosis; IV: intravenous(ly); MI: myocardial infarction; NRS: non‐randomised study; RCT: randomised controlled trial; PE: pulmonary embolism; TXA: tranexamic acid </p> </div> </div> <p>Most reviews included only RCTs; those that included a mix of study types reported data separately for RCTs. All reviews included people undergoing surgery for hip fracture. Taking into account the overlap between reviews, 2642 participants with hip fracture were randomised to the included RCTs in these reviews. Whilst some reviews specified the inclusion of participants over a certain age (&gt; 60 years of age in <a href="./references#CD013737-bbs2-0010" title="LuoX , HuangH , TangX . Efficacy and safety of tranexamic acid for reducing blood loss in elderly patients with intertrochanteric fracture treated with intramedullary fixation surgery: a meta-analysis of randomized controlled trials. Acta Orthopaedica et Traumatologica Turcica2020;54(1):4-14.">Luo 2020</a> and <a href="./references#CD013737-bbs2-0020" title="XingF , ChenW , LongC , HuangFG , WangGL , XiangZ . Postoperative outcomes of tranexamic acid use in geriatric trauma patients treated with proximal femoral intramedullary nails: a systematic review and meta-analysis. Orthopaedics &amp; Traumatology: Surgery &amp; Research2020;106(1):117-26.">Xing 2020</a>; &gt; 70 years of age in <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>), this was not usually specified; no studies included only 'frail elderly'. In addition, no studies specified the inclusion of a subset of participants according to baseline comorbidities or risk of bleeding, and no reviews reported this level of detail in their characteristics tables of included studies. </p> <p>Whilst most reviews did not limit the types of surgical treatment, five of the reviews included only studies of trochanteric fractures with internal fixation (<a href="./references#CD013737-bbs2-0010" title="LuoX , HuangH , TangX . Efficacy and safety of tranexamic acid for reducing blood loss in elderly patients with intertrochanteric fracture treated with intramedullary fixation surgery: a meta-analysis of randomized controlled trials. Acta Orthopaedica et Traumatologica Turcica2020;54(1):4-14.">Luo 2020</a>; <a href="./references#CD013737-bbs2-0018" title="WangW , YuJ . Tranexamic acid reduces blood loss in intertrochanteric fractures: a meta-analysis from randomized controlled trials. Medicine (Baltimore)2017;96(52):e9396.">Wang 2017a</a>; <a href="./references#CD013737-bbs2-0020" title="XingF , ChenW , LongC , HuangFG , WangGL , XiangZ . Postoperative outcomes of tranexamic acid use in geriatric trauma patients treated with proximal femoral intramedullary nails: a systematic review and meta-analysis. Orthopaedics &amp; Traumatology: Surgery &amp; Research2020;106(1):117-26.">Xing 2020</a>; <a href="./references#CD013737-bbs2-0025" title="ZhouXD , LiJ , FanGM , HuangY , XuNW . Efficacy and safety of tranexamic acid in elderly patients with intertrochanteric fracture: an updated meta-analysis. World Journal of Clinical Cases2019;7(11):1302-14.">Zhou 2019a</a>; <a href="./references#CD013737-bbs2-0026" title="ZhuQ , YuC , ChenX , XuX , ChenY , LiuC , et al. Efficacy and safety of tranexamic acid for blood salvage in intertrochanteric fracture surgery: a meta-analysis. Clinical and Applied Thrombosis/Hemostasis2018;24(8):1189-98.">Zhu 2018</a>). </p> <p>In seven reviews, tranexamic acid was only administered intravenously (<a href="./references#CD013737-bbs2-0001" title="AgiusC , ColeE , MifsudMG , VasireddyA . The use of tranexamic acid (TXA) in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Trauma2022;36(12):e442-8. [DOI: 10.1097/BOT.0000000000002440]">Agius 2022</a>; <a href="./references#CD013737-bbs2-0002" title="BaskaranD , RahmanS , SalmasiY , FroghiS , BerberO , GeorgeM . Effect of tranexamic acid use on blood loss and thromboembolic risk in hip fracture surgery: systematic review and meta-analysis. Hip International2018;28(1):3-10.">Baskaran 2018</a>; <a href="./references#CD013737-bbs2-0006" title="Haj-YounesB , SivakumarBS , WangM , AnVV , LorentzosP , AdieS . Tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Surgery2020;28(1):1-6.">Haj‐Younes 2020</a>; <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>; <a href="./references#CD013737-bbs2-0012" title="QiYM , WangHP , LiYJ , MaBB , XieT , WangC , et al. The efficacy and safety of intravenous tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Translation2019;19:1-11.">Qi 2019</a>; <a href="./references#CD013737-bbs2-0019" title="XiaoC , ZhangS , LongN , YuW , JiangY . Is intravenous tranexamic acid effective and safe during hip fracture surgery? An updated meta-analysis of randomized controlled trials. Archives of Orthopaedic and Trauma Surgery2019;139:893-902.">Xiao 2019</a>; <a href="./references#CD013737-bbs2-0023" title="ZhangP , HeJS , FangYC , ChenPT , LiangY , WangJC . Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis. A meta-analysis. Medicine2017;96(21):1-8.">Zhang 2017</a>). The remaining reviews included a mix of intravenous and topical administration, or a combination of both types of administration. No reviews included a specific dose or formulation. From summary information of study characteristics, all reviews included studies in which administration of tranexamic acid was before, during, or after surgery, or a combination of these time points. </p> <p>All reviews reported outcome data for the number of people who had an allogeneic blood transfusion (ABT) and adverse events. In addition, two reviews reported the volume of transfused blood (<a href="./references#CD013737-bbs2-0010" title="LuoX , HuangH , TangX . Efficacy and safety of tranexamic acid for reducing blood loss in elderly patients with intertrochanteric fracture treated with intramedullary fixation surgery: a meta-analysis of randomized controlled trials. Acta Orthopaedica et Traumatologica Turcica2020;54(1):4-14.">Luo 2020</a>; <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>). Types of adverse events varied between studies, but overall, included thromboembolic events, deep vein thrombosis (DVT), pulmonary embolism, cerebrovascular accident, acute coronary syndrome, myocardial infarction, renal failure, wound complications, haematoma, and infection. Three reviews also reported mortality (<a href="./references#CD013737-bbs2-0020" title="XingF , ChenW , LongC , HuangFG , WangGL , XiangZ . Postoperative outcomes of tranexamic acid use in geriatric trauma patients treated with proximal femoral intramedullary nails: a systematic review and meta-analysis. Orthopaedics &amp; Traumatology: Surgery &amp; Research2020;106(1):117-26.">Xing 2020</a>; <a href="./references#CD013737-bbs2-0022" title="YuXB , WangJW , WangXY , XieLZ , ChenCH , ZhengWH . The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials. Journal of Thrombosis and Thrombolysis2020;50(2):243-57.">Yu 2020</a>; <a href="./references#CD013737-bbs2-0024" title="ZhangP , BaiJ , HeJ , LiangY , ChenP , WangJ . A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery. Clinical Interventions in Aging2018;13:1579-91.">Zhang 2018</a>). No reviews of tranexamic acid reported postoperative delirium, postoperative cognitive dysfunction, activities of daily living, or health‐related quality of life. </p> <p>Three reviews reported funding from a source that we deemed to be independent, such as a government research body (<a href="./references#CD013737-bbs2-0012" title="QiYM , WangHP , LiYJ , MaBB , XieT , WangC , et al. The efficacy and safety of intravenous tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Translation2019;19:1-11.">Qi 2019</a>; <a href="./references#CD013737-bbs2-0020" title="XingF , ChenW , LongC , HuangFG , WangGL , XiangZ . Postoperative outcomes of tranexamic acid use in geriatric trauma patients treated with proximal femoral intramedullary nails: a systematic review and meta-analysis. Orthopaedics &amp; Traumatology: Surgery &amp; Research2020;106(1):117-26.">Xing 2020</a>; <a href="./references#CD013737-bbs2-0025" title="ZhouXD , LiJ , FanGM , HuangY , XuNW . Efficacy and safety of tranexamic acid in elderly patients with intertrochanteric fracture: an updated meta-analysis. World Journal of Clinical Cases2019;7(11):1302-14.">Zhou 2019a</a>); four reviews did not specify the source of research funding (<a href="./references#CD013737-bbs2-0007" title="JiangW , ShangL . Tranexamic acid can reduce blood loss in patients undergoing intertrochanteric fracture surgery: a meta-analysis. Medicine (Baltimore)2019;98(11):e14564.">Jiang 2019</a>; <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>; <a href="./references#CD013737-bbs2-0023" title="ZhangP , HeJS , FangYC , ChenPT , LiangY , WangJC . Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis. A meta-analysis. Medicine2017;96(21):1-8.">Zhang 2017</a>; <a href="./references#CD013737-bbs2-0024" title="ZhangP , BaiJ , HeJ , LiangY , ChenP , WangJ . A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery. Clinical Interventions in Aging2018;13:1579-91.">Zhang 2018</a>). The remaining studies reported that they received no funding. Most review authors declared that they had no conflicts of interest; only one study did not specify this information (<a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>). For specific declared conflicts of interest in <a href="./references#CD013737-bbs2-0039" title="PerelP , KerK , Morales UribeCH , RobertsI . Tranexamic acid for reducing mortality in emergency and urgent surgery. Cochrane Database of Systematic Reviews2013, Issue 1. Art. No: CD010245. [DOI: 10.1002/14651858.CD010245.pub2]">Perel 2013</a>, see information in <a href="./appendices#CD013737-sec-0089">Appendix 6</a>. </p> <p>Overall, this set of reviews included 29 RCTs. We found that the measure of study overlap was very high, and we used methods described by <a href="./references#CD013737-bbs2-0127" title="PieperD , AntoineS , MathesT , NeugebauerE , EikermannM . Systematic review finds overlapping reviews were not mentioned in every other overview. Journal of Clinical Epidemiology2014;67:7. [PMID: 24581293]">Pieper 2014</a> to formally calculate the level of overlap (overlap = 65.5%; covered area (CA) = 31.2%; corrected covered area (CCA) = 26.9%); see <a href="#CD013737-tbl-0002">Table 2</a>. Therefore, we used a hierarchical approach to decide from which review to report effect estimates. As the only Cochrane Review in this set of reviews was published in 2013, we instead prioritised by the publication that had the most recent search. Therefore, we prioritised the data from <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>. However, as <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>, did not report outcome data for all outcomes, we considered other reviews, again prioritising by date of search. Therefore, we also prioritised data from <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a> in order to report data for volume of transfused blood, which was not reported in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>. <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a> included 24 RCTs with broad inclusion criteria. Participants in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a> had internal fixation or arthroplasty for different types of hip fracture. Tranexamic acid was given either intravenously or by topical administration; it was given preoperatively, and sometimes also intraoperatively and postoperatively. No studies included intramuscular administration. In 20 of the studies included in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>, participants received DVT prophylaxis, and participants in most studies were screened for DVT, using ultrasound. <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a> included 10 RCTs, again with broad inclusion criteria, which did not specify type of surgery or fracture type. Study characteristics for these two reviews are summarised in <a href="#CD013737-tbl-0003">Table 3</a> and <a href="./appendices#CD013737-sec-0089">Appendix 6</a>. </p> <div class="table" id="CD013737-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Overlapping studies in systematic reviews evaluating tranexamic acid</span></div> <tbody> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign="bottom"></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0001" title="AgiusC , ColeE , MifsudMG , VasireddyA . The use of tranexamic acid (TXA) in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Trauma2022;36(12):e442-8. [DOI: 10.1097/BOT.0000000000002440]"><b>Agius 2022</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89."><b>Liu 2022</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300."><b>Masouros 2022</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0006" title="Haj-YounesB , SivakumarBS , WangM , AnVV , LorentzosP , AdieS . Tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Surgery2020;28(1):1-6."><b>Haj‐Younes 2020</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0022" title="YuXB , WangJW , WangXY , XieLZ , ChenCH , ZhengWH . The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials. Journal of Thrombosis and Thrombolysis2020;50(2):243-57."><b>Yu 2020</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0020" title="XingF , ChenW , LongC , HuangFG , WangGL , XiangZ . Postoperative outcomes of tranexamic acid use in geriatric trauma patients treated with proximal femoral intramedullary nails: a systematic review and meta-analysis. Orthopaedics &amp; Traumatology: Surgery &amp; Research2020;106(1):117-26."><b>Xing 2020</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0010" title="LuoX , HuangH , TangX . Efficacy and safety of tranexamic acid for reducing blood loss in elderly patients with intertrochanteric fracture treated with intramedullary fixation surgery: a meta-analysis of randomized controlled trials. Acta Orthopaedica et Traumatologica Turcica2020;54(1):4-14."><b>Luo 2020</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0007" title="JiangW , ShangL . Tranexamic acid can reduce blood loss in patients undergoing intertrochanteric fracture surgery: a meta-analysis. Medicine (Baltimore)2019;98(11):e14564."><b>Jiang 2019</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0025" title="ZhouXD , LiJ , FanGM , HuangY , XuNW . Efficacy and safety of tranexamic acid in elderly patients with intertrochanteric fracture: an updated meta-analysis. World Journal of Clinical Cases2019;7(11):1302-14."><b>Zhou 2019a</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0019" title="XiaoC , ZhangS , LongN , YuW , JiangY . Is intravenous tranexamic acid effective and safe during hip fracture surgery? An updated meta-analysis of randomized controlled trials. Archives of Orthopaedic and Trauma Surgery2019;139:893-902."><b>Xiao 2019</b> </a><a href="./references#CD013737-bbs2-0019" title="XiaoC , ZhangS , LongN , YuW , JiangY . Is intravenous tranexamic acid effective and safe during hip fracture surgery? An updated meta-analysis of randomized controlled trials. Archives of Orthopaedic and Trauma Surgery2019;139:893-902."><b>Xiao 2019</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0012" title="QiYM , WangHP , LiYJ , MaBB , XieT , WangC , et al. The efficacy and safety of intravenous tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Translation2019;19:1-11."><b>Qi 2019</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0026" title="ZhuQ , YuC , ChenX , XuX , ChenY , LiuC , et al. Efficacy and safety of tranexamic acid for blood salvage in intertrochanteric fracture surgery: a meta-analysis. Clinical and Applied Thrombosis/Hemostasis2018;24(8):1189-98."><b>Zhu 2018</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0024" title="ZhangP , BaiJ , HeJ , LiangY , ChenP , WangJ . A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery. Clinical Interventions in Aging2018;13:1579-91."><b>Zhang 2018</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0018" title="WangW , YuJ . Tranexamic acid reduces blood loss in intertrochanteric fractures: a meta-analysis from randomized controlled trials. Medicine (Baltimore)2017;96(52):e9396."><b>Wang 2017a</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0023" title="ZhangP , HeJS , FangYC , ChenPT , LiangY , WangJC . Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis. A meta-analysis. Medicine2017;96(21):1-8."><b>Zhang 2017</b> </a> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0002" title="BaskaranD , RahmanS , SalmasiY , FroghiS , BerberO , GeorgeM . Effect of tranexamic acid use on blood loss and thromboembolic risk in hip fracture surgery: systematic review and meta-analysis. Hip International2018;28(1):3-10."><b>Baskaran 2018</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0004" title="FarrowLS , SmithTO , AshcroftGP , MyintPK . A systematic review of tranexamic acid in hip fracture surgery. British Journal of Clinical Pharmacology2016;82:1458-70."><b>Farrow 2016</b> </a> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0046" title="AhmedM , KumarM . Reduction in blood loss with tranexamic acid in dynamic hip screw surgery for intertrochanteric hip fractures. Rawal Medical Journal2020;201(44):79-82.">Ahmed 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0049" title="BaruahRK , BorahPJ , HaqueR . Use of tranexamic acid in dynamic hip screw plate fixation for trochanteric fractures. Journal of Orthopaedic Surgery2016;24(3):379-82.">Baruah 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0056" title="ChenF , JiangZ , LiM , ZhuX . Efficacy and safety of perioperative tranexamic acid in elderly patients undergoing trochanteric fracture surgery: a randomised controlled trial. Hong Kong Medical Journal2019;25(2):120-6.">Chen 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0064" title="DrakosA , RaoulisV , KaratziosK , DoxariotisN , KontogeorgakosV , MalizosK , et al. Efficacy of local administration of tranexamic acid for blood salvage in patients undergoing intertrochanteric fracture surgery. Journal of Orthopaedic Trauma2016;30(8):409-14.">Drakos 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0065" title="EmaraWM , MoezKK , ElkhoulyAH . Topical versus intravenous tranexamic acid as a blood conservation intervention for reduction of post-operative bleeding in hemiarthroplasty. Anesthesia, Essays and Researches2014;8(1):48-53.">Emara 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0077" title="HaghighiM , EttehadH , Mardani-KiviM , MirbolookA , NabiBN , MoghaddamR , et al. Does tranexamic acid reduce bleeding during femoral fracture operation?Archives of Bone and Joint Surgery2017;5(2):103-8.">Haghighi 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0084" title="JiZW , XiaL , YaoLD , et al. Effect of tranexamic acid on perioperative hidden blood loss in aged patients receiving intramedullary fixation for treatment of intertrochanteric fractures. Chinese Journal of Gerontology2015;7:185.">Ji 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0085" title="JordanM , AguileraX , GonzálezJC , CastillónP , SalomóM , HernándezJA , et al. Prevention of postoperative bleeding in hip fractures treated with prosthetic replacement: efficacy and safety of fibrin sealant and tranexamic acid. A randomised controlled clinical trial (TRANEXFER study). Archives of Orthopaedic and Trauma Surgery2019;139(5):597-604.">Jordan 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0093" title="LeiJ , ZhangB , CongY , ZhuangY , WeiX , FuY , et al. Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial. Journal of Orthopaedic Surgery and Research2017;12(1):124.">Lei 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0101" title="LiGL , WangBP , ZhangB , LuSY . Efficacy and safety of tranexamic acid on perioperative blood loss in artificial femoral head replacement in the elderly. Orthopaedic Journal of China2015;23(24):2230-3.">Li 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0104" title="LuoGG , LinZQ , XieHF , YaoJC , ZhangHZ . Preliminary analysis of the effect of different administration routes of tranexamic acid on blood loss after total hip arthroplasty for female femur neck fractures. China Journal of Orthopaedics and Traumatology2018;31(12):1086-90.">Luo 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0105" title="LuoX , HeS , LinZ , LiZ , HuangC , LiQ . Efficacy and safety of tranexamic acid for controlling bleeding during surgical treatment of intertrochanteric fragility fracture with proximal femoral nail anti-rotation: a randomized controlled trial. Indian Journal of Orthopaedics2019;53(2):263-9.">Luo 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0109" title="MohibY , RashidRH , AliM , ZubairiAJ , UmerM . Does tranexamic acid reduce blood transfusion following surgery for inter-trochanteric fracture? A randomized control trial. Journal of the Pakistan Medical Association2015;65(11 (Suppl 3)):S17-20.">Mohib 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0119" title="NikolaouVS , MasourosP , FlorosT , ChronopoulosE , SkertsouM , BabisGC . Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial. The Bone &amp; Joint Journal2021;103-B:442-8.">Nikolaou 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0137" title="SadeghiM , Mehr-AeinA . Does a single bolus dose of tranexamic acid reduce blood loss and transfusion requirements during hip fracture surgery? A prospective randomized double blind study in 67 patients. Acta Medica Iranica2007;45(6):437-42.">Sadeghi 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0139" title="SchiavoneA , BisacciaM , InkovI , RinonapoliG , ManniM , RolloG , et al. Tranexamic acid in pertrochanteric femoral fracture: is it a safe drug or not?Folia Medica2018;60(1):67-78.">Schiavone 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0143" title="ShiQX , LiangXS , LiK , TangSB , XianC , LinF , et al. Local application of tranexamic acid and absorbable hemostatic gauze for reducing blood loss in PFNA for femoral intertrochanteric fractures in the elderly. Orthopaedic Journal of China2018;26(4):315-9.">Shi 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0150" title="TengbergPT , FossNB , PalmH , KallemoseT , TroelsenA . Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial. The Bone &amp; Joint Journal2016;98(6):747-53.">Tengberg 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0151" title="TianS , ShenZ , LiuY , ZhangY , PengA . The effect of tranexamic acid on hidden bleeding in older intertrochanteric fracture patients treated with PFNA. Injury2018;49(3):680-4.">Tian 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0154" title="VijayBS , BediV , MitraS , DasB . Role of tranexamic acid in reducing postoperative blood loss and transfusion requirement in patients undergoing hip and femoral surgeries. Saudi Journal of Anaesthesia2013;7(1):29-32.">Vijay 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0155" title="ViraniSR , DahaputeAA , PandaI , BavaSS . Role of local infiltration of tranexamic acid in reducing blood loss in peritrochanteric fracture surgery in the elderly population. Malaysian Orthopaedic Journal2016;10:26-30.">Virani 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0159" title="WangH , WangYT , LuZX , LiTF , WangSL , WangYH . Effect of repeated intravenous tranexamic acid in the perioperative period of proximal femoral nail antirotation for femoral intertrochanteric fracture. Chinese Journal of Tissue Engineering Research2021;25(21):3319.">Wang 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0157" title="WangX , ChenY , ChengH . The efficacy and safety of tranexamic acid for blood loss in intertrochanteric fracture surgery. Zhejiang Medical Journal2017;39:(no pagination).">Wang 2017b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0156" title="WangXD , JiangYY , WangJZ , GaoW , LiH , LuJ . Clinical research of tranexamic acid on the hidden blood Ioss after the treatment of intertrochanteric fractures with proximal femoral nail anti-rotation (PFNA). Medical Research and Education2013;30:51-4.">Wang 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0160" title="WattsCD , HoudekMT , SemsSA , CrossWW , PagnanoMW . Tranexamic acid safely reduced blood loss in hemi- and total hip arthroplasty for acute femoral neck fracture: a randomized clinical trial. Journal of Orthopaedic Trauma2017;31(7):345-51.">Watts 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0166" title="ZhangS , XiaoC , YuW , LongN , HeF , CaiP , et al. Tranexamic acid safely reduces hidden blood loss in patients undergoing intertrochanteric fracture surgery: a randomized controlled trial. European Journal of Emergency Surgery2022;48(2):731-41.">Zhang 2022</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0165" title="ZhangQ , XiangC , ChenX , ChenL , ChenQ , JiangK , et al. Application of intravenous injection of tranexamic acid combined with local use of tranexamic acid cocktail in intertrochanteric fracture fixation. Chinese Journal of Reparative and Reconstructive Surgery2020;34(4):463-8.">Zhang 2020b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0167" title="ZhouXD , ZhangY , JiangLF , ZhangJJ , ZhouD , WuLD , et al. Efficacy and safety of tranexamic acid in intertrochanteric fractures: a single-blind randomized controlled trial. Orthopaedic Surgery2019;11(4):635-42.">Zhou 2019b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0168" title="ZuffereyPJ , MiquetM , QuenetS , MartinP , AdamP , AlbaladejoP , et al. Tranexamic acid in hip fracture surgery: a randomized controlled trial. British Journal of Anaesthesia2010;104(1):23-30.">Zufferey 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Systematic reviews are in columns (ordered by date of publication). Included studies in the systematic reviews are in rows (ordered alphabetically). Study overlap = 65.5%; covered area (CA) for overlap = 31.2%; corrected covered area (CCA) for overlap = 26.9% </p> </div> </div> <div class="table" id="CD013737-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Characteristics of RCTs in Liu 2021 and Masouros 2021 (tranexamic acid)</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID<sup>a</sup> </b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>N (TXA; control)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Age (in years), mean (SD) (TXA; contol)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>M/F (TXA; control)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Fracture type</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Surgery</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Route, dose, number of doses (TXA; control)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Timing</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Transfusion crtieria</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0046" title="AhmedM , KumarM . Reduction in blood loss with tranexamic acid in dynamic hip screw surgery for intertrochanteric hip fractures. Rawal Medical Journal2020;201(44):79-82.">Ahmed 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60; 60</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DHS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg;</p> <p>normal saline, given once</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prior to surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0049" title="BaruahRK , BorahPJ , HaqueR . Use of tranexamic acid in dynamic hip screw plate fixation for trochanteric fractures. Journal of Orthopaedic Surgery2016;24(3):379-82.">Baruah 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30; 30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57.7 (± 14.5);</p> <p>55.3 (± 15.2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24/6;</p> <p>25/5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>stable trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ORIF with DHS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg;</p> <p>normal saline, given once</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 min prior to surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 8.5 g/dL or HCT &lt; 27%</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0056" title="ChenF , JiangZ , LiM , ZhuX . Efficacy and safety of perioperative tranexamic acid in elderly patients undergoing trochanteric fracture surgery: a randomised controlled trial. Hong Kong Medical Journal2019;25(2):120-6.">Chen 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88; 88</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76.8 (± 7); 77.4 (± 6.8)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39/49; 37/51</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DHS, PFNA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg in 100 mL of saline, given 3 times;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 min before incision, continuously through surgery, 3 h after surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL; Hb &lt; 10 g/dL at risk</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0064" title="DrakosA , RaoulisV , KaratziosK , DoxariotisN , KontogeorgakosV , MalizosK , et al. Efficacy of local administration of tranexamic acid for blood salvage in patients undergoing intertrochanteric fracture surgery. Journal of Orthopaedic Trauma2016;30(8):409-14.">Drakos 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100; 100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81 (65 to 96);</p> <p>80.7 (65 to 97)<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27/73;</p> <p>21/79</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IMN</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical 3 g, 30 mL (500 mg/5 mL × 6 amps)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At the end of surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 8 g/dL or HCT &lt; 25%, unless at risk</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0065" title="EmaraWM , MoezKK , ElkhoulyAH . Topical versus intravenous tranexamic acid as a blood conservation intervention for reduction of post-operative bleeding in hemiarthroplasty. Anesthesia, Essays and Researches2014;8(1):48-53.">Emara 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: 20; 20; </p> <p><i>control</i>: 20 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: 56.5 (± 2.8); </p> <p><i>TXA</i>: 55 (± 2.6); </p> <p><i>Control</i>: 56 (± 3.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TXA: 12/8;</p> <p>TXA: 10/10;</p> <p>Control: 14/6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>femoral</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: topical 10 mg/kg in 20 mL saline; 5 mg/kg/h in the form of 500 mg TXA in 250 mL at rate of 80 mL/h, given twice; </p> <p>topical 1.5 g in 100 mL saline, given once;</p> <p><i>control</i>: normal saline </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: a bolus dose prior to skin incision; </p> <p><i>Topical</i>: prior to wound closure </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0085" title="JordanM , AguileraX , GonzálezJC , CastillónP , SalomóM , HernándezJA , et al. Prevention of postoperative bleeding in hip fractures treated with prosthetic replacement: efficacy and safety of fibrin sealant and tranexamic acid. A randomised controlled clinical trial (TRANEXFER study). Archives of Orthopaedic and Trauma Surgery2019;139(5):597-604.">Jordan 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51; 50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84.1 (± 6.9);</p> <p>84.6 (± 10.4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9/43;</p> <p>13/37</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>sub‐capital femoral</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>THA or PHA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical 1 g in 10 mL solution, given once;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Applied on soft tissues and exposed surfaces of femur</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL or Hb &lt; 8 g/dL; Hb 9 to 10 g/dL at risk</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0093" title="LeiJ , ZhangB , CongY , ZhuangY , WeiX , FuY , et al. Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial. Journal of Orthopaedic Surgery and Research2017;12(1):124.">Lei 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37; 40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77.8 (± 9.8);</p> <p>79.2 (± 6.5)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5/32;</p> <p>7/33</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PFNA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 1 g in 200 mL saline, given once; normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>After anaesthesia, but before surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 9 g/dL</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0101" title="LiGL , WangBP , ZhangB , LuSY . Efficacy and safety of tranexamic acid on perioperative blood loss in artificial femoral head replacement in the elderly. Orthopaedic Journal of China2015;23(24):2230-3.">Li 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30; 30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77.9 (± 3.9);</p> <p>77.4 (± 3.4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15/15;</p> <p>13/17</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>femoral head</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>THA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 10 mg/kg, given once;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A bolus after anaesthesia, but before surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL; Hb 7 to 10 g/dL at risk</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0104" title="LuoGG , LinZQ , XieHF , YaoJC , ZhangHZ . Preliminary analysis of the effect of different administration routes of tranexamic acid on blood loss after total hip arthroplasty for female femur neck fractures. China Journal of Orthopaedics and Traumatology2018;31(12):1086-90.">Luo 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: 21; </p> <p><i>TXA:</i> 18; </p> <p><i>TXA:</i> 19; <i>contol</i>: 19 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: 77.1 (± 7); </p> <p><i>TXA</i>: 73.8 (± 6.6); </p> <p><i>TXA</i>: 74.2 (± 6); </p> <p><i>Control</i>: 76.7 (± 9.2) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: 0/21; </p> <p><i>TXA</i>: 0/18; </p> <p><i>TXA</i>: 0/19; </p> <p><i>Control:</i> 0/19 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>femoral neck</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>THA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: IV 15 mg/kg, given once; </p> <p><i>TXA:</i> topical 3 g, once; </p> <p><i>TXA:</i> IV + topical 15 mg/kg; 1.5 g, twice; </p> <p><i>control</i>: normal saline </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: 5 min before skin incision; </p> <p><i>TXA:</i> topical: into the joint cavity; </p> <p><i>TXA:</i> IV + topical: 5 min before skin incision, into the joint cavity </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL or HCT &lt; 25%</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0105" title="LuoX , HeS , LinZ , LiZ , HuangC , LiQ . Efficacy and safety of tranexamic acid for controlling bleeding during surgical treatment of intertrochanteric fragility fracture with proximal femoral nail anti-rotation: a randomized controlled trial. Indian Journal of Orthopaedics2019;53(2):263-9.">Luo 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44; 46</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75.1 (± 8);</p> <p>76.1 (± 9.3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23/21;</p> <p>20/26</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PFNA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg, given twice;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 min before incision and 3 h later</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 8 g/dL; Hb &gt; 8 g/dL at risk</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0109" title="MohibY , RashidRH , AliM , ZubairiAJ , UmerM . Does tranexamic acid reduce blood transfusion following surgery for inter-trochanteric fracture? A randomized control trial. Journal of the Pakistan Medical Association2015;65(11 (Suppl 3)):S17-20.">Mohib 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50; 50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69 (± 10);</p> <p>70 (± 9.4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21/29;</p> <p>24/26</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg, given twice;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Just before surgery and 3 h later</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0119" title="NikolaouVS , MasourosP , FlorosT , ChronopoulosE , SkertsouM , BabisGC . Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial. The Bone &amp; Joint Journal2021;103-B:442-8.">Nikolaou 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68; 70</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82.9;</p> <p>83.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10/58;</p> <p>18/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric; femoral neck</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IMN; HA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 mins before surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0137" title="SadeghiM , Mehr-AeinA . Does a single bolus dose of tranexamic acid reduce blood loss and transfusion requirements during hip fracture surgery? A prospective randomized double blind study in 67 patients. Acta Medica Iranica2007;45(6):437-42.">Sadeghi 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32; 35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51.8 (± 25.7);</p> <p>44.4 (± 26.2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17/15;</p> <p>24/11</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>intracapsular; extracapsular</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HA, IMN, DHS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg, given once;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A bolus at induction of anaesthesia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case by case Hb 8 to 10 g/dL</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0139" title="SchiavoneA , BisacciaM , InkovI , RinonapoliG , ManniM , RolloG , et al. Tranexamic acid in pertrochanteric femoral fracture: is it a safe drug or not?Folia Medica2018;60(1):67-78.">Schiavone 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47; 43</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84.3 (± 8.3);</p> <p>84.3 (± 8.3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12/35;</p> <p>15/28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>pertrochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DHS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg, given once;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A bolus at surgical incision</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 8.5 g/dL; Hb &lt; 9 g/dL at risk</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0143" title="ShiQX , LiangXS , LiK , TangSB , XianC , LinF , et al. Local application of tranexamic acid and absorbable hemostatic gauze for reducing blood loss in PFNA for femoral intertrochanteric fractures in the elderly. Orthopaedic Journal of China2018;26(4):315-9.">Shi 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24; 24</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88.1 (± 6.2);</p> <p>89.2 (± 7.1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PFNA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical 2 g in 20 mL saline, given once;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Into the joint cavity</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0150" title="TengbergPT , FossNB , PalmH , KallemoseT , TroelsenA . Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial. The Bone &amp; Joint Journal2016;98(6):747-53.">Tengberg 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33; 39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79.8 (± 11.5);</p> <p>70 (± 12.6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/26;</p> <p>14/25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>intracapsular; extracapsular</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IM</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 1 g; 3 g in 1 L of saline, given twice;</p> <p>placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A bolus during draping, just prior to surgery, and postoperative 24 h infusion</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 9.67 g/dL</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0151" title="TianS , ShenZ , LiuY , ZhangY , PengA . The effect of tranexamic acid on hidden bleeding in older intertrochanteric fracture patients treated with PFNA. Injury2018;49(3):680-4.">Tian 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50; 50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77.7 (± 6.5);</p> <p>79.3 (± 6.6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19/31;</p> <p>14/36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PFNA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 10 mg/kg, given twice;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 min preoperatively and 5 h postoperatively</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 9 g/dL</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0154" title="VijayBS , BediV , MitraS , DasB . Role of tranexamic acid in reducing postoperative blood loss and transfusion requirement in patients undergoing hip and femoral surgeries. Saudi Journal of Anaesthesia2013;7(1):29-32.">Vijay 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45; 45</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48.8 (± 16.2);</p> <p>49.3 (± 19.5)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10/35;</p> <p>10/35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>femoral</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ORIF, HA, THA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 10 mg/kg (500 mg in 50 mL saline; 1 mg/kg/h dissolved in 1 L saline), given twice;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A bolus 15 min before incision, a continuous infusion until the completion of surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reduction of Hb &gt; 25%</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0155" title="ViraniSR , DahaputeAA , PandaI , BavaSS . Role of local infiltration of tranexamic acid in reducing blood loss in peritrochanteric fracture surgery in the elderly population. Malaysian Orthopaedic Journal2016;10:26-30.">Virani 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67; 70</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67;</p> <p>69.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25/42;</p> <p>24/43</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>peritrochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DHS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical 2 g, given once;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In the proximal lateral thigh before closure</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 9 g/dL</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0159" title="WangH , WangYT , LuZX , LiTF , WangSL , WangYH . Effect of repeated intravenous tranexamic acid in the perioperative period of proximal femoral nail antirotation for femoral intertrochanteric fracture. Chinese Journal of Tissue Engineering Research2021;25(21):3319.">Wang 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i> : 33; <i>TXA:</i> 35; </p> <p><i>control</i>: 32 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA:</i> 75.2 (± 9.4); </p> <p><i>TXA</i>: 74.3 (± 7.1); </p> <p><i>control</i>: 72.3 (± 7.7) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: 10/23; </p> <p><i>TXA</i>: 9/26; </p> <p><i>control:</i> 10/22 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PFNA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: IV 1 g, given once; </p> <p><i>TXA</i>: IV 1g, given 3 times; </p> <p><i>control</i>: normal saline </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Half‐hour before operation; before operation; and at 3 and 6 h after operation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL; Hb 7 to 10 g/dL at risk</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0160" title="WattsCD , HoudekMT , SemsSA , CrossWW , PagnanoMW . Tranexamic acid safely reduced blood loss in hemi- and total hip arthroplasty for acute femoral neck fracture: a randomized clinical trial. Journal of Orthopaedic Trauma2017;31(7):345-51.">Watts 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69; 69</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81 (± 10);</p> <p>82.2 (± 10)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21/48;</p> <p>22/47</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>femoral neck</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HA, THA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg in 100 mL of saline, given twice;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Before incision, and at wound closure</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL; Hb &lt; 8 g/dL at risk</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0166" title="ZhangS , XiaoC , YuW , LongN , HeF , CaiP , et al. Tranexamic acid safely reduces hidden blood loss in patients undergoing intertrochanteric fracture surgery: a randomized controlled trial. European Journal of Emergency Surgery2022;48(2):731-41.">Zhang 2022</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61; 61</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79.1 (± 11.9);</p> <p>76.1 (± 16.6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33/28;</p> <p>34/27</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PFNA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 1 g in 100 mL saline, given twice;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 min before incision, and at 3 h later</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL; Hb 7 to 10 g/dL at risk</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0165" title="ZhangQ , XiangC , ChenX , ChenL , ChenQ , JiangK , et al. Application of intravenous injection of tranexamic acid combined with local use of tranexamic acid cocktail in intertrochanteric fracture fixation. Chinese Journal of Reparative and Reconstructive Surgery2020;34(4):463-8.">Zhang 2020b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i> : 15; <i>TXA:</i> 15; <i>control:</i> 15 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA:</i> 71.2 (65 to 89); </p> <p><i>TXA</i>: 71.6 (67 to 84); </p> <p><i>control:</i> 73.1 (65 to 86)<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA:</i> 7/8; </p> <p><i>TXA</i>: 6/9; </p> <p><i>control</i>: 8/7 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PFNA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: IV 1 g in 100 mL saline, given once; </p> <p><i>TXA:</i> IV + topical 1 g in 100 mL saline, 1 g in 50 mL saline, twice; </p> <p><i>control:</i> normal saline </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA:</i> 15 min before incision; </p> <p><i>TXA:</i> 15 min before incision, into the joint cavity </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0167" title="ZhouXD , ZhangY , JiangLF , ZhangJJ , ZhouD , WuLD , et al. Efficacy and safety of tranexamic acid in intertrochanteric fractures: a single-blind randomized controlled trial. Orthopaedic Surgery2019;11(4):635-42.">Zhou 2019b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50; 50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75.1 (± 8.3); 77.8 (± 6.4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15/35;</p> <p>22/28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PFNA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 1 g in 100 mL saline, given once;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 min prior to surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0168" title="ZuffereyPJ , MiquetM , QuenetS , MartinP , AdamP , AlbaladejoP , et al. Tranexamic acid in hip fracture surgery: a randomized controlled trial. British Journal of Anaesthesia2010;104(1):23-30.">Zufferey 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57; 53</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Mean (range)</i>: </p> <p>81 (51 to 99);</p> <p>82 (56 to 95)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10/47;</p> <p>4/49</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>cervical only; stable/unstable trochanteric transtrochanteric, subtrochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>THA, HA, DHS, IMN</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg, given twice;</p> <p>placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Before surgery and 3 h later</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 9 g/dL; Hb &lt; 10 g/dL at risk</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>All information for individual studies is taken from <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>; except for <a href="./references#CD013737-bbs2-0119" title="NikolaouVS , MasourosP , FlorosT , ChronopoulosE , SkertsouM , BabisGC . Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial. The Bone &amp; Joint Journal2021;103-B:442-8.">Nikolaou 2021</a>, which is taken from <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>.<br/><sup>b</sup>Average (mean or median) and distribution type was not specified in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>, or in the original study reports. </p> <p>CHS: cannulated hip screw; DHS: dynamic hip screw; DVT: deep vein thrombosis; h: hours; Hb: haemoglobin; HA: hemiarthroplasty; IMN: intramedullary nail; IV: intravenous(ly); LMWH: low‐molecular‐weight heparin; M/F: male/female; min: minute(s); N: number of participants; NS: not specified; ORIF: open reduction and internal fixation; PFNA: proximal femoral nail antirotation; PHA: partial hip arthroplasty; SD: standard deviation; THA: total hip arthroplasty; TXA: tranexamic acid </p> </div> </div> </section> <section id="CD013737-sec-0036"> <h4 class="title">Iron and erythropoietin (EPO)</h4> <p>We included nine reviews of iron or iron with EPO (<a href="./references#CD013737-bbs2-0003" title="ChenR , LiL , XiangZ , LiH , HouXL . Association of iron supplementation with risk of transfusion, hospital length of stay, and mortality in geriatric patients undergoing hip fracture surgeries: a meta-analysis. European Geriatric Medicine2021;12(1):5-15. [PMID: 32691389]">Chen 2021</a>; <a href="./references#CD013737-bbs2-0005" title="Gomez-RamirezS , Maldonado-RuizMA , Campos-GarriguesA , HerreraA , MunozM . Short-term perioperative iron in major orthopedic surgery: state of the art. Vox Sanguinis2019;114(1):3-16. [PMID: 30411362]">Gomez‐Ramirez 2019</a>; <a href="./references#CD013737-bbs2-0008" title="LinDM , LinES , TranMH . Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfusion Medicine Reviews2013;27(4):221-34. [PMID: 24135037]">Lin 2013</a>; <a href="./references#CD013737-bbs2-0013" title="SchackA , BerkforsAA , EkeloefS , GögenurI , BurcharthJ . The effect of perioperative iron therapy in acute major non-cardiac surgery on allogenic blood transfusion and postoperative haemoglobin levels: a systematic review and meta-analysis. World Journal of Surgery2019;43(7):1677-91. [PMID: 30824959]">Schack 2019</a>; <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a>; <a href="./references#CD013737-bbs2-0015" title="ShinHW , ParkJJ , KimHJ , YouHS , ChoiSU , LeeMJ . Efficacy of perioperative intravenous iron therapy for transfusion in orthopedic surgery: a systematic review and meta-analysis. PLoS One2019;14(5):e0215427. [PMID: 31059515]">Shin 2019</a>; <a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a>; <a href="./references#CD013737-bbs2-0017" title="SmithA , MoonT , PakT , ParkB , UrmanRD . Preoperative anemia treatment with intravenous iron in patients undergoing major orthopedic surgery: a systematic review. Geriatric Orthopaedic Surgery &amp; Rehabilitation2020;11:2151459320935094. [PMID: 32637197]">Smith 2020</a>; <a href="./references#CD013737-bbs2-0021" title="YangY , LiH , LiB , WangY , JiangS , JiangL . Efficacy and safety of iron supplementation for the elderly patients undergoing hip or knee surgery: a meta-analysis of randomized controlled trials. The Journal of Surgical Research2011;171(2):e201-7. [PMID: 21962806]">Yang 2011</a>). At the time of the search and data extraction for this review, <a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a> was still unpublished, and all information and outcome data from the review were supplied through personal communication with the review authors. Communication from Sinclair and colleagues included an unpublished manuscript prepared for a journal; we used this manuscript to extract data and make our AMSTAR 2 judgements. Searches in the included reviews were conducted between May 2011 (<a href="./references#CD013737-bbs2-0021" title="YangY , LiH , LiB , WangY , JiangS , JiangL . Efficacy and safety of iron supplementation for the elderly patients undergoing hip or knee surgery: a meta-analysis of randomized controlled trials. The Journal of Surgical Research2011;171(2):e201-7. [PMID: 21962806]">Yang 2011</a>) and January 2021 (<a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a>). Characteristics of these reviews are summarised in <a href="#CD013737-tbl-0004">Table 4</a> and more detailed information is in <a href="./appendices#CD013737-sec-0090">Appendix 7</a>. </p> <div class="table" id="CD013737-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Summary of systematic review characteristics evaluating iron and iron with EPO</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Review</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Date of search</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study designs</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number of RCTs (participants)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participants</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention</b> </p> <p><b>Comparison</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Relevant outcomes</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk of bias assessment</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Certainty of evidence assessment</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0003" title="ChenR , LiL , XiangZ , LiH , HouXL . Association of iron supplementation with risk of transfusion, hospital length of stay, and mortality in geriatric patients undergoing hip fracture surgeries: a meta-analysis. European Geriatric Medicine2021;12(1):5-15. [PMID: 32691389]">Chen 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>April 2019</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs and NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (803)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Femoral neck fractures, trochanteric fractures, or subtrochanteric fractures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iron or iron + EPO (included studies used iron sucrose and ferrous sulphate)</p> <p><i>Control:</i> placebo or standard care </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (rate and volume); adverse events (infection); mortality</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Jadad<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0005" title="Gomez-RamirezS , Maldonado-RuizMA , Campos-GarriguesA , HerreraA , MunozM . Short-term perioperative iron in major orthopedic surgery: state of the art. Vox Sanguinis2019;114(1):3-16. [PMID: 30411362]">Gomez‐Ramirez 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs and NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (948)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Major orthopaedic surgery (including hip fracture)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iron or iron + EPO (included studies used iron sucrose or FCM)</p> <p><i>Control:</i> placebo or standard care </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (gastrointestinal symptoms, hypotension, headache, general discomfort, skin rash, flushing and tingling in the lips, infection); mortality </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0008" title="LinDM , LinES , TranMH . Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfusion Medicine Reviews2013;27(4):221-34. [PMID: 24135037]">Lin 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>July 2012</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs and NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (279)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mixed surgery (including hip fracture)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iron + EPO</p> <p><i>Control:</i> autologous blood donation, oral iron, or placebo </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (rate and volume); adverse events (infection, thromboembolic events); mortality </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane risk of bias tool<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0013" title="SchackA , BerkforsAA , EkeloefS , GögenurI , BurcharthJ . The effect of perioperative iron therapy in acute major non-cardiac surgery on allogenic blood transfusion and postoperative haemoglobin levels: a systematic review and meta-analysis. World Journal of Surgery2019;43(7):1677-91. [PMID: 30824959]">Schack 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>November 2017</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs and NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (485)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Major non‐cardiac surgery (including hip fracture)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral or IV iron with or without EPO</p> <p><i>Control:</i> no intervention, active comparator, or another iron treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (mild and severe); mortality</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>June 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (503)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐elective surgery (including hip fracture)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV iron with and without EPO</p> <p><i>Control:</i> placebo or standard care </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (rate and volume); delirium; adverse events (nausea, gastrointestinal symptoms, cholestasis, peripheral phlebitis, hypotension, low‐grade fever, skin rash, general discomfort, acute coronary disease, CVA, COPD exacerbation, heart failure, renal function deterioration, skin pressure ulcer); HRQoL; mortality </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0015" title="ShinHW , ParkJJ , KimHJ , YouHS , ChoiSU , LeeMJ . Efficacy of perioperative intravenous iron therapy for transfusion in orthopedic surgery: a systematic review and meta-analysis. PLoS One2019;14(5):e0215427. [PMID: 31059515]">Shin 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>September 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs and NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (491)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Orthopaedic surgery (including hip fracture)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iron</p> <p><i>Control</i> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (rate and volume); adverse events (infection); mortality</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January 2021</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs and NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (832)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip fracture surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV iron (any preparation)</p> <p><i>Control:</i> placebo or standard care </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; HRQoL; mortality; ADL</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GRADE</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0017" title="SmithA , MoonT , PakT , ParkB , UrmanRD . Preoperative anemia treatment with intravenous iron in patients undergoing major orthopedic surgery: a systematic review. Geriatric Orthopaedic Surgery &amp; Rehabilitation2020;11:2151459320935094. [PMID: 32637197]">Smith 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>September 2019</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs and NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (579)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Major orthopaedic surgery (including hip fracture)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV iron or iron with EPO, given preoperatively</p> <p><i>Control:</i> placebo or standard care </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (rate and volume); adverse events (serious adverse events, cardiovascular events, infection); HRQoL; mortality </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0021" title="YangY , LiH , LiB , WangY , JiangS , JiangL . Efficacy and safety of iron supplementation for the elderly patients undergoing hip or knee surgery: a meta-analysis of randomized controlled trials. The Journal of Surgical Research2011;171(2):e201-7. [PMID: 21962806]">Yang 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>May 2011</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (568)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip or knee surgery (including hip fracture</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral or IV iron</p> <p><i>Control:</i> placebo or no treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (rate and volume); adverse events<sup>c</sup>; mortality </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane risk of bias tool (<a href="./references#CD013737-bbs2-0153" title="vanTulderM , FurlanA , BombardierC , BouterL , Editorial Board Cochrane Back Review Group. Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine2003;28:1290. [PMID: 12811274]">van Tulder 2003</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>Review authors did not report a citation for this tool and we could not be certain which version was used<br/><sup>b</sup>We used only unpublished data for this review, which were supplied by personal communication with the review author (by email)<br/><sup>c</sup>Type of adverse events not specified in the study; because not all studies were eligible for inclusion in our review, we could not determine which of the reported adverse events were relevant. </p> <p>ADL: activities of daily living; EPO: erythropoeitin; HRQoL: health‐related quality of life; IV: intravenous(ly); NRS: non‐randomised studies; RCTs: randomised controlled trials </p> </div> </div> <p>Only two reviews included only RCTs, however, all reviews reported data for RCTs that could be extracted separately from data for non‐randomised trials; not all the data for RCTs were pooled. Only two reviews included only studies of participants who had hip fracture (<a href="./references#CD013737-bbs2-0003" title="ChenR , LiL , XiangZ , LiH , HouXL . Association of iron supplementation with risk of transfusion, hospital length of stay, and mortality in geriatric patients undergoing hip fracture surgeries: a meta-analysis. European Geriatric Medicine2021;12(1):5-15. [PMID: 32691389]">Chen 2021</a>; <a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a>); again, it was possible to extract separately pooled or unpooled data for hip fractures from the remaining reviews of mixed populations. The type of treatment for hip fractures was not specified in these two reviews, and we assumed they included participants undergoing any type of treatment. Taking into account the overlap between the reviews, 1281 participants with hip fracture were randomised to the included RCTs. Age limits at recruitment were limited in <a href="./references#CD013737-bbs2-0003" title="ChenR , LiL , XiangZ , LiH , HouXL . Association of iron supplementation with risk of transfusion, hospital length of stay, and mortality in geriatric patients undergoing hip fracture surgeries: a meta-analysis. European Geriatric Medicine2021;12(1):5-15. [PMID: 32691389]">Chen 2021</a> (&gt; 64 years of age), but all other reviews included studies regardless of participant age; no studies included only 'frail elderly'. As for reviews of tranexamic acid, we found that no studies specified the inclusion of a subset of participants according to baseline comorbidities or risk of bleeding, and no reviews reported this level of detail in their characteristics tables of included studies. </p> <p>All reviews reported the number of people who needed a blood transfusion, and all but two reviews reported the volume of transfused blood (<a href="./references#CD013737-bbs2-0005" title="Gomez-RamirezS , Maldonado-RuizMA , Campos-GarriguesA , HerreraA , MunozM . Short-term perioperative iron in major orthopedic surgery: state of the art. Vox Sanguinis2019;114(1):3-16. [PMID: 30411362]">Gomez‐Ramirez 2019</a>; <a href="./references#CD013737-bbs2-0013" title="SchackA , BerkforsAA , EkeloefS , GögenurI , BurcharthJ . The effect of perioperative iron therapy in acute major non-cardiac surgery on allogenic blood transfusion and postoperative haemoglobin levels: a systematic review and meta-analysis. World Journal of Surgery2019;43(7):1677-91. [PMID: 30824959]">Schack 2019</a>). All reviews reported mortality and most also reported adverse events. The types of adverse events were wide‐ranging, and differed between studies. Examples of adverse events included gastrointestinal symptoms, general discomfort, skin rash, infection, and thromboembolic events. Three studies reported health‐related quality of life (<a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a>; <a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a>; <a href="./references#CD013737-bbs2-0017" title="SmithA , MoonT , PakT , ParkB , UrmanRD . Preoperative anemia treatment with intravenous iron in patients undergoing major orthopedic surgery: a systematic review. Geriatric Orthopaedic Surgery &amp; Rehabilitation2020;11:2151459320935094. [PMID: 32637197]">Smith 2020</a>). In addition, <a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a> reported activities of daily living and <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> reported incidences of delirium. No studies reported postoperative cognitive dysfunction. </p> <p>Six reviews received either no funding or no external funding for their research (<a href="./references#CD013737-bbs2-0005" title="Gomez-RamirezS , Maldonado-RuizMA , Campos-GarriguesA , HerreraA , MunozM . Short-term perioperative iron in major orthopedic surgery: state of the art. Vox Sanguinis2019;114(1):3-16. [PMID: 30411362]">Gomez‐Ramirez 2019</a>; <a href="./references#CD013737-bbs2-0008" title="LinDM , LinES , TranMH . Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfusion Medicine Reviews2013;27(4):221-34. [PMID: 24135037]">Lin 2013</a>; <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a>; <a href="./references#CD013737-bbs2-0015" title="ShinHW , ParkJJ , KimHJ , YouHS , ChoiSU , LeeMJ . Efficacy of perioperative intravenous iron therapy for transfusion in orthopedic surgery: a systematic review and meta-analysis. PLoS One2019;14(5):e0215427. [PMID: 31059515]">Shin 2019</a>; <a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a>; <a href="./references#CD013737-bbs2-0017" title="SmithA , MoonT , PakT , ParkB , UrmanRD . Preoperative anemia treatment with intravenous iron in patients undergoing major orthopedic surgery: a systematic review. Geriatric Orthopaedic Surgery &amp; Rehabilitation2020;11:2151459320935094. [PMID: 32637197]">Smith 2020</a>); one review received funding from a government research body, which we deemed to be independent (<a href="./references#CD013737-bbs2-0003" title="ChenR , LiL , XiangZ , LiH , HouXL . Association of iron supplementation with risk of transfusion, hospital length of stay, and mortality in geriatric patients undergoing hip fracture surgeries: a meta-analysis. European Geriatric Medicine2021;12(1):5-15. [PMID: 32691389]">Chen 2021</a>). Funding sources were not specified in <a href="./references#CD013737-bbs2-0013" title="SchackA , BerkforsAA , EkeloefS , GögenurI , BurcharthJ . The effect of perioperative iron therapy in acute major non-cardiac surgery on allogenic blood transfusion and postoperative haemoglobin levels: a systematic review and meta-analysis. World Journal of Surgery2019;43(7):1677-91. [PMID: 30824959]">Schack 2019</a> or <a href="./references#CD013737-bbs2-0021" title="YangY , LiH , LiB , WangY , JiangS , JiangL . Efficacy and safety of iron supplementation for the elderly patients undergoing hip or knee surgery: a meta-analysis of randomized controlled trials. The Journal of Surgical Research2011;171(2):e201-7. [PMID: 21962806]">Yang 2011</a>. Three reviews declared that they had no conflicts of interest (<a href="./references#CD013737-bbs2-0003" title="ChenR , LiL , XiangZ , LiH , HouXL . Association of iron supplementation with risk of transfusion, hospital length of stay, and mortality in geriatric patients undergoing hip fracture surgeries: a meta-analysis. European Geriatric Medicine2021;12(1):5-15. [PMID: 32691389]">Chen 2021</a>; <a href="./references#CD013737-bbs2-0015" title="ShinHW , ParkJJ , KimHJ , YouHS , ChoiSU , LeeMJ . Efficacy of perioperative intravenous iron therapy for transfusion in orthopedic surgery: a systematic review and meta-analysis. PLoS One2019;14(5):e0215427. [PMID: 31059515]">Shin 2019</a>; <a href="./references#CD013737-bbs2-0017" title="SmithA , MoonT , PakT , ParkB , UrmanRD . Preoperative anemia treatment with intravenous iron in patients undergoing major orthopedic surgery: a systematic review. Geriatric Orthopaedic Surgery &amp; Rehabilitation2020;11:2151459320935094. [PMID: 32637197]">Smith 2020</a>), and three reviews did not specify (<a href="./references#CD013737-bbs2-0008" title="LinDM , LinES , TranMH . Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfusion Medicine Reviews2013;27(4):221-34. [PMID: 24135037]">Lin 2013</a>; <a href="./references#CD013737-bbs2-0013" title="SchackA , BerkforsAA , EkeloefS , GögenurI , BurcharthJ . The effect of perioperative iron therapy in acute major non-cardiac surgery on allogenic blood transfusion and postoperative haemoglobin levels: a systematic review and meta-analysis. World Journal of Surgery2019;43(7):1677-91. [PMID: 30824959]">Schack 2019</a>; <a href="./references#CD013737-bbs2-0021" title="YangY , LiH , LiB , WangY , JiangS , JiangL . Efficacy and safety of iron supplementation for the elderly patients undergoing hip or knee surgery: a meta-analysis of randomized controlled trials. The Journal of Surgical Research2011;171(2):e201-7. [PMID: 21962806]">Yang 2011</a>). For specific declared conflicts of interest in <a href="./references#CD013737-bbs2-0005" title="Gomez-RamirezS , Maldonado-RuizMA , Campos-GarriguesA , HerreraA , MunozM . Short-term perioperative iron in major orthopedic surgery: state of the art. Vox Sanguinis2019;114(1):3-16. [PMID: 30411362]">Gomez‐Ramirez 2019</a>, <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> and <a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a>, see information in <a href="./appendices#CD013737-sec-0090">Appendix 7</a>. </p> <p>Overall, this set of reviews included seven RCTs. Again, we found that the measure of study overlap was very high (overlap = 85.7%; CA = 42.9%; CCA = 35.7%); see <a href="#CD013737-tbl-0005">Table 5</a>. We found no Cochrane Reviews in this set of reviews. <a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a> had the most recent search date as well as the highest overall scores from AMSTAR 2 (see <a href="#CD013737-sec-0037">Methodological quality of included reviews</a>). However, because data from this review were unpublished, and therefore, not subject to external peer review, we did not prioritise this review for the reporting of outcome data. Subsequently, our hierarchical approach for this comparison considered which was the most relevant systematic review. Only two reviews in this comparison reported effect estimates for our primary outcome, with pooled data taken only from RCTs in a hip fracture surgical population (<a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a>; <a href="./references#CD013737-bbs2-0021" title="YangY , LiH , LiB , WangY , JiangS , JiangL . Efficacy and safety of iron supplementation for the elderly patients undergoing hip or knee surgery: a meta-analysis of randomized controlled trials. The Journal of Surgical Research2011;171(2):e201-7. [PMID: 21962806]">Yang 2011</a>). As <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> had the most recent search, we prioritised data from <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a>, assuming this to be the most relevant review for this comparison. <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> included only RCTs, but with a broader non‐elective surgical population that included hip fracture surgery, of which there were two RCTs. Both studies compared iron given intravenously to a control; one of the studies also included a comparison group of iron with EPO. In both studies, treatment was given preoperatively; in one study, further doses were also given postoperatively. Study characteristics from <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> are summarised in <a href="#CD013737-tbl-0006">Table 6</a>; because review authors provided only minimal study characteristics, we obtained additional detail from the primary study reports. </p> <div class="table" id="CD013737-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Overlapping studies in systematic reviews evaluating iron and iron with erythropoeitin (EPO)</span></div> <tbody> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign="bottom"></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0003" title="ChenR , LiL , XiangZ , LiH , HouXL . Association of iron supplementation with risk of transfusion, hospital length of stay, and mortality in geriatric patients undergoing hip fracture surgeries: a meta-analysis. European Geriatric Medicine2021;12(1):5-15. [PMID: 32691389]"><b>Chen 2021</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0005" title="Gomez-RamirezS , Maldonado-RuizMA , Campos-GarriguesA , HerreraA , MunozM . Short-term perioperative iron in major orthopedic surgery: state of the art. Vox Sanguinis2019;114(1):3-16. [PMID: 30411362]"><b>Gomez‐Ramirez 2019</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0008" title="LinDM , LinES , TranMH . Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfusion Medicine Reviews2013;27(4):221-34. [PMID: 24135037]"><b>Lin 2013</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0013" title="SchackA , BerkforsAA , EkeloefS , GögenurI , BurcharthJ . The effect of perioperative iron therapy in acute major non-cardiac surgery on allogenic blood transfusion and postoperative haemoglobin levels: a systematic review and meta-analysis. World Journal of Surgery2019;43(7):1677-91. [PMID: 30824959]"><b>Schack 2019</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]"><b>Shah 2018</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0015" title="ShinHW , ParkJJ , KimHJ , YouHS , ChoiSU , LeeMJ . Efficacy of perioperative intravenous iron therapy for transfusion in orthopedic surgery: a systematic review and meta-analysis. PLoS One2019;14(5):e0215427. [PMID: 31059515]"><b>Shin 2019</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020."><b>Sinclair 2020</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0017" title="SmithA , MoonT , PakT , ParkB , UrmanRD . Preoperative anemia treatment with intravenous iron in patients undergoing major orthopedic surgery: a systematic review. Geriatric Orthopaedic Surgery &amp; Rehabilitation2020;11:2151459320935094. [PMID: 32637197]"><b>Smith 2020</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0021" title="YangY , LiH , LiB , WangY , JiangS , JiangL . Efficacy and safety of iron supplementation for the elderly patients undergoing hip or knee surgery: a meta-analysis of randomized controlled trials. The Journal of Surgical Research2011;171(2):e201-7. [PMID: 21962806]"><b>Yang 2011</b> </a> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0050" title="Bernabeu-WittelM , RomeroM , Ollero-BaturoneM , AparicioR , Murcia-ZaragozaJ , Rincon-GomezM , et al. Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial. Transfusion 56;9:2199-211. [PMID: 27195774]">Bernabeu‐Wittel 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0051" title="BielzaR , LlorenteJ , ThuissardIJ , Andreu-VázquezC , BlancoD , SanjurjoJ , et al. Effect of intravenous iron on functional outcomes in hip fracture: a randomised controlled trial. Age and Ageing2021;50(1):127-34. [PMID: 32542370]">Bielza 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0090" title="KaterosK , SakellariouVI , SofianosIP , PapagelopoulosPJ . Epoetin alfa reduces blood transfusion requirements in patients with intertrochanteric fracture. Journal of Critical Care2010;25:348-53. [PMID: 19592206]">Kateros 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0111" title="MoppettIK , RowlandsM , ManningsAM , MarufuTC , SahotaO , YeungJ . The effect of intravenous iron on erythropoiesis in older people with hip fracture. Age and Ageing2019;48(5):751-5. [PMID: 31127269]">Moppett 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0124" title="ParkerMJ . Iron supplementation for anemia after hip fracture surgery: a randomized trial of 300 patients. The Jounral of Bone and Joint Surgery. American Volume2010;92(2):265-9. [PMID: 20124051]">Parker 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0129" title="PrasadN , RajamaniV , HullinD , MurrayJM . Post-operative anaemia in femoral neck fracture patients: does it need treatment? A single blinded prospective randomised controlled trial. Injury2009;40:1073-6. [PMID: 19524906]">Prasad 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0141" title="Serrano-TrenasJA , UgaldePF , CabelloLM , ChofesLC , LázaroPS , BenítezPC . Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. Transfusion2011;51(1):97-104. [PMID: 20630042]">Serrano‐Trenas 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Systematic reviews are in columns (ordered by date of publication). Included studies in the systematic reviews are in rows (ordered alphabetically). Study overlap = 85.7%; covered area (CA) for overlap = 42.9%; corrected covered area (CCA) for overlap = 35.7% </p> </div> </div> <div class="table" id="CD013737-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Characteristics of RCTs in Shah 2018 (iron)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant criteria</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>N</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Years of age, mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>M/F</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Fracture type</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Surgery</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Administration dose, route, and number of doses</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Timing</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Transfusion crtieria</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0050" title="Bernabeu-WittelM , RomeroM , Ollero-BaturoneM , AparicioR , Murcia-ZaragozaJ , Rincon-GomezM , et al. Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial. Transfusion 56;9:2199-211. [PMID: 27195774]">Bernabeu‐Wittel 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 65 years, osteoporotic hip fracture, Hb 90 to 120 g/L</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Iron:</i> 103; </p> <p><i>Iron + EPO:</i> 100 </p> <p><i>Control:</i> 100 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Iron:</i> 84.6 (± 6.2) </p> <p><i>Iron + EPO:</i> 83.4 (± 6.4) </p> <p><i>Control:</i> 82.3 (± 6.9) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Iron:</i> 19/84 </p> <p><i>Iron + EPO</i>: 13/87 </p> <p><i>Control:</i> 13/87 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pertrochanteric, subcapital, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IF, HA or THA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Iron</i>: 1000 mg of IV ferric carboxymaltose (2 x 500 mg vials diluted in 250 mL saline) in 20 min infusion </p> <p><i>Iron + EPO:</i> 1000 mg of IV ferric carboxymaltose (2 x 500 mg vials diluted in 250 mL saline) in 20 min infusion; subcutaneous single dose of 40,000 IU or EPO in prefilled 1 mL syringe </p> <p><i>Control:</i> IV placebo (250 mL saline) in 20 min infusion </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prior to surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 70 g/L: 3 RBC transfusions (independent of symptoms)</p> <p>Hb 71 to 89 g/L with severe symptoms: 2 RBC transfusions</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0141" title="Serrano-TrenasJA , UgaldePF , CabelloLM , ChofesLC , LázaroPS , BenítezPC . Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. Transfusion2011;51(1):97-104. [PMID: 20630042]">Serrano‐Trenas 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 65 years, hip fracture</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Iron</i>: 99 </p> <p><i>Control:</i> 97 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Iron:</i> 83.46 (± 7.11) </p> <p><i>Control:</i> 82.53 (± 6.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Iron</i>: 20/79 </p> <p><i>Control:</i> 20/77 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Extracapsular, intracapsular</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IF, HA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Iron:</i> standard protocol treatment; plus 600 mg iron sucrose IV (3 x 200 mg over 48 hour period, in 90‐min infusion) </p> <p><i>Control</i>: standard protocol treatment<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Iron:</i> first dose 24 hours after admission and before surgery; other doses given before or after surgery, all within 48 hours </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assumed to follow standard protocol<sup>a</sup> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>criteria for RBC transfusion: preoperative Hb &lt; 10 g/dL; postoperative Hb &lt; 8 g/dL, or &lt; 9 g/dL if participant had history of cardiorespiratory conditions; or any Hb with symptoms of untreated anaemia </p> <p>EPO: erythropoietin; Hb: haemoglobin levels; IV: intravenous(ly); M/F: male/female; N: number of participants randomised to group; RBC: red blood cell </p> </div> </div> </section> </section> <section id="CD013737-sec-0037"> <h3 class="title" id="CD013737-sec-0037">Methodological quality of included reviews</h3> <section id="CD013737-sec-0038"> <h4 class="title">AMSTAR 2 for tranexamic acid</h4> <p>Using the methods described in <a href="#CD013737-sec-0028">Assessment of methodological quality of included reviews</a>, we rated our overall confidence in these reviews from very low to moderate (<a href="#CD013737-tbl-0007">Table 7</a>). We rated our overall confidence as moderate in two reviews (<a href="./references#CD013737-bbs2-0004" title="FarrowLS , SmithTO , AshcroftGP , MyintPK . A systematic review of tranexamic acid in hip fracture surgery. British Journal of Clinical Pharmacology2016;82:1458-70.">Farrow 2016</a>; <a href="./references#CD013737-bbs2-0007" title="JiangW , ShangL . Tranexamic acid can reduce blood loss in patients undergoing intertrochanteric fracture surgery: a meta-analysis. Medicine (Baltimore)2019;98(11):e14564.">Jiang 2019</a>), low in five reviews (<a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>; <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>; <a href="./references#CD013737-bbs2-0022" title="YuXB , WangJW , WangXY , XieLZ , ChenCH , ZhengWH . The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials. Journal of Thrombosis and Thrombolysis2020;50(2):243-57.">Yu 2020</a>; <a href="./references#CD013737-bbs2-0023" title="ZhangP , HeJS , FangYC , ChenPT , LiangY , WangJC . Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis. A meta-analysis. Medicine2017;96(21):1-8.">Zhang 2017</a>; <a href="./references#CD013737-bbs2-0026" title="ZhuQ , YuC , ChenX , XuX , ChenY , LiuC , et al. Efficacy and safety of tranexamic acid for blood salvage in intertrochanteric fracture surgery: a meta-analysis. Clinical and Applied Thrombosis/Hemostasis2018;24(8):1189-98.">Zhu 2018</a>), and very low in the remaining 10 reviews. We present a narrative summary of our judgements on the methodological quality of reviews for this treatment in <a href="./appendices#CD013737-sec-0091">Appendix 8</a>. </p> <div class="table" id="CD013737-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">AMSTAR 2 summary for reviews evaluating tranexamic acid</span></div> <tbody> <tr> <td align="left" class="headercell" colspan="1" rowspan="1" valign="bottom"></td> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>1</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>2</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>3</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>4</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>5</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>6</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>7</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>8</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>9</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>10</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>11</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>12</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>13</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>14</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>15</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>16</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall confidence in the results of the review</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0001" title="AgiusC , ColeE , MifsudMG , VasireddyA . The use of tranexamic acid (TXA) in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Trauma2022;36(12):e442-8. [DOI: 10.1097/BOT.0000000000002440]"><b>Agius 2022</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0002" title="BaskaranD , RahmanS , SalmasiY , FroghiS , BerberO , GeorgeM . Effect of tranexamic acid use on blood loss and thromboembolic risk in hip fracture surgery: systematic review and meta-analysis. Hip International2018;28(1):3-10."><b>Baskaran 2018</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0004" title="FarrowLS , SmithTO , AshcroftGP , MyintPK . A systematic review of tranexamic acid in hip fracture surgery. British Journal of Clinical Pharmacology2016;82:1458-70."><b>Farrow 2016</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0006" title="Haj-YounesB , SivakumarBS , WangM , AnVV , LorentzosP , AdieS . Tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Surgery2020;28(1):1-6."><b>Haj‐Younes 2020</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0007" title="JiangW , ShangL . Tranexamic acid can reduce blood loss in patients undergoing intertrochanteric fracture surgery: a meta-analysis. Medicine (Baltimore)2019;98(11):e14564."><b>Jiang 2019</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89."><b>Liu 2022</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0010" title="LuoX , HuangH , TangX . Efficacy and safety of tranexamic acid for reducing blood loss in elderly patients with intertrochanteric fracture treated with intramedullary fixation surgery: a meta-analysis of randomized controlled trials. Acta Orthopaedica et Traumatologica Turcica2020;54(1):4-14."><b>Luo 2020</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300."><b>Masouros 2022</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0012" title="QiYM , WangHP , LiYJ , MaBB , XieT , WangC , et al. The efficacy and safety of intravenous tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Translation2019;19:1-11."><b>Qi 2019</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0018" title="WangW , YuJ . Tranexamic acid reduces blood loss in intertrochanteric fractures: a meta-analysis from randomized controlled trials. Medicine (Baltimore)2017;96(52):e9396."><b>Wang 2017a</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0019" title="XiaoC , ZhangS , LongN , YuW , JiangY . Is intravenous tranexamic acid effective and safe during hip fracture surgery? An updated meta-analysis of randomized controlled trials. Archives of Orthopaedic and Trauma Surgery2019;139:893-902."><b>Xiao 2019</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0020" title="XingF , ChenW , LongC , HuangFG , WangGL , XiangZ . Postoperative outcomes of tranexamic acid use in geriatric trauma patients treated with proximal femoral intramedullary nails: a systematic review and meta-analysis. Orthopaedics &amp; Traumatology: Surgery &amp; Research2020;106(1):117-26."><b>Xing 2020</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0022" title="YuXB , WangJW , WangXY , XieLZ , ChenCH , ZhengWH . The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials. Journal of Thrombosis and Thrombolysis2020;50(2):243-57."><b>Yu 2020</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0023" title="ZhangP , HeJS , FangYC , ChenPT , LiangY , WangJC . Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis. A meta-analysis. Medicine2017;96(21):1-8."><b>Zhang 2017</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0024" title="ZhangP , BaiJ , HeJ , LiangY , ChenP , WangJ . A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery. Clinical Interventions in Aging2018;13:1579-91."><b>Zhang 2018</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0025" title="ZhouXD , LiJ , FanGM , HuangY , XuNW . Efficacy and safety of tranexamic acid in elderly patients with intertrochanteric fracture: an updated meta-analysis. World Journal of Clinical Cases2019;7(11):1302-14."><b>Zhou 2019a</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0026" title="ZhuQ , YuC , ChenX , XuX , ChenY , LiuC , et al. Efficacy and safety of tranexamic acid for blood salvage in intertrochanteric fracture surgery: a meta-analysis. Clinical and Applied Thrombosis/Hemostasis2018;24(8):1189-98."><b>Zhu 2018</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Scores from the 16 questions in the AMSTAR 2 critical appraisal tool (see <a href="./appendices#CD013737-sec-0085">Appendix 2</a>). N: no; PY: partial yes; Y: yes </p> <p><sup>a</sup>Funnel plot not performed, but we noted that fewer than 10 trials were included<br/><sup>b</sup>Although citations for individual studies were not given, reasons for exclusion were enumerated<br/><sup>c</sup>No studies excluded at full‐text review<br/><sup>d</sup>Protocol did not clearly state a rationale for choosing to combine studies; however, we judged the studies to be sufficiently similar </p> </div> </div> </section> <section id="CD013737-sec-0039"> <h4 class="title">Risk of bias assessment for prioritised reviews for tranexamic acid</h4> <p>Because we reported the outcome data for <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a> and <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>, we also collected the risk of bias assessments conducted by these review authors (see <a href="#CD013737-fig-0002">Figure 2</a> and <a href="#CD013737-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD013737-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Liu 2022 risk of bias summary" data-id="CD013737-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/image_n/nCD013737-FIG-02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a> risk of bias summary </p> </div> </div> </div> <div class="figure" id="CD013737-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Masouros 2022 risk of bias summaryWhen making judgements for the summary of findings table, we did not include risk of bias assessments for Luo 2019, Zhang 2022, and Zufferey 2009; these studies did not provide data for the outcomes reported in our summary of findings table" data-id="CD013737-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/image_n/nCD013737-FIG-03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a> risk of bias summary </p> <p>When making judgements for the summary of findings table, we did not include risk of bias assessments for <a href="./references#CD013737-bbs2-0105" title="LuoX , HeS , LinZ , LiZ , HuangC , LiQ . Efficacy and safety of tranexamic acid for controlling bleeding during surgical treatment of intertrochanteric fragility fracture with proximal femoral nail anti-rotation: a randomized controlled trial. Indian Journal of Orthopaedics2019;53(2):263-9.">Luo 2019</a>, <a href="./references#CD013737-bbs2-0166" title="ZhangS , XiaoC , YuW , LongN , HeF , CaiP , et al. Tranexamic acid safely reduces hidden blood loss in patients undergoing intertrochanteric fracture surgery: a randomized controlled trial. European Journal of Emergency Surgery2022;48(2):731-41.">Zhang 2022</a>, and <a href="./references#CD013737-bbs2-0168" title="ZuffereyPJ , MiquetM , QuenetS , MartinP , AdamP , AlbaladejoP , et al. Tranexamic acid in hip fracture surgery: a randomized controlled trial. British Journal of Anaesthesia2010;104(1):23-30.">Zufferey 2009</a>; these studies did not provide data for the outcomes reported in our summary of findings table </p> </div> </div> </div> <p>In <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>, we noted that review authors had assessed six studies to be at low risk of bias in all domains (<a href="./references#CD013737-bbs2-0137" title="SadeghiM , Mehr-AeinA . Does a single bolus dose of tranexamic acid reduce blood loss and transfusion requirements during hip fracture surgery? A prospective randomized double blind study in 67 patients. Acta Medica Iranica2007;45(6):437-42.">Sadeghi 2007</a>; <a href="./references#CD013737-bbs2-0150" title="TengbergPT , FossNB , PalmH , KallemoseT , TroelsenA . Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial. The Bone &amp; Joint Journal2016;98(6):747-53.">Tengberg 2016</a>; <a href="./references#CD013737-bbs2-0160" title="WattsCD , HoudekMT , SemsSA , CrossWW , PagnanoMW . Tranexamic acid safely reduced blood loss in hemi- and total hip arthroplasty for acute femoral neck fracture: a randomized clinical trial. Journal of Orthopaedic Trauma2017;31(7):345-51.">Watts 2017</a>; <a href="./references#CD013737-bbs2-0166" title="ZhangS , XiaoC , YuW , LongN , HeF , CaiP , et al. Tranexamic acid safely reduces hidden blood loss in patients undergoing intertrochanteric fracture surgery: a randomized controlled trial. European Journal of Emergency Surgery2022;48(2):731-41.">Zhang 2022</a>; <a href="./references#CD013737-bbs2-0167" title="ZhouXD , ZhangY , JiangLF , ZhangJJ , ZhouD , WuLD , et al. Efficacy and safety of tranexamic acid in intertrochanteric fractures: a single-blind randomized controlled trial. Orthopaedic Surgery2019;11(4):635-42.">Zhou 2019b</a>; <a href="./references#CD013737-bbs2-0168" title="ZuffereyPJ , MiquetM , QuenetS , MartinP , AdamP , AlbaladejoP , et al. Tranexamic acid in hip fracture surgery: a randomized controlled trial. British Journal of Anaesthesia2010;104(1):23-30.">Zufferey 2009</a>). Whilst all other studies included some judgements of unclear risks of bias, review authors judged three studies to be at high risk of bias for performance and detection bias (<a href="./references#CD013737-bbs2-0085" title="JordanM , AguileraX , GonzálezJC , CastillónP , SalomóM , HernándezJA , et al. Prevention of postoperative bleeding in hip fractures treated with prosthetic replacement: efficacy and safety of fibrin sealant and tranexamic acid. A randomised controlled clinical trial (TRANEXFER study). Archives of Orthopaedic and Trauma Surgery2019;139(5):597-604.">Jordan 2019</a>; <a href="./references#CD013737-bbs2-0093" title="LeiJ , ZhangB , CongY , ZhuangY , WeiX , FuY , et al. Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial. Journal of Orthopaedic Surgery and Research2017;12(1):124.">Lei 2017</a>; <a href="./references#CD013737-bbs2-0155" title="ViraniSR , DahaputeAA , PandaI , BavaSS . Role of local infiltration of tranexamic acid in reducing blood loss in peritrochanteric fracture surgery in the elderly population. Malaysian Orthopaedic Journal2016;10:26-30.">Virani 2016</a>), and judged <a href="./references#CD013737-bbs2-0085" title="JordanM , AguileraX , GonzálezJC , CastillónP , SalomóM , HernándezJA , et al. Prevention of postoperative bleeding in hip fractures treated with prosthetic replacement: efficacy and safety of fibrin sealant and tranexamic acid. A randomised controlled clinical trial (TRANEXFER study). Archives of Orthopaedic and Trauma Surgery2019;139(5):597-604.">Jordan 2019</a> to also be at high risk of selective reporting bias. </p> <p>In <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>, we noted that all studies included some judgements of unclear risk of bias, with all having an unclear risk of bias in the domain of Other bias. Review authors judged one study to be at high risk of bias for performance bias (<a href="./references#CD013737-bbs2-0093" title="LeiJ , ZhangB , CongY , ZhuangY , WeiX , FuY , et al. Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial. Journal of Orthopaedic Surgery and Research2017;12(1):124.">Lei 2017</a>). </p> </section> <section id="CD013737-sec-0040"> <h4 class="title">AMSTAR 2 for iron and iron with EPO</h4> <p>Using the methods described in <a href="#CD013737-sec-0028">Assessment of methodological quality of included reviews</a>, we rated our overall confidence in these reviews from high to very low (<a href="#CD013737-tbl-0008">Table 8</a>). We assessed high confidence in one study (<a href="./references#CD013737-bbs2-0008" title="LinDM , LinES , TranMH . Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfusion Medicine Reviews2013;27(4):221-34. [PMID: 24135037]">Lin 2013</a>), moderate confidence in five reviews (<a href="./references#CD013737-bbs2-0003" title="ChenR , LiL , XiangZ , LiH , HouXL . Association of iron supplementation with risk of transfusion, hospital length of stay, and mortality in geriatric patients undergoing hip fracture surgeries: a meta-analysis. European Geriatric Medicine2021;12(1):5-15. [PMID: 32691389]">Chen 2021</a>; <a href="./references#CD013737-bbs2-0013" title="SchackA , BerkforsAA , EkeloefS , GögenurI , BurcharthJ . The effect of perioperative iron therapy in acute major non-cardiac surgery on allogenic blood transfusion and postoperative haemoglobin levels: a systematic review and meta-analysis. World Journal of Surgery2019;43(7):1677-91. [PMID: 30824959]">Schack 2019</a>; <a href="./references#CD013737-bbs2-0015" title="ShinHW , ParkJJ , KimHJ , YouHS , ChoiSU , LeeMJ . Efficacy of perioperative intravenous iron therapy for transfusion in orthopedic surgery: a systematic review and meta-analysis. PLoS One2019;14(5):e0215427. [PMID: 31059515]">Shin 2019</a>; <a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a>; <a href="./references#CD013737-bbs2-0017" title="SmithA , MoonT , PakT , ParkB , UrmanRD . Preoperative anemia treatment with intravenous iron in patients undergoing major orthopedic surgery: a systematic review. Geriatric Orthopaedic Surgery &amp; Rehabilitation2020;11:2151459320935094. [PMID: 32637197]">Smith 2020</a>), low confidence in two reviews (<a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a>; <a href="./references#CD013737-bbs2-0021" title="YangY , LiH , LiB , WangY , JiangS , JiangL . Efficacy and safety of iron supplementation for the elderly patients undergoing hip or knee surgery: a meta-analysis of randomized controlled trials. The Journal of Surgical Research2011;171(2):e201-7. [PMID: 21962806]">Yang 2011</a>), and very low confidence in the remaining review (<a href="./references#CD013737-bbs2-0005" title="Gomez-RamirezS , Maldonado-RuizMA , Campos-GarriguesA , HerreraA , MunozM . Short-term perioperative iron in major orthopedic surgery: state of the art. Vox Sanguinis2019;114(1):3-16. [PMID: 30411362]">Gomez‐Ramirez 2019</a>). We present a narrative summary of our judgements of the methodological quality of reviews for this treatment in <a href="./appendices#CD013737-sec-0092">Appendix 9</a>. </p> <div class="table" id="CD013737-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">AMSTAR 2 summary for reviews evaluating iron or iron with erythropoeitin (EPO)</span></div> <tbody> <tr> <td align="left" class="headercell" colspan="1" rowspan="1" valign="bottom"></td> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>1</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>2</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>3</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>4</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>5</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>6</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>7</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>8</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>9</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>10</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>11</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>12</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>13</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>14</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>15</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>16</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall confidence in the results of the review</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0003" title="ChenR , LiL , XiangZ , LiH , HouXL . Association of iron supplementation with risk of transfusion, hospital length of stay, and mortality in geriatric patients undergoing hip fracture surgeries: a meta-analysis. European Geriatric Medicine2021;12(1):5-15. [PMID: 32691389]">Chen 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0005" title="Gomez-RamirezS , Maldonado-RuizMA , Campos-GarriguesA , HerreraA , MunozM . Short-term perioperative iron in major orthopedic surgery: state of the art. Vox Sanguinis2019;114(1):3-16. [PMID: 30411362]">Gomez‐Ramirez 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0008" title="LinDM , LinES , TranMH . Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfusion Medicine Reviews2013;27(4):221-34. [PMID: 24135037]">Lin 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0013" title="SchackA , BerkforsAA , EkeloefS , GögenurI , BurcharthJ . The effect of perioperative iron therapy in acute major non-cardiac surgery on allogenic blood transfusion and postoperative haemoglobin levels: a systematic review and meta-analysis. World Journal of Surgery2019;43(7):1677-91. [PMID: 30824959]">Schack 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0015" title="ShinHW , ParkJJ , KimHJ , YouHS , ChoiSU , LeeMJ . Efficacy of perioperative intravenous iron therapy for transfusion in orthopedic surgery: a systematic review and meta-analysis. PLoS One2019;14(5):e0215427. [PMID: 31059515]">Shin 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0017" title="SmithA , MoonT , PakT , ParkB , UrmanRD . Preoperative anemia treatment with intravenous iron in patients undergoing major orthopedic surgery: a systematic review. Geriatric Orthopaedic Surgery &amp; Rehabilitation2020;11:2151459320935094. [PMID: 32637197]">Smith 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0021" title="YangY , LiH , LiB , WangY , JiangS , JiangL . Efficacy and safety of iron supplementation for the elderly patients undergoing hip or knee surgery: a meta-analysis of randomized controlled trials. The Journal of Surgical Research2011;171(2):e201-7. [PMID: 21962806]">Yang 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Scores from the 16 questions in the AMSTAR 2 critical appraisal tool (see <a href="./appendices#CD013737-sec-0085">Appendix 2</a>). N: no; N/A: not applicable, as no meta‐analysis was conducted; PY: partial yes; Y: yes </p> <p><sup>a</sup>Although citations for individual studies were not given, reasons for exclusion were enumerated<br/><sup>b</sup>Funnel plot not performed, but we noted that anaylsis included fewer than 10 trials </p> </div> </div> </section> <section id="CD013737-sec-0041"> <h4 class="title">Risk of bias for prioritised review for iron</h4> <p>Because we reported the outcome data for <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a>, we also collected the risk of bias assessments conducted by Shah and colleagues for individual studies (see <a href="#CD013737-fig-0004">Figure 4</a>). We noted that review authors had assessed both studies to be at low risk of bias for all domains, except for allocation concealment, for which risk of bias for <a href="./references#CD013737-bbs2-0050" title="Bernabeu-WittelM , RomeroM , Ollero-BaturoneM , AparicioR , Murcia-ZaragozaJ , Rincon-GomezM , et al. Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial. Transfusion 56;9:2199-211. [PMID: 27195774]">Bernabeu‐Wittel 2016</a> was unclear. </p> <div class="figure" id="CD013737-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Shah 2018 risk of bias summary" data-id="CD013737-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/image_n/nCD013737-FIG-04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> risk of bias summary </p> </div> </div> </div> </section> </section> <section id="CD013737-sec-0042"> <h3 class="title" id="CD013737-sec-0042">Effect of interventions</h3> <section id="CD013737-sec-0043"> <h4 class="title">Tranexamic acid</h4> <p>Here, we report the outcome data as presented in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a> and <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>. We prioritised the data from <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a> when data were available for our overview outcomes, otherwise, we reported data from <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>. No reviews reported postoperative delirium, postoperative cognitive dysfunction, activities of daily living, or health‐related quality of life. See the summary of findings in <a href="#CD013737-tbl-0009">Table 9</a>. </p> <div class="table" id="CD013737-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Summary of findings table: tranexamic acid versus control for reducing blood cell transfusion in adults undergoing hip fracture surgery</span></div> <tbody> <tr> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Tranexamic acid versus control for reducing blood cell transfusion in adults undergoing hip fracture surgery</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> people undergoing surgery for hip fracture </p> <p><b>Setting:</b> hospital settings </p> <p><b>Intervention:</b> tranexamic acid, given at any dose by any route of administration; studies included in these reviews gave tranexamic acid intravenously, topically, or both </p> <p><b>Comparison:</b> placebo or no treatment </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Number of participants (studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence (GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with control</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with TXA</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Number of people requiring ABT</b><sup>a</sup> </p> <p><i>during perioperative period</i> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.56</b> </p> <p>(0.46 to 0.68)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2148 participants (21 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Moderate<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>451 per 1000<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>257 per 1000</b> </p> <p>(207 to 307)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Volume of transfused allogeneic blood (measured as units of PRC)</b><sup>d</sup> </p> <p><i>during perioperative period</i> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean volume of transfused PRC in the control group ranged from <b>0.53 to 2.4 units</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.53 units lower</b> </p> <p>(0.27 lower to 0.80 lower)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>813 participants (7 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate<sup>e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Postoperative delirium</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b><sup>a</sup> </p> <p>DVT</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.16</b> </p> <p>(0.74 to 1.81)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(22 studies)<sup>g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Moderate<sup>h</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Effects of other adverse events were:</p> <p>PE: RR 1.01, 95% CI 0.36 to 2.86; 9 studies</p> <p>MI: RR 1.00, 95% CI 0.23 to 4.33; 8 studies</p> <p>CVA: RR 1.45, 95% CI 0.56 to 3.70; 8 studies</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79 per 1000<sup>f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>92 per 1000</b> </p> <p>(58 to 142)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Activities of daily living</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Health‐related quality of life</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All‐cause mortality</b><sup>a</sup> </p> <p><i>within 1 month of surgery</i> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.01</b> </p> <p>(0.70 to 1.46)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(10 studies)<sup>g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Moderate<sup>h</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Time point was not reported; we assumed from other information that this effect estimate includes data from &lt; 3 months and ≥ 3 months </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67 per 1000<sup>i</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>67 per 1000</b> </p> <p>(47 to 98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>ABT:</b> allogenic blood transfusion; <b>CI:</b> confidence interval; <b>CVA:</b> cerebrovascular accident; <b>DVT:</b> deep vein thrombosis; <b>MI:</b> myocardial infarction; <b>PE:</b> pulmonary embolism; <b>PRC:</b> packed red blood cells; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>The data for this outcome were reported in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>, which did not include a summary of findings table. We judged the certainty of the evidence based on the information presented in the published report. We did not re‐analyse the data, or re‐assess any risk of bias judgements in the published report.<br/><sup>b</sup>Derived from the pooled estimate of the control groups in the included studies in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a><br/><sup>c</sup>Downgraded by one level for publication bias. Review authors noted evidence of publication bias from funnel plot investigation and Eggers test (P = 0.001)<br/><sup>d</sup>The data for this outcome were reported in <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>, which did not include a summary of findings table. We judged the certainty of the evidence based on the information presented in the published report. We did not re‐analyse the data, or re‐assess any risk of bias judgements in the published report.<br/><sup>e</sup>Downgraded by one level for inconsistency, owing to statistical heterogeneity (I² = 78%)<br/><sup>f</sup>We were unable to determine a pooled estimate of the control group in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>, because these data were not reported by the study authors; therefore, we derived the control group risk of DVT from <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>.<br/><sup>g</sup>Number of participants included in this effect estimate was not reported in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a><br/><sup>h</sup>Downgraded by one level for imprecision, owing to wide CI that includes both benefit and harm<br/><sup>i</sup>Risk in the control group taken from the National Hip Fracture Database (NHFD) for England, Wales and Northern Island for 2016 </p> </div> </div> <section id="CD013737-sec-0044"> <h5 class="title">Primary outcomes</h5> <section id="CD013737-sec-0045"> <h6 class="title">Number of people requiring allogenic blood transfusion</h6> <p>Based on evidence in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>, fewer people required ABT after receiving tranexamic acid (risk ratio (RR) 0.56, 95% confidence interval (CI) 0.46 to 0.68; I² = 60.1%; 21 studies, 2148 participants). <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a> presented a forest plot for each study in this effect estimate, but these data did not include participant numbers. Therefore, we extracted the number of participants separately from each primary study to include alongside this effect estimate. Of the 21 studies that reported data for this outcome, 17 studies (1785 participants) overlapped with studies in other reviews; hence, the weight of overlap in this effect estimate is 83%. Using information presented in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>, we judged this to be moderate‐certainty evidence. We downgraded the evidence by one level for publication bias, because <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a> identified a risk of publication bias (Egger's test P = 0.001). </p> </section> <section id="CD013737-sec-0046"> <h6 class="title">Volume of transfused allogeneic blood</h6> <p>Based on evidence in <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>, fewer units of packed red blood cells (PRC) were transfused in participants receiving tranexamic acid (mean difference (MD) ‐0.53 units per person, 95% CI ‐0.27 to ‐0.80; I² = 78%; 7 studies, 813 participants). Of the seven studies that reported data for this outcome, three studies (252 participants) overlapped with studies in another review; giving a weight of overlap in this effect estimate of 31%. Using information presented in <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>, we judged this to be moderate‐certainty evidence. We downgraded the evidence by one level for inconsistency, because the effect estimate included substantial levels of statistical heterogeneity, which were not explained. </p> </section> </section> <section id="CD013737-sec-0047"> <h5 class="title">Secondary outcomes</h5> <section id="CD013737-sec-0048"> <h6 class="title">Adverse events</h6> <p>Based on evidence in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>, there is probably little or no difference in the incidence of adverse events. Study authors reported: </p> <p> <ul id="CD013737-list-0018"> <li> <p>little or no difference in the incidence of DVT (RR 1.16, 95% CI 0.74 to 1.81; I² = 0%; 22 studies); </p> </li> <li> <p>little or no difference in the incidence of pulmonary embolism (RR 1.01, 95% CI 0.36 to 2.86; I² = 0%; 9 studies); </p> </li> <li> <p>little or no difference in the incidence of myocardial infarction (RR 1.00, 95% CI 0.23 to 4.33; I² = 0%; 8 studies); </p> </li> <li> <p>little or no difference in the incidence of cerebrovascular accident (RR 1.45, 95% CI 0.56 to 3.70; I² = 0%; 8 studies). </p> </li> </ul> </p> <p>We were unable to report participant numbers for these effects as the names of individual studies were not included in the review report. Because we did not know which studies were included in these effect estimates, we could not determine the weight from overlapping studies in these findings. We judged the evidence for adverse events to be moderate certainty. We downgraded the certainty of the evidence by one level because effect estimates were imprecise, i.e. the CIs included the possibility of both benefit and harm. </p> </section> <section id="CD013737-sec-0049"> <h6 class="title">All‐cause mortality at one month and at four months postoperatively</h6> <p>Based on evidence from 10 studies in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>, there was little or no difference in mortality (RR 1.01, 95% CI 0.70 to 1.46; I² = 0%; 10 studies). The time point for mortality was not clearly reported, but we assumed from other information in the report that it included data measured both before and later than three months. Again, we were unable to report participant numbers because we could not determine from which studies the data were derived, so neither could we determine the weight of study overlap. We judged the evidence for mortality to be moderate certainty. We downgraded the evidence by one level because the effect estimate was imprecise, including the possibility of both benefit and harm. </p> </section> </section> <section id="CD013737-sec-0050"> <h5 class="title">Sensitivity analysis</h5> <p>In a sensitivity analysis, we assessed the impact of selecting data from only <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a> and <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a> by comparing the effect estimates from other reviews with the effect estimates from these two reviews (see <a href="./appendices#CD013737-sec-0093">Appendix 10</a>). We found that all but one review reported effect estimates consistent with those in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>, indicating that fewer people required ABT after receiving tranexamic acid. Only <a href="./references#CD013737-bbs2-0026" title="ZhuQ , YuC , ChenX , XuX , ChenY , LiuC , et al. Efficacy and safety of tranexamic acid for blood salvage in intertrochanteric fracture surgery: a meta-analysis. Clinical and Applied Thrombosis/Hemostasis2018;24(8):1189-98.">Zhu 2018</a> reported an imprecise effect estimate, with evidence of both increased and reduced blood transfusions after tranexamic acid (RR 0.75, 95% CI 0.50 to 1.11); this effect estimate included considerable levels of statistical heterogeneity (I² = 98%), which were not explained by subgroup analyses. However, review authors conducted sensitivity analysis, and found that excluding <a href="./references#CD013737-bbs2-0049" title="BaruahRK , BorahPJ , HaqueR . Use of tranexamic acid in dynamic hip screw plate fixation for trochanteric fractures. Journal of Orthopaedic Surgery2016;24(3):379-82.">Baruah 2016</a> from their primary analysis led to a finding consistent with other reviews (RR 0.73, 95% CI 0.55 to 0.96). Only one other review reported volume of transfused blood, which was consistent with the effect estimate in <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>. </p> <p>Effect estimates for adverse events (which were DVT, pulmonary embolism, myocardial infarction, and cerebrovascular accident) were consistent with <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>, indicating little or no difference between treatments (see <a href="./appendices#CD013737-sec-0093">Appendix 10</a>). Some reviews reported a composite outcome for adverse events, i.e. any thromboembolic events, and other reviews reported adverse events in addition to those reported in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>; again, these are missing from the report of our primary findings, therefore, we reported the effect estimates for all adverse events in all reviews in <a href="./appendices#CD013737-sec-0094">Appendix 11</a>. Except for the incidence of haematoma, we found that all effect estimates indicated little or no difference between treatments in these adverse events. Both reviews that measured haematoma reported a decreased incidence after the use of tranexamic acid (RR 0.34, 95% CI 0.15 to 0.78; I² = 0%; 4 studies (<a href="./references#CD013737-bbs2-0007" title="JiangW , ShangL . Tranexamic acid can reduce blood loss in patients undergoing intertrochanteric fracture surgery: a meta-analysis. Medicine (Baltimore)2019;98(11):e14564.">Jiang 2019</a>): and RR ‐0.05, 95% CI ‐0.09 to ‐0.00; 2 studies, 277 participants (<a href="./references#CD013737-bbs2-0020" title="XingF , ChenW , LongC , HuangFG , WangGL , XiangZ . Postoperative outcomes of tranexamic acid use in geriatric trauma patients treated with proximal femoral intramedullary nails: a systematic review and meta-analysis. Orthopaedics &amp; Traumatology: Surgery &amp; Research2020;106(1):117-26.">Xing 2020</a>)). </p> <p>Effect estimates from other reviews that reported mortality were similar to those in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>. </p> </section> <section id="CD013737-sec-0051"> <h5 class="title">Subgroup analysis</h5> <p>We summarised whether each review included information on our subgroup categories in <a href="./appendices#CD013737-sec-0095">Appendix 12</a>. For completeness, we also listed all subgroup analyses conducted in each review in this appendix (including subgroup analyses that were not specified in this overview); we did not report data for these subgroup analyses. </p> <section id="CD013737-sec-0052"> <h6 class="title">Time of administration</h6> <p>Of the reviews in which time of administration was described, no reviews included the administration of tranexamic acid at only one time point (e.g. only preoperative or only postoperative administration). No reviews conducted subgroup analysis for this criterium, either. </p> </section> <section id="CD013737-sec-0053"> <h6 class="title">Age of participants</h6> <p>Only three reviews included an age cutoff in their inclusion criteria (<a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>; <a href="./references#CD013737-bbs2-0010" title="LuoX , HuangH , TangX . Efficacy and safety of tranexamic acid for reducing blood loss in elderly patients with intertrochanteric fracture treated with intramedullary fixation surgery: a meta-analysis of randomized controlled trials. Acta Orthopaedica et Traumatologica Turcica2020;54(1):4-14.">Luo 2020</a>; <a href="./references#CD013737-bbs2-0020" title="XingF , ChenW , LongC , HuangFG , WangGL , XiangZ . Postoperative outcomes of tranexamic acid use in geriatric trauma patients treated with proximal femoral intramedullary nails: a systematic review and meta-analysis. Orthopaedics &amp; Traumatology: Surgery &amp; Research2020;106(1):117-26.">Xing 2020</a>); of these, no reviews included only participants that might be described as 'frail elderly'. </p> <p>However, three reviews reported subgroup data according to the age of participants (<a href="./references#CD013737-bbs2-0004" title="FarrowLS , SmithTO , AshcroftGP , MyintPK . A systematic review of tranexamic acid in hip fracture surgery. British Journal of Clinical Pharmacology2016;82:1458-70.">Farrow 2016</a>; <a href="./references#CD013737-bbs2-0023" title="ZhangP , HeJS , FangYC , ChenPT , LiangY , WangJC . Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis. A meta-analysis. Medicine2017;96(21):1-8.">Zhang 2017</a>; <a href="./references#CD013737-bbs2-0024" title="ZhangP , BaiJ , HeJ , LiangY , ChenP , WangJ . A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery. Clinical Interventions in Aging2018;13:1579-91.">Zhang 2018</a>). For older participants (≥ 76 years of age), <a href="./references#CD013737-bbs2-0004" title="FarrowLS , SmithTO , AshcroftGP , MyintPK . A systematic review of tranexamic acid in hip fracture surgery. British Journal of Clinical Pharmacology2016;82:1458-70.">Farrow 2016</a> noted an imprecise effect estimate for blood transfusion requirement (RR 0.67, 95% CI 0.37 to 1.22; I² = 84%; 3 studies, 453 participants). The CI in this effect estimate included the possibility of both benefit and harm; we noted that these subgroup data included high levels of statistical heterogeneity. Such imprecision was not evident in their findings for participants ≤ 75 years of age, in which the effect estimate indicated a reduction in blood transfusion after tranexamic acid use (RR 0.48, 95% CI 0.33 to 0.72; I² = 10%; 4 studies, 297 participants); the result for younger participants was consistent with pooled data across all age groups in other reviews. <a href="./references#CD013737-bbs2-0004" title="FarrowLS , SmithTO , AshcroftGP , MyintPK . A systematic review of tranexamic acid in hip fracture surgery. British Journal of Clinical Pharmacology2016;82:1458-70.">Farrow 2016</a> found no evidence of a difference in the risk of thromboembolic events when subgrouping data according to these age categories. We noted that the data for these subgroups were not supported in the review by statistical results of formal tests for subgroup differences. </p> <p>Both <a href="./references#CD013737-bbs2-0023" title="ZhangP , HeJS , FangYC , ChenPT , LiangY , WangJC . Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis. A meta-analysis. Medicine2017;96(21):1-8.">Zhang 2017</a> and <a href="./references#CD013737-bbs2-0024" title="ZhangP , BaiJ , HeJ , LiangY , ChenP , WangJ . A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery. Clinical Interventions in Aging2018;13:1579-91.">Zhang 2018</a> reported subgroup data using an earlier age cutoff of 65 years, and noted no evidence of a difference in blood transfusion risk between the two age groups (results for both age groups were consistent with the pooled data in other reviews). <a href="./references#CD013737-bbs2-0024" title="ZhangP , BaiJ , HeJ , LiangY , ChenP , WangJ . A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery. Clinical Interventions in Aging2018;13:1579-91.">Zhang 2018</a> also reported no evidence of a difference in thromboembolic events between the age groups. Again, none of these subgroup data were supported by statistical results of formal tests for subgroup differences. </p> </section> <section id="CD013737-sec-0054"> <h6 class="title">Baseline co‐morbidities and people at higher risk of bleeding</h6> <p>No reviews specified inclusion criteria, or included only reviews from a distinct subgroup category, according to baseline comorbidities, or people who were at higher risk of bleeding. </p> <p><a href="./references#CD013737-bbs2-0004" title="FarrowLS , SmithTO , AshcroftGP , MyintPK . A systematic review of tranexamic acid in hip fracture surgery. British Journal of Clinical Pharmacology2016;82:1458-70.">Farrow 2016</a> reported subgroup data according to body mass index (BMI) ≤ 40 or &gt; 40. Four of their six included studies provided this information, all of which included participants with a BMI ≤ 40; review authors did not explain whether BMI status was absent in the remaining two studies. In this smaller subgroup of participants, <a href="./references#CD013737-bbs2-0004" title="FarrowLS , SmithTO , AshcroftGP , MyintPK . A systematic review of tranexamic acid in hip fracture surgery. British Journal of Clinical Pharmacology2016;82:1458-70.">Farrow 2016</a> found an imprecise effect estimate for ABT requirement (RR 0.73, 95% CI 0.49 to 1.11; I² = 68%; 4 studies, 289 participants). The CI in this effect estimate included the possibility of both benefit and harm; we noted that these subgroup data included moderate levels of statistical heterogeneity. Subgroup data for other outcomes were consistent with pooled data in other reviews. None of the subgroup data in <a href="./references#CD013737-bbs2-0004" title="FarrowLS , SmithTO , AshcroftGP , MyintPK . A systematic review of tranexamic acid in hip fracture surgery. British Journal of Clinical Pharmacology2016;82:1458-70.">Farrow 2016</a> were supported by statistical results of formal tests for subgroup differences. No other reviews reported subgroup data for baseline comorbidities or for people at higher risk of bleeding. </p> </section> <section id="CD013737-sec-0055"> <h6 class="title">Route of administration</h6> <p>Eight reviews only included studies in which tranexamic acid was given intravenously; no reviews included studies in which tranexamic acid was only given topically. We observed no important differences between effect estimates according to whether reviews pooled data with only IV tranexamic administration, or both IV and topical administration; this finding was the same for all outcomes. </p> <p>Four reviews reported subgroup data according to route of administration (<a href="./references#CD013737-bbs2-0007" title="JiangW , ShangL . Tranexamic acid can reduce blood loss in patients undergoing intertrochanteric fracture surgery: a meta-analysis. Medicine (Baltimore)2019;98(11):e14564.">Jiang 2019</a>; <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>; <a href="./references#CD013737-bbs2-0010" title="LuoX , HuangH , TangX . Efficacy and safety of tranexamic acid for reducing blood loss in elderly patients with intertrochanteric fracture treated with intramedullary fixation surgery: a meta-analysis of randomized controlled trials. Acta Orthopaedica et Traumatologica Turcica2020;54(1):4-14.">Luo 2020</a>; <a href="./references#CD013737-bbs2-0026" title="ZhuQ , YuC , ChenX , XuX , ChenY , LiuC , et al. Efficacy and safety of tranexamic acid for blood salvage in intertrochanteric fracture surgery: a meta-analysis. Clinical and Applied Thrombosis/Hemostasis2018;24(8):1189-98.">Zhu 2018</a>). <a href="./references#CD013737-bbs2-0007" title="JiangW , ShangL . Tranexamic acid can reduce blood loss in patients undergoing intertrochanteric fracture surgery: a meta-analysis. Medicine (Baltimore)2019;98(11):e14564.">Jiang 2019</a> reported effect estimates indicating a decrease in the need for blood transfusion with both IV and topical administration, which is consistent with the findings of other reviews. However, in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>, pooled data for topical administration indicated a less precise result, with the possibility of no benefit in blood transfusion risk (RR 0.74, 95% CI 0.54 to 1.01; I² = 0%; 4 studies); the pooled data in 18 studies with IV administration were consistent with the findings of other reviews. </p> <p><a href="./references#CD013737-bbs2-0010" title="LuoX , HuangH , TangX . Efficacy and safety of tranexamic acid for reducing blood loss in elderly patients with intertrochanteric fracture treated with intramedullary fixation surgery: a meta-analysis of randomized controlled trials. Acta Orthopaedica et Traumatologica Turcica2020;54(1):4-14.">Luo 2020</a> only reported subgroup data according to administration route for thromboembolic events, with each subgroup showing similar findings to the other reviews, and no evidence of subgroup differences in formal tests (P = 0.86). </p> <p><a href="./references#CD013737-bbs2-0026" title="ZhuQ , YuC , ChenX , XuX , ChenY , LiuC , et al. Efficacy and safety of tranexamic acid for blood salvage in intertrochanteric fracture surgery: a meta-analysis. Clinical and Applied Thrombosis/Hemostasis2018;24(8):1189-98.">Zhu 2018</a> conducted subgroup analysis with studies in which administration was given locally at the end of surgery, one dose intravenously before surgery, or intravenously before and after surgery. Whilst pooled estimates from two studies of local administration did not show a clear reduction in blood transfusion rates (RR 0.83, 95% CI 0.55 to 1.26; 2 studies, 337 participants), review authors noted no statistical evidence of subgroup differences between these three administration types (P = 0.89). In addition, <a href="./references#CD013737-bbs2-0026" title="ZhuQ , YuC , ChenX , XuX , ChenY , LiuC , et al. Efficacy and safety of tranexamic acid for blood salvage in intertrochanteric fracture surgery: a meta-analysis. Clinical and Applied Thrombosis/Hemostasis2018;24(8):1189-98.">Zhu 2018</a> noted no differences in thromboembolic events according to administration route. </p> </section> </section> </section> <section id="CD013737-sec-0056"> <h4 class="title">Iron and iron with EPO</h4> <p>Here we report the outcome data as reported in <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a>, in which all participants received iron intravenously. Although the review included studies of iron given with or without EPO, the pooled outcome data in <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> only included studies in which participants were given iron alone; therefore, the data reported in this review do not include evidence for iron given with EPO. All the studies in this review overlapped with those in other reviews, therefore, overlapping studies contributed 100% of the weight in these analyses. No reviews reported data for postoperative cognitive dysfunction and activities of daily living. See the summary of findings in <a href="#CD013737-tbl-0010">Table 10</a>. We downgraded all the evidence by two levels to low certainty for imprecision, owing to wide CIs and evidence derived from few participants. </p> <div class="table" id="CD013737-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Summary of findings table: iron versus control for reducing blood cell transfusion in adults undergoing hip fracture surgery</span></div> <tbody> <tr> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Iron versus control for reducing blood cell transfusion in adults undergoing hip fracture surgery</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> people undergoing surgery for hip fracture </p> <p><b>Setting:</b> hospitals </p> <p><b>Intervention:</b> iron or iron with EPO, given at any dose for any duration; studies in the review used intravenous administration, starting preoperatively </p> <p><b>Comparison:</b> placebo control or standard care treatment </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Number of participants (studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence (GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with control</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with iron</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Number of people requiring ABT</b><sup>a</sup> </p> <p><i>during perioperative period</i> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.90</b> </p> <p>(0.73 to 1.11)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>403 participants (2 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Low<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>475 per 1000<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>428 per 1000</b> </p> <p>(347 to 527)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Volume of transfused allogeneic blood (measured as units of PRC)</b><sup>a</sup> </p> <p><i>during perioperative period</i> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean volume of transfused PRC in the control group ranged from <b>0.87 to 1.28 units</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.07 fewer units</b> </p> <p>(0.31 fewer to 0.17 more)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>403 participants (2 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Postoperative delirium</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>303 participants (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No effect estimate reported; however, review authors reported that 25 participants in the iron group had delirium compared to 26 participants in the control group. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b><sup>a</sup> </p> <p>Infection</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.99</b> </p> <p>0.55 to 1.80</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>403 participants (2 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Low<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>110 per 1000<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>111 per 1000</b> </p> <p>(61 to 198)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Activities of daily living</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No effect estimate or data reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Health‐related quality of life</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No effect estimate or data reported. Review authors reported that there were no significant differences between groups </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All‐cause mortality</b><sup>a</sup> </p> <p><i>1‐month follow‐up</i> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.06</b> </p> <p>(0.53 to 2.13)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>403 participants (2 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Low<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70 per 1000<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>70 per 1000</b> </p> <p>(37 to 149)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>ABT:</b> allogenic blood transfusion; <b>CI:</b> confidence interval; <b>EPO:</b> erythropoietin; <b>PRC:</b> packed red blood cells; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>The data for this outcome were reported in <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a>, which did not include a summary of findings table. We judged the certainty of the evidence based on the information presented in the published report. We did not re‐analyse the data or re‐assess any risk of bias judgements in the published report.<br/><sup>b</sup>Derived from the pooled estimate in the control groups in <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a><br/><sup>c</sup>We downgraded the evidence by two levels for imprecision, because the effect estimate was imprecise, and because the evidence was derived from a few participants in only two studies. </p> </div> </div> <section id="CD013737-sec-0057"> <h5 class="title">Primary outcomes</h5> <section id="CD013737-sec-0058"> <h6 class="title">Number of people requiring allogenic blood transfusion</h6> <p><a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> reported an imprecise effect estimate, indicating little or no difference in the number of people given a blood transfusion according to whether they received iron (RR 0.90, 95% CI 0.73 to 1.11; I² = 0%; 2 studies, 403 participants). </p> </section> <section id="CD013737-sec-0059"> <h6 class="title">Volume of transfused allogenic blood</h6> <p>The review also found little or no difference between groups in the volume of transfused PRC (MD ‐0.07 units, 95% CI ‐0.31 to 0.17; I² = 0%; 2 studies, 403 participants). </p> </section> </section> <section id="CD013737-sec-0060"> <h5 class="title">Secondary outcomes</h5> <section id="CD013737-sec-0061"> <h6 class="title">Postoperative delirium</h6> <p><a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> noted that one study (303 participants) reported delirium. Review authors did not present an effect estimate for these data, but reported there were 25 events in the intervention group and 26 events in the control group. </p> </section> <section id="CD013737-sec-0062"> <h6 class="title">Adverse events</h6> <p>The review found little or no difference in the risk of infection (RR 0.99, 95% CI 0.55 to 1.80; I² = 9%; 2 studies, 403 participants). Data for other adverse events were not pooled, however, study authors reported no significant differences between groups for these outcomes. Types of reported adverse events included gastrointestinal events, hypotension, low‐grade fever, cholestasis, peripheral phlebitis, drug‐related side effects (skin rash, general discomfort), and medical complications (acute coronary disease, stroke, heart failure, venous thromboembolism, chronic obstructive pulmonary disease exacerbation, renal function deterioration, delirium, and skin pressure ulcer). </p> </section> <section id="CD013737-sec-0063"> <h6 class="title">Health‐related quality of life (HRQoL)</h6> <p><a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> noted that one study (303 participants) reported this outcome, measured at 60 days after hospital discharge, using the SF‐36. Review authors did not report an effect estimate, but noted that the study found no significant differences between groups. </p> </section> <section id="CD013737-sec-0064"> <h6 class="title">All‐cause mortality at one month postoperatively</h6> <p>The review reported no evidence of a difference in short‐term mortality, which we assumed meant mortality within one month of surgery (RR 1.06; 95% CI 0.53 to 2.13; I² = 0%; 2 studies, 403 participants). </p> </section> <section id="CD013737-sec-0065"> <h6 class="title">All‐cause mortality at four months postoperatively</h6> <p>Similarly, the review reported little difference in mortality at 60 days, as reported in one study (12 in the iron group versus 10 deaths in the control group; no denominators; P &gt; 0.05). </p> </section> </section> <section id="CD013737-sec-0066"> <h5 class="title">Sensitivity analysis</h5> <p>In a sensitivity analysis, we assessed the impact of selecting data from <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> only, by comparing the effect estimates from each review with the effect estimates from <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> (see <a href="./appendices#CD013737-sec-0096">Appendix 13</a>). The data from <a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a> were most comparable to <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a>, as it included separate pooled estimates for RCTs in a hip fracture population. <a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a> included evidence from an additional two studies for the number of people requiring ABT, and for mortality within one month. Effect estimates from these two outcomes also showed no evidence of a difference, according to whether participants received iron. <a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a> also noted that one study measured the Barthel Index score in participants (a measure used to assess activities of daily living); the review did not report an effect estimate or data from this study, but noted that there was no difference in improvement in scores during a median 10‐day hospital stay. </p> <p>Most effect estimates from other reviews pooled data across population groups (i.e. including participants undergoing hip fracture surgery, as well as other types of surgery), or pooled data from both RCTs and non‐randomised trials. For completeness, we also reported these indirect data in <a href="./appendices#CD013737-sec-0096">Appendix 13</a>. All findings were comparable to those in <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> (i.e. little or no difference in effect for each outcome), except infection in <a href="./references#CD013737-bbs2-0003" title="ChenR , LiL , XiangZ , LiH , HouXL . Association of iron supplementation with risk of transfusion, hospital length of stay, and mortality in geriatric patients undergoing hip fracture surgeries: a meta-analysis. European Geriatric Medicine2021;12(1):5-15. [PMID: 32691389]">Chen 2021</a>, which reported a reduced infection risk with iron use. Although we could not clearly determine a reason for this difference, we noted that these data were derived from both RCTs and non‐randomised trials. </p> </section> <section id="CD013737-sec-0067"> <h5 class="title">Subgroup analysis</h5> <section id="CD013737-sec-0068"> <h6 class="title">Time of administration</h6> <p>No reviews included administration of iron at only one time point. Two reviews conducted subgroup analysis for the time of administration (<a href="./references#CD013737-bbs2-0003" title="ChenR , LiL , XiangZ , LiH , HouXL . Association of iron supplementation with risk of transfusion, hospital length of stay, and mortality in geriatric patients undergoing hip fracture surgeries: a meta-analysis. European Geriatric Medicine2021;12(1):5-15. [PMID: 32691389]">Chen 2021</a>; <a href="./references#CD013737-bbs2-0015" title="ShinHW , ParkJJ , KimHJ , YouHS , ChoiSU , LeeMJ . Efficacy of perioperative intravenous iron therapy for transfusion in orthopedic surgery: a systematic review and meta-analysis. PLoS One2019;14(5):e0215427. [PMID: 31059515]">Shin 2019</a>). In <a href="./references#CD013737-bbs2-0003" title="ChenR , LiL , XiangZ , LiH , HouXL . Association of iron supplementation with risk of transfusion, hospital length of stay, and mortality in geriatric patients undergoing hip fracture surgeries: a meta-analysis. European Geriatric Medicine2021;12(1):5-15. [PMID: 32691389]">Chen 2021</a>, these analyses included pooled data from both RCTs and non‐randomised trials, therefore, we did not include the findings here. In <a href="./references#CD013737-bbs2-0015" title="ShinHW , ParkJJ , KimHJ , YouHS , ChoiSU , LeeMJ . Efficacy of perioperative intravenous iron therapy for transfusion in orthopedic surgery: a systematic review and meta-analysis. PLoS One2019;14(5):e0215427. [PMID: 31059515]">Shin 2019</a>, the effect estimates when the intervention was given preoperatively, postoperatively, or perioperatively were similar to those reported in <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> and in other reviews. </p> </section> <section id="CD013737-sec-0069"> <h6 class="title">Age of participants, baseline co‐morbidities and people at higher risk of bleeding.</h6> <p>Most reviews did not specify an age limit other than adults; no reviews only included participants that might be described as 'frail elderly'. No reviews specified inclusion criteria, or only included reviews from a distinct subgroup category, according to baseline co‐morbidities, or people who were at higher risk of bleeding. In addition, no reviews conducted subgroup analysis for these criteria. </p> </section> <section id="CD013737-sec-0070"> <h6 class="title">Route of administration</h6> <p>Four reviews only included studies in which iron was given intravenously (<a href="./references#CD013737-bbs2-0008" title="LinDM , LinES , TranMH . Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfusion Medicine Reviews2013;27(4):221-34. [PMID: 24135037]">Lin 2013</a>; <a href="./references#CD013737-bbs2-0015" title="ShinHW , ParkJJ , KimHJ , YouHS , ChoiSU , LeeMJ . Efficacy of perioperative intravenous iron therapy for transfusion in orthopedic surgery: a systematic review and meta-analysis. PLoS One2019;14(5):e0215427. [PMID: 31059515]">Shin 2019</a>; <a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a>; <a href="./references#CD013737-bbs2-0017" title="SmithA , MoonT , PakT , ParkB , UrmanRD . Preoperative anemia treatment with intravenous iron in patients undergoing major orthopedic surgery: a systematic review. Geriatric Orthopaedic Surgery &amp; Rehabilitation2020;11:2151459320935094. [PMID: 32637197]">Smith 2020</a>). As described in the sensitivity analysis (above), we observed no evidence of differences between effect estimates in each review, regardless of the route of administration. </p> <p>Only one review conducted subgroup analysis according to route of administration, but because this analysis included pooled data from both RCTs and non‐randomised trials, we did not include the findings here (<a href="./references#CD013737-bbs2-0003" title="ChenR , LiL , XiangZ , LiH , HouXL . Association of iron supplementation with risk of transfusion, hospital length of stay, and mortality in geriatric patients undergoing hip fracture surgeries: a meta-analysis. European Geriatric Medicine2021;12(1):5-15. [PMID: 32691389]">Chen 2021</a>). </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013737-sec-0071" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013737-sec-0071"></div> <section id="CD013737-sec-0072"> <h3 class="title" id="CD013737-sec-0072">Summary of main results</h3> <p>We found 26 systematic reviews assessing the effectiveness of interventions for reducing blood transfusion in adults undergoing hip fracture surgery. Most reviews reported data for tranexamic acid; the remaining reviews reported data for iron given with or without erythropoietin (EPO). We found no reviews for other types of pharmacological interventions, and no reviews for non‐pharmacological interventions. </p> <section id="CD013737-sec-0073"> <h4 class="title">Tranexamic acid</h4> <p>There was a large degree of overlap in the reviews of each intervention type, and we used a hierarchical approach to select reviews that provided the most relevant evidence for this overview. We compared the results of selected reviews with those reported in the other reviews, and found that the results were largely comparable. Selected reviews did not report GRADE judgements of their evidence, therefore, we assessed the certainty of the evidence in these reviews using the information presented in the review reports. </p> <p>For tranexamic acid, we prioritised data from <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>. This review included 24 randomised controlled trials (RCTs) with 2148 participants undergoing hip fracture surgery. Studies in the review included administration of tranexamic acid intravenously or topically (or both), given at different doses, and at different times during the perioperative period; no studies included intramuscular administration. The review included moderate‐certainty evidence of reduced risk of blood transfusion after tranexamic acid. Based on a control group risk of 451 per 1000, it is probable that 194 fewer people are likely to need allogeneic blood transfusion (ABT) after receiving tranexamic acid. The review also reported data for adverse events (deep vein thrombosis, pulmonary embolism, myocardial infarction, and cerebrovascular accident) and mortality within one month of surgery. Data for some of these adverse events were limited by fewer studies than for the effectiveness data. We judged the evidence for these outcomes to be moderate certainty, with imprecise effect estimates that indicated that there is probably little or no difference in the risk of these adverse events, or in early mortality when tranexamic acid is administered. </p> <p>The review by <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a> did not include data for all outcomes relevant to this overview. Therefore, we also prioritised data from <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>, which reported data for the volume of transfused blood. This similarly recent review included 10 RCTs with 1123 participants, and also included broad criteria for the administration of tranexamic acid in people having hip fracture surgery. The review included moderate‐certainty evidence that tranexamic acid probably reduces the volume of transfused units of packed red blood cells (PRC) given to those undergoing hip fracture surgery. We identified no reviews that reported outcome data for postoperative delirium, activities of daily living, or health‐related quality of life. </p> </section> <section id="CD013737-sec-0074"> <h4 class="title">Iron</h4> <p>For the use of iron, we prioritised data from <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a>. This small review, including two RCTs with 503 participants, provided the most up‐to‐date, direct, published evidence solely from RCTs in people who had hip fractures. The review reported low‐certainty evidence that after administration of iron, there may be little or no difference in the number of people who need ABT, the volume of transfused PRC, infection rates, or mortality within one month. Whilst <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> did not report an effect estimate for postoperative delirium, data from one study indicated that there may be little or no difference in incidence. <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> also reported that there were no significant differences between groups in health‐related quality of life, but this finding was reported without quantitative data, and we could not be certain of this finding. We identified no reviews of iron given to people with hip fracture that reported outcome data for postoperative delirium, or activities of daily living. </p> </section> </section> <section id="CD013737-sec-0075"> <h3 class="title" id="CD013737-sec-0075">Overall completeness and applicability of evidence</h3> <p>The evidence in this overview relates to only two possible types of interventions for reducing ABT in a people with hip fracture. Whilst other pharmacological and non‐pharmacological interventions may be used, we found no systematic reviews. </p> <p>It was apparent that data were available from more published studies, with a larger number of systematic reviews evaluating the use of tranexamic acid than for iron use. </p> <p>For tranexamic acid, the evidence presented in this overview is applicable to the general hip fracture population. None of the reviews reported important secondary outcomes, including postoperative delirium, activities of daily living, or health‐related quality of life. We could not confidently interpret the results of subgroup analyses, reported within a subset of the published reviews, to determine whether tranexamic acid may be more or less effective in some groups of people (according to age, baseline risk of bleeding, and different types of fracture and surgical approaches to its treatment). In addition, we could not be certain of any other effect modifiers that may affect the results of these subgroups, for example the use of concomitant medication (such as antithrombotics for cardiovascular disease) in older participants when subgrouping by age, or the appropriateness of subgroup thresholds for body mass index (BMI), when the impact of a low BMI (18 to 25 kg/m²) might be more useful for older, frail adults. Similarly, we could not determine whether one route of administration was more effective than another; some reviews included only intravenous administration, but no reviews exclusively evaluated topical administration. In the prioritised reviews for tranexamic acid, no studies evaluated intramuscular administration of tranexamic acid; although intramuscular administration is rarely used. In addition, no studies evaluated oral administration of tranexamic acid. </p> <p>For iron, the evidence was more sparse, with more reviews including a broader surgical population, and often incorporating the results of non‐randomised trials. None of the reviews reported outcome data for postoperative delirium or activities of daily living. The prioritised review in this overview only pooled data for iron, rather than data available from one of its included studies for participants given iron with erythropoietin. Again, we were not confident about the reliability of subgroup analyses within reviews to determine whether iron may be more effective in some patient groups, or when administered by a particular route. </p> <p>For both types of intervention, we identified recently published reviews with some included studies conducted as recently as 2021. Due to the limitations in reporting in the reviews, we could not determine the range of countries in which studies were conducted. </p> <p>Additional data will become available in the future from the unpublished and ongoing reviews identified within this overview. No ongoing reviews are assessing non‐pharmacological interventions. </p> </section> <section id="CD013737-sec-0076"> <h3 class="title" id="CD013737-sec-0076">Certainty of the evidence</h3> <p>For the certainty of the evidence in this overview, we report the results of two separate assessments. </p> <p>Firstly, we used AMSTAR 2 to critically appraise the methodological quality of included reviews, and rate our overall confidence in the results of the reviews. For tranexamic acid, our confidence in the reviews ranged from moderate to very low. For iron, our confidence in the reviews ranged from high to very low. The wide range of judgements for each review represents the differences in reporting standards in these reviews. We did not contact individual review authors for additional details about their review methods, and it is possible that some of our judgements may be a consequence of poor reporting, with reporting standards not imposed by journal requirements at the time of publication, rather than lack of methodological rigour. </p> <p>When prioritising key reviews to manage the high degree of study overlap, we based our decisions on relevancy (e.g. recency of the search date, or completeness of the study populations) before review quality. Our prioritised reviews for both types of interventions all had an overall rating of low confidence. </p> <p>Secondly, we used GRADE to judge the certainty of the evidence within our selected reviews. For tranexamic acid, we judged that all the evidence was moderate‐certainty. We did not re‐assess any of the risk of bias judgements in the published reports, and we did not downgrade for risk of bias in the evidence. We also did not downgrade for indirectness because the population and intervention types in the studies included in these reviews met our own inclusion criteria. In <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>, for which we only reported data for the volume of transfused blood, we downgraded the evidence for inconsistency, owing to unexplained, considerable statistical heterogeneity in the effect estimate; we judged that this outcome provided moderate‐certainty evidence.  We downgraded the certainty of the evidence for outcomes where we noted imprecise effect estimates in which wide confidence intervals (CIs) included the possibility of both benefit and harm. We noted that <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a> found evidence of publication bias for one of the outcomes (number of people requiring ABT), and therefore, we downgraded the evidence.  </p> <p>For the evidence for iron use, we were less certain of the effect estimates, and judged all the evidence to be low certainty. We did not downgrade for risk of bias because the review authors judged risk of bias in the included studies to be largely low. We also did not downgrade for indirectness because data for our selected study population were separately reported in the review. There were no important differences between studies and therefore, we did not downgrade for inconsistency. The evidence for this treatment was from a few, small studies, and the effect estimates included the possibility of both benefit and harm; we downgraded all the evidence for this treatment for imprecision. We did not downgrade the evidence for publication bias; the evidence was based on only a few studies, and the review authors did not formally assess the risk. </p> <p>We note the distinction between the results of AMSTAR 2 and those of GRADE in this overview. Whilst we used the five GRADE criteria to judge the certainty of the evidence for each outcome, which ranged from moderate to very low, we judged our selected reviews to have methodological flaws such that we were only able to give them an overall rating of low. Therefore, it is reasonable to infer that we could have less confidence in the findings from these reviews than from the reviews that had fewer methodological flaws. However, we also collected the effect estimates from other reviews and compared their findings with those in our selected reviews. Given that the results are largely comparable across all reviews, and any differences could be explained by inclusion criteria, we believed that the differences in methodological quality of all the reviews in this overview was not a reason to reduce our certainty of the evidence for each outcome. </p> </section> <section id="CD013737-sec-0077"> <h3 class="title" id="CD013737-sec-0077">Potential biases in the overview process</h3> <p>We planned to include systematic reviews of studies that evaluated the effects of interventions for preventing or minimising blood loss, for treating the effects of anaemia by improving the oxygen‐carrying potential of the blood, and for reducing the need for allogeneic blood transfusion. We found that it was sometimes difficult to determine eligibility of reviews against these criteria. We excluded some reviews that we expected would meet these eligibility criteria (e.g. <a href="./references#CD013737-bbs2-0036" title="LewisSR , ButlerAR , BrammarA , NicholsonA , SmithAF . Perioperative fluid volume optimization following proximal femoral fracture. Cochrane Database of Systematic Reviews2016, Issue 3. Art. No: CD003004. [DOI: 10.1002/14651858.CD003004.pub4]">Lewis 2016</a>, which evaluated perioperative fluid volume optimisation), because the reviews did not include blood transfusion as an outcome, and therefore, the aim of the review, rather than the studies within the review, did not meet the criteria. </p> <p>We found many reviews that compared different surgical implants for hip fracture repair or different surgical approaches. We were aware that many of these reviews reported blood loss or ABT risks, but did so as a secondary outcome measure, and therefore, again, we judged that the review aim did not meet our criteria. In addition, we expected that the primary aim of the included studies within these reviews was unlikely to be about minimising blood loss or the effects of anaemia. This opinion was reached based on our own experience of conducting systematic reviews about the effectiveness of surgical treatments for hip fracture repair in which the primary aim of included studies was not related to minimising blood loss (<a href="./references#CD013737-bbs2-0096" title="LewisSR , MaceyR , EardleyWGP , DixonJR , CookJ , GiriffinXL . Internal fixation implants for intracapsular hip fractures in older adults. Cochrane Database of Systematic Reviews2021, Issue 3. Art. No: CD013409. [DOI: 10.1002/14651858.CD013409.pub2]">Lewis 2021</a>; <a href="./references#CD013737-bbs2-0097" title="LewisSR , MaceyR , GillJR , ParkerMJ , GriffinXL . Cephalomedullary nails versus extramedullary implants for extracapsular hip fractures in older adults. Cochrane Database of Systematic Reviews2022, Issue 1. Art. No: CD000093. [DOI: 10.1002/14651858.CD000093.pub6]">Lewis 2022a</a>; <a href="./references#CD013737-bbs2-0098" title="LewisSR , MaceyR , LewisJ , StokesJ , GillJR , CookJA , et al. Surgical interventions for treating extracapsular hip fractures in older adults: a network meta‐analysis. Cochrane Database of Systematic Reviews2022, Issue 2. Art. No: CD013405. [DOI: 10.1002/14651858.CD013405.pub2]">Lewis 2022b</a>; <a href="./references#CD013737-bbs2-0099" title="LewisSR , MaceyR , ParkerMJ , CookJA , GriffinXL . Arthroplasties for hip fracture in adults. Cochrane Database of Systematic Reviews2022, Issue 2. Art. No: CD013410. [DOI: 10.1002/14651858.CD013410.pub2]">Lewis 2022c</a>; <a href="./references#CD013737-bbs2-0100" title="LewisSR , MaceyR , StokesJ , CookJA , EardleyWGP , GriffinXL . Surgical interventions for treating intracapsular hip fractures in older adults: a network meta‐analysis. Cochrane Database of Systematic Reviews2022, Issue 2. Art. No: CD013404. [DOI: 10.1002/14651858.CD013404.pub2]">Lewis 2022d</a>). However, we did not explore these eligibility decisions further, for example, by assessing the full texts of individual studies within other similar reviews, and therefore, we cannot rule out the possibility that we incorrectly assessed eligibility for some reviews. We could also not rule out the possibility that we excluded reviews that had mixed surgical populations but did not clearly report whether their results included studies that exclusively recruited people with hip fracture. </p> <p>We were largely guided by <a href="./references#CD013737-bbs2-0142" title="SheaBJ , ReevesBC , WellsG , ThukuM , HamelC , MoranJ , et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ (Clinical Research ed.)2017;358:j4008. [PMID: 28935701]">Shea 2017</a> when conducting assessment of the methodological quality of the included reviews. As noted above, we could not rule out the possibility that our judgements were based on lack of reporting rather than methodological flaws. For example, we found that many reviews did not justify their reason for including only RCTs, or did not cite all excluded studies. For this latter methodological issue, deemed to be critical in a high‐quality review according to AMSTAR 2 guidance, we took a more lenient approach; we did not downgrade our overall judgement if review authors reported numbers of excluded studies with reasons in their flow chart or main text, but did not cite excluded studies. However, on other occasions, we adhered strictly to the questions and answers in the AMSTAR 2 checklist. </p> <p>We also noted that the AMSTAR 2 tool did not always account for review author competency. For example, whilst we judged whether a review conducted a risk of bias assessment, and whether a Cochrane risk of bias tool was used, we did not determine whether review authors had used the tool correctly; it is possible that some review authors were more generous than others in their judgements. It was outside the scope of this overview to check all risk of bias judgements, reporting of publication bias, and indeed, the accuracy of meta‐analysis within included reviews. As we were limited by the information in published reviews, we could not rule out the possibility that this may have impacted our GRADE judgements. </p> <p>Rather than follow a systematic order for prioritising a single review from a series of reviews with overlapping studies, we adapted our priority order to ensure that we selected the review that was predominantly the most relevant to the overview question (in terms of participant and intervention characteristics). We acknowledge that this meant we did not always select the review with the highest methodological quality, or with the most recent search. However, we found that the findings in most reviews were comparable to those in our selected reviews. </p> </section> <section id="CD013737-sec-0078"> <h3 class="title" id="CD013737-sec-0078">Agreements and disagreements with other studies or reviews</h3> <p>We are not aware of any overviews of systematic reviews for this topic. We found that reviews for each type of intervention were largely consistent in their meta‐analyses and interpretation of their findings. For tranexamic acid, reviews in other populations also indicated a benefit in favour of tranexamic acid (e.g. <a href="./references#CD013737-bbs2-0079" title="HenryDA , CarlessPA , MoxeyAJ , O'ConnellD , StokesBJ , FergussonDA , et al. Anti‐fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews2011, Issue 3. Art. No: CD001886. [DOI: 10.1002/14651858.CD001886.pub4]">Henry 2011</a>; <a href="./references#CD013737-bbs2-0120" title="NovikovaN , HofmeyrGJ , CluverC . Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews2015, Issue 6. Art. No: CD007872. [DOI: 10.1002/14651858.CD007872.pub3]">Novikova 2015</a>). Whilst we are aware of reviews for iron in other populations, we could not always determine the effectiveness of this treatment. For example, <a href="./references#CD013737-bbs2-0074" title="GurusamyKS , NagendranM , BroadhurstJF , AnkerSD , RichardsT . Iron therapy in anaemic adults without chronic kidney disease. Cochrane Database of Systematic Reviews2014, Issue 12. Art. No: CD010640. [DOI: 10.1002/14651858.CD010640.pub2]">Gurusamy 2014</a> evaluated iron therapy to treat anaemia, but the evidence of a reduction in blood transfusion after iron use was very low‐certainty. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013737-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/urn:x-wiley:14651858:media:CD013737:CD013737-FIG-01" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD013737-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/image_n/nCD013737-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/image_t/tCD013737-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/image_n/nCD013737-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013737-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/urn:x-wiley:14651858:media:CD013737:CD013737-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Liu 2022 risk of bias summary" data-id="CD013737-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/image_n/nCD013737-FIG-02.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/image_t/tCD013737-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p><a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a> risk of bias summary </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/image_n/nCD013737-FIG-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013737-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/urn:x-wiley:14651858:media:CD013737:CD013737-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Masouros 2022 risk of bias summaryWhen making judgements for the summary of findings table, we did not include risk of bias assessments for Luo 2019, Zhang 2022, and Zufferey 2009; these studies did not provide data for the outcomes reported in our summary of findings table" data-id="CD013737-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/image_n/nCD013737-FIG-03.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/image_t/tCD013737-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p><a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a> risk of bias summary </p> <p>When making judgements for the summary of findings table, we did not include risk of bias assessments for <a href="./references#CD013737-bbs2-0105" title="LuoX , HeS , LinZ , LiZ , HuangC , LiQ . Efficacy and safety of tranexamic acid for controlling bleeding during surgical treatment of intertrochanteric fragility fracture with proximal femoral nail anti-rotation: a randomized controlled trial. Indian Journal of Orthopaedics2019;53(2):263-9.">Luo 2019</a>, <a href="./references#CD013737-bbs2-0166" title="ZhangS , XiaoC , YuW , LongN , HeF , CaiP , et al. Tranexamic acid safely reduces hidden blood loss in patients undergoing intertrochanteric fracture surgery: a randomized controlled trial. European Journal of Emergency Surgery2022;48(2):731-41.">Zhang 2022</a>, and <a href="./references#CD013737-bbs2-0168" title="ZuffereyPJ , MiquetM , QuenetS , MartinP , AdamP , AlbaladejoP , et al. Tranexamic acid in hip fracture surgery: a randomized controlled trial. British Journal of Anaesthesia2010;104(1):23-30.">Zufferey 2009</a>; these studies did not provide data for the outcomes reported in our summary of findings table </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/image_n/nCD013737-FIG-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013737-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/urn:x-wiley:14651858:media:CD013737:CD013737-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Shah 2018 risk of bias summary" data-id="CD013737-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/image_n/nCD013737-FIG-04.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/image_t/tCD013737-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p><a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> risk of bias summary </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/media/CDSR/CD013737/image_n/nCD013737-FIG-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD013737-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of systematic review characteristics evaluating tranexamic acid</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Review</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Date of search</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study designs</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number of RCTs (participants)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participants</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention/</b> </p> <p><b>comparison</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Relevant outcomes</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk of bias assessment</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Certainty of evidence assessment</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0001" title="AgiusC , ColeE , MifsudMG , VasireddyA . The use of tranexamic acid (TXA) in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Trauma2022;36(12):e442-8. [DOI: 10.1097/BOT.0000000000002440]">Agius 2022</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>February 2021</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13 (1194)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip fracture surgery (type of fracture specified)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV TXA/ control (placebo or no treatment)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (thomboembolic events)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane risk of bias tool (<a href="./references#CD013737-bbs2-0148" title="SterneJA , SavovićJ , PageMJ , ElbersRG , BlencoweNS , BoutronI , et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ (Clinical Research ed.)2019;366:14898.">Sterne 2019</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GRADE</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0002" title="BaskaranD , RahmanS , SalmasiY , FroghiS , BerberO , GeorgeM . Effect of tranexamic acid use on blood loss and thromboembolic risk in hip fracture surgery: systematic review and meta-analysis. Hip International2018;28(1):3-10.">Baskaran 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>July 2016</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> <p>NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 (479)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip fracture surgery (any type)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV TXA/ control (placebo or no treatment)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (thomboembolic events)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0004" title="FarrowLS , SmithTO , AshcroftGP , MyintPK . A systematic review of tranexamic acid in hip fracture surgery. British Journal of Clinical Pharmacology2016;82:1458-70.">Farrow 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>June 2016</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> <p>NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 (499)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip fracture surgery (any type)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV and topical TXA/ control (type not specified)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (thomboembolic events, CVA, PE, DVT); mortality</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GRADE</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0006" title="Haj-YounesB , SivakumarBS , WangM , AnVV , LorentzosP , AdieS . Tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Surgery2020;28(1):1-6.">Haj‐Younes 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>March 2019</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 (842)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip/proximal femoral fractures (AO types 31‐A and 31‐B)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV TXA/ placebo or no control</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (DVT, PE, acute coronary syndrome, CVA, wound complications)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane risk of bias tool<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0007" title="JiangW , ShangL . Tranexamic acid can reduce blood loss in patients undergoing intertrochanteric fracture surgery: a meta-analysis. Medicine (Baltimore)2019;98(11):e14564.">Jiang 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>October 2017</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (584)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intertrochanteric hip fractures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV and topical TXA/ placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (DVT, PE, infection, haematoma)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>February 2021</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> <p>NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 (2340)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip fractures (type not specified)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV, topical, or combined IV and topical TXA/ placebo or no treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (DVT, PE, MI, CVA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0010" title="LuoX , HuangH , TangX . Efficacy and safety of tranexamic acid for reducing blood loss in elderly patients with intertrochanteric fracture treated with intramedullary fixation surgery: a meta-analysis of randomized controlled trials. Acta Orthopaedica et Traumatologica Turcica2020;54(1):4-14.">Luo 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>December 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (552)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intertrochanteric fractures treated with intramedullary fixation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV and topical TXA/ placebo or no treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (number of people, and volume); adverse events (thrombotic events); mortality </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane risk of bias tool<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>February 2021</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 (1123)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intra‐or extracapsular hip fractures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV TXA/ placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (number of people, and volume); adverse events (thrombotic events)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane risk of bias tool<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0012" title="QiYM , WangHP , LiYJ , MaBB , XieT , WangC , et al. The efficacy and safety of intravenous tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Translation2019;19:1-11.">Qi 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>March 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 (854)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip fracture</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV TXA/ placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (thromboembolic events)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane risk of bias tool (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0018" title="WangW , YuJ . Tranexamic acid reduces blood loss in intertrochanteric fractures: a meta-analysis from randomized controlled trials. Medicine (Baltimore)2017;96(52):e9396.">Wang 2017a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>September 2017</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (514)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intertrochanteric fractures with internal fixation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV and topical TXA/ placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; Adaerse events (DVT, PE, infection)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GRADE</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0019" title="XiaoC , ZhangS , LongN , YuW , JiangY . Is intravenous tranexamic acid effective and safe during hip fracture surgery? An updated meta-analysis of randomized controlled trials. Archives of Orthopaedic and Trauma Surgery2019;139:893-902.">Xiao 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>May 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 (892)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip fractures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV TXA/ control (placebo, saline, or no treatment)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (DVT, total thromboembolic events)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane risk of bias tool and Jadad<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0020" title="XingF , ChenW , LongC , HuangFG , WangGL , XiangZ . Postoperative outcomes of tranexamic acid use in geriatric trauma patients treated with proximal femoral intramedullary nails: a systematic review and meta-analysis. Orthopaedics &amp; Traumatology: Surgery &amp; Research2020;106(1):117-26.">Xing 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>April 2019</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (539)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intertrochanteric fractures with intramedullary nailing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV and topical TXA/ control (placebo, saline, or no treatment)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (DVT, PE, haematoma, wound infection, respiratory infection, renal failure, CVA); mortality </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0022" title="YuXB , WangJW , WangXY , XieLZ , ChenCH , ZhengWH . The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials. Journal of Thrombosis and Thrombolysis2020;50(2):243-57.">Yu 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>October 2019</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 (1202)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intertrochanteric fractures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV and topical TXA/ control (placebo, saline, or no treatment)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (DVT, PE, CVA, MI, wound complications); mortality</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0023" title="ZhangP , HeJS , FangYC , ChenPT , LiangY , WangJC . Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis. A meta-analysis. Medicine2017;96(21):1-8.">Zhang 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>December 2016</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 (598)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip fracture</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV TXA/ control (placebo or saline)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (thromboembolic events)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12‐item tool (<a href="./references#CD013737-bbs2-0070" title="FurlanAD , PennickV , BombardierC , vanTulderM , Editorial Board Cochrane Back Group. Updated method guideline for systematic reviews in the Cochrane Back Group. Spine2009;34:1929-41. [PMID: 19680101]">Furlan 2009</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GRADE</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0024" title="ZhangP , BaiJ , HeJ , LiangY , ChenP , WangJ . A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery. Clinical Interventions in Aging2018;13:1579-91.">Zhang 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> <p>NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 (1129)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip fracture</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV and topical TXA/ control (placebo or saline)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (thromboembolic events); mortality (3 months)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12‐item tool (<a href="./references#CD013737-bbs2-0070" title="FurlanAD , PennickV , BombardierC , vanTulderM , Editorial Board Cochrane Back Group. Updated method guideline for systematic reviews in the Cochrane Back Group. Spine2009;34:1929-41. [PMID: 19680101]">Furlan 2009</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0025" title="ZhouXD , LiJ , FanGM , HuangY , XuNW . Efficacy and safety of tranexamic acid in elderly patients with intertrochanteric fracture: an updated meta-analysis. World Journal of Clinical Cases2019;7(11):1302-14.">Zhou 2019a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>October 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 (836)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intertrochanteric fractures with internal fixation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV and topical TXA/ control (placebo, saline, or no treatment)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (DVT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GRADE</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0026" title="ZhuQ , YuC , ChenX , XuX , ChenY , LiuC , et al. Efficacy and safety of tranexamic acid for blood salvage in intertrochanteric fracture surgery: a meta-analysis. Clinical and Applied Thrombosis/Hemostasis2018;24(8):1189-98.">Zhu 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>February 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 (746)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intertrochanteric fractures with internal fixation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV and topical TXA/ control (placebo, saline, or no treatment)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (DVT, PE)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane risk of bias tool<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GRADE</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p><sup>a</sup>review reported no citation for the Cochrane risk of bias tool and we could not be certain which version of the tool was used in the review </p> <p>CVA: cerebrovascular accident; DVT: deep vein thrombosis; IV: intravenous(ly); MI: myocardial infarction; NRS: non‐randomised study; RCT: randomised controlled trial; PE: pulmonary embolism; TXA: tranexamic acid </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of systematic review characteristics evaluating tranexamic acid</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013737-tbl-0002"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Overlapping studies in systematic reviews evaluating tranexamic acid</span></div> <tbody> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign="bottom"></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0001" title="AgiusC , ColeE , MifsudMG , VasireddyA . The use of tranexamic acid (TXA) in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Trauma2022;36(12):e442-8. [DOI: 10.1097/BOT.0000000000002440]"><b>Agius 2022</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89."><b>Liu 2022</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300."><b>Masouros 2022</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0006" title="Haj-YounesB , SivakumarBS , WangM , AnVV , LorentzosP , AdieS . Tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Surgery2020;28(1):1-6."><b>Haj‐Younes 2020</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0022" title="YuXB , WangJW , WangXY , XieLZ , ChenCH , ZhengWH . The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials. Journal of Thrombosis and Thrombolysis2020;50(2):243-57."><b>Yu 2020</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0020" title="XingF , ChenW , LongC , HuangFG , WangGL , XiangZ . Postoperative outcomes of tranexamic acid use in geriatric trauma patients treated with proximal femoral intramedullary nails: a systematic review and meta-analysis. Orthopaedics &amp; Traumatology: Surgery &amp; Research2020;106(1):117-26."><b>Xing 2020</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0010" title="LuoX , HuangH , TangX . Efficacy and safety of tranexamic acid for reducing blood loss in elderly patients with intertrochanteric fracture treated with intramedullary fixation surgery: a meta-analysis of randomized controlled trials. Acta Orthopaedica et Traumatologica Turcica2020;54(1):4-14."><b>Luo 2020</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0007" title="JiangW , ShangL . Tranexamic acid can reduce blood loss in patients undergoing intertrochanteric fracture surgery: a meta-analysis. Medicine (Baltimore)2019;98(11):e14564."><b>Jiang 2019</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0025" title="ZhouXD , LiJ , FanGM , HuangY , XuNW . Efficacy and safety of tranexamic acid in elderly patients with intertrochanteric fracture: an updated meta-analysis. World Journal of Clinical Cases2019;7(11):1302-14."><b>Zhou 2019a</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0019" title="XiaoC , ZhangS , LongN , YuW , JiangY . Is intravenous tranexamic acid effective and safe during hip fracture surgery? An updated meta-analysis of randomized controlled trials. Archives of Orthopaedic and Trauma Surgery2019;139:893-902."><b>Xiao 2019</b> </a><a href="./references#CD013737-bbs2-0019" title="XiaoC , ZhangS , LongN , YuW , JiangY . Is intravenous tranexamic acid effective and safe during hip fracture surgery? An updated meta-analysis of randomized controlled trials. Archives of Orthopaedic and Trauma Surgery2019;139:893-902."><b>Xiao 2019</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0012" title="QiYM , WangHP , LiYJ , MaBB , XieT , WangC , et al. The efficacy and safety of intravenous tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Translation2019;19:1-11."><b>Qi 2019</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0026" title="ZhuQ , YuC , ChenX , XuX , ChenY , LiuC , et al. Efficacy and safety of tranexamic acid for blood salvage in intertrochanteric fracture surgery: a meta-analysis. Clinical and Applied Thrombosis/Hemostasis2018;24(8):1189-98."><b>Zhu 2018</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0024" title="ZhangP , BaiJ , HeJ , LiangY , ChenP , WangJ . A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery. Clinical Interventions in Aging2018;13:1579-91."><b>Zhang 2018</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0018" title="WangW , YuJ . Tranexamic acid reduces blood loss in intertrochanteric fractures: a meta-analysis from randomized controlled trials. Medicine (Baltimore)2017;96(52):e9396."><b>Wang 2017a</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0023" title="ZhangP , HeJS , FangYC , ChenPT , LiangY , WangJC . Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis. A meta-analysis. Medicine2017;96(21):1-8."><b>Zhang 2017</b> </a> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0002" title="BaskaranD , RahmanS , SalmasiY , FroghiS , BerberO , GeorgeM . Effect of tranexamic acid use on blood loss and thromboembolic risk in hip fracture surgery: systematic review and meta-analysis. Hip International2018;28(1):3-10."><b>Baskaran 2018</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0004" title="FarrowLS , SmithTO , AshcroftGP , MyintPK . A systematic review of tranexamic acid in hip fracture surgery. British Journal of Clinical Pharmacology2016;82:1458-70."><b>Farrow 2016</b> </a> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0046" title="AhmedM , KumarM . Reduction in blood loss with tranexamic acid in dynamic hip screw surgery for intertrochanteric hip fractures. Rawal Medical Journal2020;201(44):79-82.">Ahmed 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0049" title="BaruahRK , BorahPJ , HaqueR . Use of tranexamic acid in dynamic hip screw plate fixation for trochanteric fractures. Journal of Orthopaedic Surgery2016;24(3):379-82.">Baruah 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0056" title="ChenF , JiangZ , LiM , ZhuX . Efficacy and safety of perioperative tranexamic acid in elderly patients undergoing trochanteric fracture surgery: a randomised controlled trial. Hong Kong Medical Journal2019;25(2):120-6.">Chen 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0064" title="DrakosA , RaoulisV , KaratziosK , DoxariotisN , KontogeorgakosV , MalizosK , et al. Efficacy of local administration of tranexamic acid for blood salvage in patients undergoing intertrochanteric fracture surgery. Journal of Orthopaedic Trauma2016;30(8):409-14.">Drakos 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0065" title="EmaraWM , MoezKK , ElkhoulyAH . Topical versus intravenous tranexamic acid as a blood conservation intervention for reduction of post-operative bleeding in hemiarthroplasty. Anesthesia, Essays and Researches2014;8(1):48-53.">Emara 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0077" title="HaghighiM , EttehadH , Mardani-KiviM , MirbolookA , NabiBN , MoghaddamR , et al. Does tranexamic acid reduce bleeding during femoral fracture operation?Archives of Bone and Joint Surgery2017;5(2):103-8.">Haghighi 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0084" title="JiZW , XiaL , YaoLD , et al. Effect of tranexamic acid on perioperative hidden blood loss in aged patients receiving intramedullary fixation for treatment of intertrochanteric fractures. Chinese Journal of Gerontology2015;7:185.">Ji 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0085" title="JordanM , AguileraX , GonzálezJC , CastillónP , SalomóM , HernándezJA , et al. Prevention of postoperative bleeding in hip fractures treated with prosthetic replacement: efficacy and safety of fibrin sealant and tranexamic acid. A randomised controlled clinical trial (TRANEXFER study). Archives of Orthopaedic and Trauma Surgery2019;139(5):597-604.">Jordan 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0093" title="LeiJ , ZhangB , CongY , ZhuangY , WeiX , FuY , et al. Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial. Journal of Orthopaedic Surgery and Research2017;12(1):124.">Lei 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0101" title="LiGL , WangBP , ZhangB , LuSY . Efficacy and safety of tranexamic acid on perioperative blood loss in artificial femoral head replacement in the elderly. Orthopaedic Journal of China2015;23(24):2230-3.">Li 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0104" title="LuoGG , LinZQ , XieHF , YaoJC , ZhangHZ . Preliminary analysis of the effect of different administration routes of tranexamic acid on blood loss after total hip arthroplasty for female femur neck fractures. China Journal of Orthopaedics and Traumatology2018;31(12):1086-90.">Luo 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0105" title="LuoX , HeS , LinZ , LiZ , HuangC , LiQ . Efficacy and safety of tranexamic acid for controlling bleeding during surgical treatment of intertrochanteric fragility fracture with proximal femoral nail anti-rotation: a randomized controlled trial. Indian Journal of Orthopaedics2019;53(2):263-9.">Luo 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0109" title="MohibY , RashidRH , AliM , ZubairiAJ , UmerM . Does tranexamic acid reduce blood transfusion following surgery for inter-trochanteric fracture? A randomized control trial. Journal of the Pakistan Medical Association2015;65(11 (Suppl 3)):S17-20.">Mohib 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0119" title="NikolaouVS , MasourosP , FlorosT , ChronopoulosE , SkertsouM , BabisGC . Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial. The Bone &amp; Joint Journal2021;103-B:442-8.">Nikolaou 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0137" title="SadeghiM , Mehr-AeinA . Does a single bolus dose of tranexamic acid reduce blood loss and transfusion requirements during hip fracture surgery? A prospective randomized double blind study in 67 patients. Acta Medica Iranica2007;45(6):437-42.">Sadeghi 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0139" title="SchiavoneA , BisacciaM , InkovI , RinonapoliG , ManniM , RolloG , et al. Tranexamic acid in pertrochanteric femoral fracture: is it a safe drug or not?Folia Medica2018;60(1):67-78.">Schiavone 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0143" title="ShiQX , LiangXS , LiK , TangSB , XianC , LinF , et al. Local application of tranexamic acid and absorbable hemostatic gauze for reducing blood loss in PFNA for femoral intertrochanteric fractures in the elderly. Orthopaedic Journal of China2018;26(4):315-9.">Shi 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0150" title="TengbergPT , FossNB , PalmH , KallemoseT , TroelsenA . Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial. The Bone &amp; Joint Journal2016;98(6):747-53.">Tengberg 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0151" title="TianS , ShenZ , LiuY , ZhangY , PengA . The effect of tranexamic acid on hidden bleeding in older intertrochanteric fracture patients treated with PFNA. Injury2018;49(3):680-4.">Tian 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0154" title="VijayBS , BediV , MitraS , DasB . Role of tranexamic acid in reducing postoperative blood loss and transfusion requirement in patients undergoing hip and femoral surgeries. Saudi Journal of Anaesthesia2013;7(1):29-32.">Vijay 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0155" title="ViraniSR , DahaputeAA , PandaI , BavaSS . Role of local infiltration of tranexamic acid in reducing blood loss in peritrochanteric fracture surgery in the elderly population. Malaysian Orthopaedic Journal2016;10:26-30.">Virani 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0159" title="WangH , WangYT , LuZX , LiTF , WangSL , WangYH . Effect of repeated intravenous tranexamic acid in the perioperative period of proximal femoral nail antirotation for femoral intertrochanteric fracture. Chinese Journal of Tissue Engineering Research2021;25(21):3319.">Wang 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0157" title="WangX , ChenY , ChengH . The efficacy and safety of tranexamic acid for blood loss in intertrochanteric fracture surgery. Zhejiang Medical Journal2017;39:(no pagination).">Wang 2017b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0156" title="WangXD , JiangYY , WangJZ , GaoW , LiH , LuJ . Clinical research of tranexamic acid on the hidden blood Ioss after the treatment of intertrochanteric fractures with proximal femoral nail anti-rotation (PFNA). Medical Research and Education2013;30:51-4.">Wang 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0160" title="WattsCD , HoudekMT , SemsSA , CrossWW , PagnanoMW . Tranexamic acid safely reduced blood loss in hemi- and total hip arthroplasty for acute femoral neck fracture: a randomized clinical trial. Journal of Orthopaedic Trauma2017;31(7):345-51.">Watts 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0166" title="ZhangS , XiaoC , YuW , LongN , HeF , CaiP , et al. Tranexamic acid safely reduces hidden blood loss in patients undergoing intertrochanteric fracture surgery: a randomized controlled trial. European Journal of Emergency Surgery2022;48(2):731-41.">Zhang 2022</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0165" title="ZhangQ , XiangC , ChenX , ChenL , ChenQ , JiangK , et al. Application of intravenous injection of tranexamic acid combined with local use of tranexamic acid cocktail in intertrochanteric fracture fixation. Chinese Journal of Reparative and Reconstructive Surgery2020;34(4):463-8.">Zhang 2020b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0167" title="ZhouXD , ZhangY , JiangLF , ZhangJJ , ZhouD , WuLD , et al. Efficacy and safety of tranexamic acid in intertrochanteric fractures: a single-blind randomized controlled trial. Orthopaedic Surgery2019;11(4):635-42.">Zhou 2019b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0168" title="ZuffereyPJ , MiquetM , QuenetS , MartinP , AdamP , AlbaladejoP , et al. Tranexamic acid in hip fracture surgery: a randomized controlled trial. British Journal of Anaesthesia2010;104(1):23-30.">Zufferey 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="18"> <div class="table-footnote"> <p>Systematic reviews are in columns (ordered by date of publication). Included studies in the systematic reviews are in rows (ordered alphabetically). Study overlap = 65.5%; covered area (CA) for overlap = 31.2%; corrected covered area (CCA) for overlap = 26.9% </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Overlapping studies in systematic reviews evaluating tranexamic acid</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013737-tbl-0003"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Characteristics of RCTs in Liu 2021 and Masouros 2021 (tranexamic acid)</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID<sup>a</sup> </b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>N (TXA; control)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Age (in years), mean (SD) (TXA; contol)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>M/F (TXA; control)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Fracture type</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Surgery</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Route, dose, number of doses (TXA; control)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Timing</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Transfusion crtieria</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0046" title="AhmedM , KumarM . Reduction in blood loss with tranexamic acid in dynamic hip screw surgery for intertrochanteric hip fractures. Rawal Medical Journal2020;201(44):79-82.">Ahmed 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60; 60</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DHS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg;</p> <p>normal saline, given once</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prior to surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0049" title="BaruahRK , BorahPJ , HaqueR . Use of tranexamic acid in dynamic hip screw plate fixation for trochanteric fractures. Journal of Orthopaedic Surgery2016;24(3):379-82.">Baruah 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30; 30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57.7 (± 14.5);</p> <p>55.3 (± 15.2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24/6;</p> <p>25/5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>stable trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ORIF with DHS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg;</p> <p>normal saline, given once</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 min prior to surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 8.5 g/dL or HCT &lt; 27%</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0056" title="ChenF , JiangZ , LiM , ZhuX . Efficacy and safety of perioperative tranexamic acid in elderly patients undergoing trochanteric fracture surgery: a randomised controlled trial. Hong Kong Medical Journal2019;25(2):120-6.">Chen 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88; 88</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76.8 (± 7); 77.4 (± 6.8)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39/49; 37/51</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DHS, PFNA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg in 100 mL of saline, given 3 times;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 min before incision, continuously through surgery, 3 h after surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL; Hb &lt; 10 g/dL at risk</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0064" title="DrakosA , RaoulisV , KaratziosK , DoxariotisN , KontogeorgakosV , MalizosK , et al. Efficacy of local administration of tranexamic acid for blood salvage in patients undergoing intertrochanteric fracture surgery. Journal of Orthopaedic Trauma2016;30(8):409-14.">Drakos 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100; 100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81 (65 to 96);</p> <p>80.7 (65 to 97)<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27/73;</p> <p>21/79</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IMN</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical 3 g, 30 mL (500 mg/5 mL × 6 amps)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At the end of surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 8 g/dL or HCT &lt; 25%, unless at risk</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0065" title="EmaraWM , MoezKK , ElkhoulyAH . Topical versus intravenous tranexamic acid as a blood conservation intervention for reduction of post-operative bleeding in hemiarthroplasty. Anesthesia, Essays and Researches2014;8(1):48-53.">Emara 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: 20; 20; </p> <p><i>control</i>: 20 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: 56.5 (± 2.8); </p> <p><i>TXA</i>: 55 (± 2.6); </p> <p><i>Control</i>: 56 (± 3.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TXA: 12/8;</p> <p>TXA: 10/10;</p> <p>Control: 14/6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>femoral</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: topical 10 mg/kg in 20 mL saline; 5 mg/kg/h in the form of 500 mg TXA in 250 mL at rate of 80 mL/h, given twice; </p> <p>topical 1.5 g in 100 mL saline, given once;</p> <p><i>control</i>: normal saline </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: a bolus dose prior to skin incision; </p> <p><i>Topical</i>: prior to wound closure </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0085" title="JordanM , AguileraX , GonzálezJC , CastillónP , SalomóM , HernándezJA , et al. Prevention of postoperative bleeding in hip fractures treated with prosthetic replacement: efficacy and safety of fibrin sealant and tranexamic acid. A randomised controlled clinical trial (TRANEXFER study). Archives of Orthopaedic and Trauma Surgery2019;139(5):597-604.">Jordan 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51; 50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84.1 (± 6.9);</p> <p>84.6 (± 10.4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9/43;</p> <p>13/37</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>sub‐capital femoral</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>THA or PHA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical 1 g in 10 mL solution, given once;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Applied on soft tissues and exposed surfaces of femur</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL or Hb &lt; 8 g/dL; Hb 9 to 10 g/dL at risk</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0093" title="LeiJ , ZhangB , CongY , ZhuangY , WeiX , FuY , et al. Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial. Journal of Orthopaedic Surgery and Research2017;12(1):124.">Lei 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37; 40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77.8 (± 9.8);</p> <p>79.2 (± 6.5)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5/32;</p> <p>7/33</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PFNA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 1 g in 200 mL saline, given once; normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>After anaesthesia, but before surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 9 g/dL</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0101" title="LiGL , WangBP , ZhangB , LuSY . Efficacy and safety of tranexamic acid on perioperative blood loss in artificial femoral head replacement in the elderly. Orthopaedic Journal of China2015;23(24):2230-3.">Li 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30; 30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77.9 (± 3.9);</p> <p>77.4 (± 3.4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15/15;</p> <p>13/17</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>femoral head</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>THA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 10 mg/kg, given once;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A bolus after anaesthesia, but before surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL; Hb 7 to 10 g/dL at risk</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0104" title="LuoGG , LinZQ , XieHF , YaoJC , ZhangHZ . Preliminary analysis of the effect of different administration routes of tranexamic acid on blood loss after total hip arthroplasty for female femur neck fractures. China Journal of Orthopaedics and Traumatology2018;31(12):1086-90.">Luo 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: 21; </p> <p><i>TXA:</i> 18; </p> <p><i>TXA:</i> 19; <i>contol</i>: 19 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: 77.1 (± 7); </p> <p><i>TXA</i>: 73.8 (± 6.6); </p> <p><i>TXA</i>: 74.2 (± 6); </p> <p><i>Control</i>: 76.7 (± 9.2) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: 0/21; </p> <p><i>TXA</i>: 0/18; </p> <p><i>TXA</i>: 0/19; </p> <p><i>Control:</i> 0/19 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>femoral neck</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>THA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: IV 15 mg/kg, given once; </p> <p><i>TXA:</i> topical 3 g, once; </p> <p><i>TXA:</i> IV + topical 15 mg/kg; 1.5 g, twice; </p> <p><i>control</i>: normal saline </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: 5 min before skin incision; </p> <p><i>TXA:</i> topical: into the joint cavity; </p> <p><i>TXA:</i> IV + topical: 5 min before skin incision, into the joint cavity </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL or HCT &lt; 25%</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0105" title="LuoX , HeS , LinZ , LiZ , HuangC , LiQ . Efficacy and safety of tranexamic acid for controlling bleeding during surgical treatment of intertrochanteric fragility fracture with proximal femoral nail anti-rotation: a randomized controlled trial. Indian Journal of Orthopaedics2019;53(2):263-9.">Luo 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44; 46</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75.1 (± 8);</p> <p>76.1 (± 9.3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23/21;</p> <p>20/26</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PFNA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg, given twice;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 min before incision and 3 h later</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 8 g/dL; Hb &gt; 8 g/dL at risk</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0109" title="MohibY , RashidRH , AliM , ZubairiAJ , UmerM . Does tranexamic acid reduce blood transfusion following surgery for inter-trochanteric fracture? A randomized control trial. Journal of the Pakistan Medical Association2015;65(11 (Suppl 3)):S17-20.">Mohib 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50; 50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69 (± 10);</p> <p>70 (± 9.4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21/29;</p> <p>24/26</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg, given twice;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Just before surgery and 3 h later</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0119" title="NikolaouVS , MasourosP , FlorosT , ChronopoulosE , SkertsouM , BabisGC . Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial. The Bone &amp; Joint Journal2021;103-B:442-8.">Nikolaou 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68; 70</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82.9;</p> <p>83.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10/58;</p> <p>18/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric; femoral neck</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IMN; HA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 mins before surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0137" title="SadeghiM , Mehr-AeinA . Does a single bolus dose of tranexamic acid reduce blood loss and transfusion requirements during hip fracture surgery? A prospective randomized double blind study in 67 patients. Acta Medica Iranica2007;45(6):437-42.">Sadeghi 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32; 35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51.8 (± 25.7);</p> <p>44.4 (± 26.2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17/15;</p> <p>24/11</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>intracapsular; extracapsular</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HA, IMN, DHS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg, given once;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A bolus at induction of anaesthesia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case by case Hb 8 to 10 g/dL</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0139" title="SchiavoneA , BisacciaM , InkovI , RinonapoliG , ManniM , RolloG , et al. Tranexamic acid in pertrochanteric femoral fracture: is it a safe drug or not?Folia Medica2018;60(1):67-78.">Schiavone 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47; 43</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84.3 (± 8.3);</p> <p>84.3 (± 8.3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12/35;</p> <p>15/28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>pertrochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DHS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg, given once;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A bolus at surgical incision</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 8.5 g/dL; Hb &lt; 9 g/dL at risk</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0143" title="ShiQX , LiangXS , LiK , TangSB , XianC , LinF , et al. Local application of tranexamic acid and absorbable hemostatic gauze for reducing blood loss in PFNA for femoral intertrochanteric fractures in the elderly. Orthopaedic Journal of China2018;26(4):315-9.">Shi 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24; 24</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88.1 (± 6.2);</p> <p>89.2 (± 7.1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PFNA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical 2 g in 20 mL saline, given once;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Into the joint cavity</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0150" title="TengbergPT , FossNB , PalmH , KallemoseT , TroelsenA . Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial. The Bone &amp; Joint Journal2016;98(6):747-53.">Tengberg 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33; 39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79.8 (± 11.5);</p> <p>70 (± 12.6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/26;</p> <p>14/25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>intracapsular; extracapsular</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IM</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 1 g; 3 g in 1 L of saline, given twice;</p> <p>placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A bolus during draping, just prior to surgery, and postoperative 24 h infusion</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 9.67 g/dL</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0151" title="TianS , ShenZ , LiuY , ZhangY , PengA . The effect of tranexamic acid on hidden bleeding in older intertrochanteric fracture patients treated with PFNA. Injury2018;49(3):680-4.">Tian 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50; 50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77.7 (± 6.5);</p> <p>79.3 (± 6.6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19/31;</p> <p>14/36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PFNA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 10 mg/kg, given twice;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 min preoperatively and 5 h postoperatively</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 9 g/dL</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0154" title="VijayBS , BediV , MitraS , DasB . Role of tranexamic acid in reducing postoperative blood loss and transfusion requirement in patients undergoing hip and femoral surgeries. Saudi Journal of Anaesthesia2013;7(1):29-32.">Vijay 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45; 45</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48.8 (± 16.2);</p> <p>49.3 (± 19.5)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10/35;</p> <p>10/35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>femoral</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ORIF, HA, THA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 10 mg/kg (500 mg in 50 mL saline; 1 mg/kg/h dissolved in 1 L saline), given twice;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A bolus 15 min before incision, a continuous infusion until the completion of surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reduction of Hb &gt; 25%</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0155" title="ViraniSR , DahaputeAA , PandaI , BavaSS . Role of local infiltration of tranexamic acid in reducing blood loss in peritrochanteric fracture surgery in the elderly population. Malaysian Orthopaedic Journal2016;10:26-30.">Virani 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67; 70</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67;</p> <p>69.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25/42;</p> <p>24/43</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>peritrochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DHS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical 2 g, given once;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In the proximal lateral thigh before closure</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 9 g/dL</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0159" title="WangH , WangYT , LuZX , LiTF , WangSL , WangYH . Effect of repeated intravenous tranexamic acid in the perioperative period of proximal femoral nail antirotation for femoral intertrochanteric fracture. Chinese Journal of Tissue Engineering Research2021;25(21):3319.">Wang 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i> : 33; <i>TXA:</i> 35; </p> <p><i>control</i>: 32 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA:</i> 75.2 (± 9.4); </p> <p><i>TXA</i>: 74.3 (± 7.1); </p> <p><i>control</i>: 72.3 (± 7.7) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: 10/23; </p> <p><i>TXA</i>: 9/26; </p> <p><i>control:</i> 10/22 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PFNA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: IV 1 g, given once; </p> <p><i>TXA</i>: IV 1g, given 3 times; </p> <p><i>control</i>: normal saline </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Half‐hour before operation; before operation; and at 3 and 6 h after operation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL; Hb 7 to 10 g/dL at risk</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0160" title="WattsCD , HoudekMT , SemsSA , CrossWW , PagnanoMW . Tranexamic acid safely reduced blood loss in hemi- and total hip arthroplasty for acute femoral neck fracture: a randomized clinical trial. Journal of Orthopaedic Trauma2017;31(7):345-51.">Watts 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69; 69</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81 (± 10);</p> <p>82.2 (± 10)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21/48;</p> <p>22/47</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>femoral neck</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HA, THA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg in 100 mL of saline, given twice;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Before incision, and at wound closure</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL; Hb &lt; 8 g/dL at risk</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0166" title="ZhangS , XiaoC , YuW , LongN , HeF , CaiP , et al. Tranexamic acid safely reduces hidden blood loss in patients undergoing intertrochanteric fracture surgery: a randomized controlled trial. European Journal of Emergency Surgery2022;48(2):731-41.">Zhang 2022</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61; 61</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79.1 (± 11.9);</p> <p>76.1 (± 16.6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33/28;</p> <p>34/27</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PFNA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 1 g in 100 mL saline, given twice;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 min before incision, and at 3 h later</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL; Hb 7 to 10 g/dL at risk</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0165" title="ZhangQ , XiangC , ChenX , ChenL , ChenQ , JiangK , et al. Application of intravenous injection of tranexamic acid combined with local use of tranexamic acid cocktail in intertrochanteric fracture fixation. Chinese Journal of Reparative and Reconstructive Surgery2020;34(4):463-8.">Zhang 2020b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i> : 15; <i>TXA:</i> 15; <i>control:</i> 15 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA:</i> 71.2 (65 to 89); </p> <p><i>TXA</i>: 71.6 (67 to 84); </p> <p><i>control:</i> 73.1 (65 to 86)<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA:</i> 7/8; </p> <p><i>TXA</i>: 6/9; </p> <p><i>control</i>: 8/7 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PFNA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA</i>: IV 1 g in 100 mL saline, given once; </p> <p><i>TXA:</i> IV + topical 1 g in 100 mL saline, 1 g in 50 mL saline, twice; </p> <p><i>control:</i> normal saline </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>TXA:</i> 15 min before incision; </p> <p><i>TXA:</i> 15 min before incision, into the joint cavity </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0167" title="ZhouXD , ZhangY , JiangLF , ZhangJJ , ZhouD , WuLD , et al. Efficacy and safety of tranexamic acid in intertrochanteric fractures: a single-blind randomized controlled trial. Orthopaedic Surgery2019;11(4):635-42.">Zhou 2019b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50; 50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75.1 (± 8.3); 77.8 (± 6.4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15/35;</p> <p>22/28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>trochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PFNA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 1 g in 100 mL saline, given once;</p> <p>normal saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 min prior to surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0168" title="ZuffereyPJ , MiquetM , QuenetS , MartinP , AdamP , AlbaladejoP , et al. Tranexamic acid in hip fracture surgery: a randomized controlled trial. British Journal of Anaesthesia2010;104(1):23-30.">Zufferey 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57; 53</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Mean (range)</i>: </p> <p>81 (51 to 99);</p> <p>82 (56 to 95)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10/47;</p> <p>4/49</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>cervical only; stable/unstable trochanteric transtrochanteric, subtrochanteric</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>THA, HA, DHS, IMN</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV 15 mg/kg, given twice;</p> <p>placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Before surgery and 3 h later</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 9 g/dL; Hb &lt; 10 g/dL at risk</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p><sup>a</sup>All information for individual studies is taken from <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>; except for <a href="./references#CD013737-bbs2-0119" title="NikolaouVS , MasourosP , FlorosT , ChronopoulosE , SkertsouM , BabisGC . Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial. The Bone &amp; Joint Journal2021;103-B:442-8.">Nikolaou 2021</a>, which is taken from <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>.<br/><sup>b</sup>Average (mean or median) and distribution type was not specified in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>, or in the original study reports. </p> <p>CHS: cannulated hip screw; DHS: dynamic hip screw; DVT: deep vein thrombosis; h: hours; Hb: haemoglobin; HA: hemiarthroplasty; IMN: intramedullary nail; IV: intravenous(ly); LMWH: low‐molecular‐weight heparin; M/F: male/female; min: minute(s); N: number of participants; NS: not specified; ORIF: open reduction and internal fixation; PFNA: proximal femoral nail antirotation; PHA: partial hip arthroplasty; SD: standard deviation; THA: total hip arthroplasty; TXA: tranexamic acid </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Characteristics of RCTs in Liu 2021 and Masouros 2021 (tranexamic acid)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013737-tbl-0004"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Summary of systematic review characteristics evaluating iron and iron with EPO</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Review</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Date of search</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study designs</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number of RCTs (participants)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participants</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention</b> </p> <p><b>Comparison</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Relevant outcomes</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk of bias assessment</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Certainty of evidence assessment</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0003" title="ChenR , LiL , XiangZ , LiH , HouXL . Association of iron supplementation with risk of transfusion, hospital length of stay, and mortality in geriatric patients undergoing hip fracture surgeries: a meta-analysis. European Geriatric Medicine2021;12(1):5-15. [PMID: 32691389]">Chen 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>April 2019</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs and NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (803)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Femoral neck fractures, trochanteric fractures, or subtrochanteric fractures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iron or iron + EPO (included studies used iron sucrose and ferrous sulphate)</p> <p><i>Control:</i> placebo or standard care </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (rate and volume); adverse events (infection); mortality</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Jadad<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0005" title="Gomez-RamirezS , Maldonado-RuizMA , Campos-GarriguesA , HerreraA , MunozM . Short-term perioperative iron in major orthopedic surgery: state of the art. Vox Sanguinis2019;114(1):3-16. [PMID: 30411362]">Gomez‐Ramirez 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs and NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (948)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Major orthopaedic surgery (including hip fracture)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iron or iron + EPO (included studies used iron sucrose or FCM)</p> <p><i>Control:</i> placebo or standard care </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (gastrointestinal symptoms, hypotension, headache, general discomfort, skin rash, flushing and tingling in the lips, infection); mortality </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0008" title="LinDM , LinES , TranMH . Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfusion Medicine Reviews2013;27(4):221-34. [PMID: 24135037]">Lin 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>July 2012</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs and NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (279)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mixed surgery (including hip fracture)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iron + EPO</p> <p><i>Control:</i> autologous blood donation, oral iron, or placebo </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (rate and volume); adverse events (infection, thromboembolic events); mortality </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane risk of bias tool<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0013" title="SchackA , BerkforsAA , EkeloefS , GögenurI , BurcharthJ . The effect of perioperative iron therapy in acute major non-cardiac surgery on allogenic blood transfusion and postoperative haemoglobin levels: a systematic review and meta-analysis. World Journal of Surgery2019;43(7):1677-91. [PMID: 30824959]">Schack 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>November 2017</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs and NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (485)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Major non‐cardiac surgery (including hip fracture)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral or IV iron with or without EPO</p> <p><i>Control:</i> no intervention, active comparator, or another iron treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; adverse events (mild and severe); mortality</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>June 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (503)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐elective surgery (including hip fracture)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV iron with and without EPO</p> <p><i>Control:</i> placebo or standard care </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (rate and volume); delirium; adverse events (nausea, gastrointestinal symptoms, cholestasis, peripheral phlebitis, hypotension, low‐grade fever, skin rash, general discomfort, acute coronary disease, CVA, COPD exacerbation, heart failure, renal function deterioration, skin pressure ulcer); HRQoL; mortality </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0015" title="ShinHW , ParkJJ , KimHJ , YouHS , ChoiSU , LeeMJ . Efficacy of perioperative intravenous iron therapy for transfusion in orthopedic surgery: a systematic review and meta-analysis. PLoS One2019;14(5):e0215427. [PMID: 31059515]">Shin 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>September 2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs and NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (491)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Orthopaedic surgery (including hip fracture)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iron</p> <p><i>Control</i> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (rate and volume); adverse events (infection); mortality</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January 2021</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs and NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (832)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip fracture surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV iron (any preparation)</p> <p><i>Control:</i> placebo or standard care </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion; HRQoL; mortality; ADL</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GRADE</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0017" title="SmithA , MoonT , PakT , ParkB , UrmanRD . Preoperative anemia treatment with intravenous iron in patients undergoing major orthopedic surgery: a systematic review. Geriatric Orthopaedic Surgery &amp; Rehabilitation2020;11:2151459320935094. [PMID: 32637197]">Smith 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>September 2019</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs and NRS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (579)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Major orthopaedic surgery (including hip fracture)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV iron or iron with EPO, given preoperatively</p> <p><i>Control:</i> placebo or standard care </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (rate and volume); adverse events (serious adverse events, cardiovascular events, infection); HRQoL; mortality </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RoB 1 (<a href="./references#CD013737-bbs2-0080" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0021" title="YangY , LiH , LiB , WangY , JiangS , JiangL . Efficacy and safety of iron supplementation for the elderly patients undergoing hip or knee surgery: a meta-analysis of randomized controlled trials. The Journal of Surgical Research2011;171(2):e201-7. [PMID: 21962806]">Yang 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>May 2011</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (568)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hip or knee surgery (including hip fracture</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral or IV iron</p> <p><i>Control:</i> placebo or no treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (rate and volume); adverse events<sup>c</sup>; mortality </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cochrane risk of bias tool (<a href="./references#CD013737-bbs2-0153" title="vanTulderM , FurlanA , BombardierC , BouterL , Editorial Board Cochrane Back Review Group. Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine2003;28:1290. [PMID: 12811274]">van Tulder 2003</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p><sup>a</sup>Review authors did not report a citation for this tool and we could not be certain which version was used<br/><sup>b</sup>We used only unpublished data for this review, which were supplied by personal communication with the review author (by email)<br/><sup>c</sup>Type of adverse events not specified in the study; because not all studies were eligible for inclusion in our review, we could not determine which of the reported adverse events were relevant. </p> <p>ADL: activities of daily living; EPO: erythropoeitin; HRQoL: health‐related quality of life; IV: intravenous(ly); NRS: non‐randomised studies; RCTs: randomised controlled trials </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Summary of systematic review characteristics evaluating iron and iron with EPO</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013737-tbl-0005"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Overlapping studies in systematic reviews evaluating iron and iron with erythropoeitin (EPO)</span></div> <tbody> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign="bottom"></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0003" title="ChenR , LiL , XiangZ , LiH , HouXL . Association of iron supplementation with risk of transfusion, hospital length of stay, and mortality in geriatric patients undergoing hip fracture surgeries: a meta-analysis. European Geriatric Medicine2021;12(1):5-15. [PMID: 32691389]"><b>Chen 2021</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0005" title="Gomez-RamirezS , Maldonado-RuizMA , Campos-GarriguesA , HerreraA , MunozM . Short-term perioperative iron in major orthopedic surgery: state of the art. Vox Sanguinis2019;114(1):3-16. [PMID: 30411362]"><b>Gomez‐Ramirez 2019</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0008" title="LinDM , LinES , TranMH . Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfusion Medicine Reviews2013;27(4):221-34. [PMID: 24135037]"><b>Lin 2013</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0013" title="SchackA , BerkforsAA , EkeloefS , GögenurI , BurcharthJ . The effect of perioperative iron therapy in acute major non-cardiac surgery on allogenic blood transfusion and postoperative haemoglobin levels: a systematic review and meta-analysis. World Journal of Surgery2019;43(7):1677-91. [PMID: 30824959]"><b>Schack 2019</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]"><b>Shah 2018</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0015" title="ShinHW , ParkJJ , KimHJ , YouHS , ChoiSU , LeeMJ . Efficacy of perioperative intravenous iron therapy for transfusion in orthopedic surgery: a systematic review and meta-analysis. PLoS One2019;14(5):e0215427. [PMID: 31059515]"><b>Shin 2019</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020."><b>Sinclair 2020</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0017" title="SmithA , MoonT , PakT , ParkB , UrmanRD . Preoperative anemia treatment with intravenous iron in patients undergoing major orthopedic surgery: a systematic review. Geriatric Orthopaedic Surgery &amp; Rehabilitation2020;11:2151459320935094. [PMID: 32637197]"><b>Smith 2020</b> </a> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD013737-bbs2-0021" title="YangY , LiH , LiB , WangY , JiangS , JiangL . Efficacy and safety of iron supplementation for the elderly patients undergoing hip or knee surgery: a meta-analysis of randomized controlled trials. The Journal of Surgical Research2011;171(2):e201-7. [PMID: 21962806]"><b>Yang 2011</b> </a> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0050" title="Bernabeu-WittelM , RomeroM , Ollero-BaturoneM , AparicioR , Murcia-ZaragozaJ , Rincon-GomezM , et al. Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial. Transfusion 56;9:2199-211. [PMID: 27195774]">Bernabeu‐Wittel 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0051" title="BielzaR , LlorenteJ , ThuissardIJ , Andreu-VázquezC , BlancoD , SanjurjoJ , et al. Effect of intravenous iron on functional outcomes in hip fracture: a randomised controlled trial. Age and Ageing2021;50(1):127-34. [PMID: 32542370]">Bielza 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0090" title="KaterosK , SakellariouVI , SofianosIP , PapagelopoulosPJ . Epoetin alfa reduces blood transfusion requirements in patients with intertrochanteric fracture. Journal of Critical Care2010;25:348-53. [PMID: 19592206]">Kateros 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0111" title="MoppettIK , RowlandsM , ManningsAM , MarufuTC , SahotaO , YeungJ . The effect of intravenous iron on erythropoiesis in older people with hip fracture. Age and Ageing2019;48(5):751-5. [PMID: 31127269]">Moppett 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0124" title="ParkerMJ . Iron supplementation for anemia after hip fracture surgery: a randomized trial of 300 patients. The Jounral of Bone and Joint Surgery. American Volume2010;92(2):265-9. [PMID: 20124051]">Parker 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0129" title="PrasadN , RajamaniV , HullinD , MurrayJM . Post-operative anaemia in femoral neck fracture patients: does it need treatment? A single blinded prospective randomised controlled trial. Injury2009;40:1073-6. [PMID: 19524906]">Prasad 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0141" title="Serrano-TrenasJA , UgaldePF , CabelloLM , ChofesLC , LázaroPS , BenítezPC . Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. Transfusion2011;51(1):97-104. [PMID: 20630042]">Serrano‐Trenas 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p>Systematic reviews are in columns (ordered by date of publication). Included studies in the systematic reviews are in rows (ordered alphabetically). Study overlap = 85.7%; covered area (CA) for overlap = 42.9%; corrected covered area (CCA) for overlap = 35.7% </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Overlapping studies in systematic reviews evaluating iron and iron with erythropoeitin (EPO)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013737-tbl-0006"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Characteristics of RCTs in Shah 2018 (iron)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant criteria</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>N</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Years of age, mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>M/F</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Fracture type</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Surgery</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Administration dose, route, and number of doses</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Timing</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Transfusion crtieria</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0050" title="Bernabeu-WittelM , RomeroM , Ollero-BaturoneM , AparicioR , Murcia-ZaragozaJ , Rincon-GomezM , et al. Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial. Transfusion 56;9:2199-211. [PMID: 27195774]">Bernabeu‐Wittel 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 65 years, osteoporotic hip fracture, Hb 90 to 120 g/L</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Iron:</i> 103; </p> <p><i>Iron + EPO:</i> 100 </p> <p><i>Control:</i> 100 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Iron:</i> 84.6 (± 6.2) </p> <p><i>Iron + EPO:</i> 83.4 (± 6.4) </p> <p><i>Control:</i> 82.3 (± 6.9) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Iron:</i> 19/84 </p> <p><i>Iron + EPO</i>: 13/87 </p> <p><i>Control:</i> 13/87 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pertrochanteric, subcapital, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IF, HA or THA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Iron</i>: 1000 mg of IV ferric carboxymaltose (2 x 500 mg vials diluted in 250 mL saline) in 20 min infusion </p> <p><i>Iron + EPO:</i> 1000 mg of IV ferric carboxymaltose (2 x 500 mg vials diluted in 250 mL saline) in 20 min infusion; subcutaneous single dose of 40,000 IU or EPO in prefilled 1 mL syringe </p> <p><i>Control:</i> IV placebo (250 mL saline) in 20 min infusion </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prior to surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 70 g/L: 3 RBC transfusions (independent of symptoms)</p> <p>Hb 71 to 89 g/L with severe symptoms: 2 RBC transfusions</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0141" title="Serrano-TrenasJA , UgaldePF , CabelloLM , ChofesLC , LázaroPS , BenítezPC . Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. Transfusion2011;51(1):97-104. [PMID: 20630042]">Serrano‐Trenas 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 65 years, hip fracture</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Iron</i>: 99 </p> <p><i>Control:</i> 97 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Iron:</i> 83.46 (± 7.11) </p> <p><i>Control:</i> 82.53 (± 6.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Iron</i>: 20/79 </p> <p><i>Control:</i> 20/77 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Extracapsular, intracapsular</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IF, HA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Iron:</i> standard protocol treatment; plus 600 mg iron sucrose IV (3 x 200 mg over 48 hour period, in 90‐min infusion) </p> <p><i>Control</i>: standard protocol treatment<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Iron:</i> first dose 24 hours after admission and before surgery; other doses given before or after surgery, all within 48 hours </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assumed to follow standard protocol<sup>a</sup> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p><sup>a</sup>criteria for RBC transfusion: preoperative Hb &lt; 10 g/dL; postoperative Hb &lt; 8 g/dL, or &lt; 9 g/dL if participant had history of cardiorespiratory conditions; or any Hb with symptoms of untreated anaemia </p> <p>EPO: erythropoietin; Hb: haemoglobin levels; IV: intravenous(ly); M/F: male/female; N: number of participants randomised to group; RBC: red blood cell </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Characteristics of RCTs in Shah 2018 (iron)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013737-tbl-0007"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">AMSTAR 2 summary for reviews evaluating tranexamic acid</span></div> <tbody> <tr> <td align="left" class="headercell" colspan="1" rowspan="1" valign="bottom"></td> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>1</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>2</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>3</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>4</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>5</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>6</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>7</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>8</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>9</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>10</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>11</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>12</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>13</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>14</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>15</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>16</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall confidence in the results of the review</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0001" title="AgiusC , ColeE , MifsudMG , VasireddyA . The use of tranexamic acid (TXA) in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Trauma2022;36(12):e442-8. [DOI: 10.1097/BOT.0000000000002440]"><b>Agius 2022</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0002" title="BaskaranD , RahmanS , SalmasiY , FroghiS , BerberO , GeorgeM . Effect of tranexamic acid use on blood loss and thromboembolic risk in hip fracture surgery: systematic review and meta-analysis. Hip International2018;28(1):3-10."><b>Baskaran 2018</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0004" title="FarrowLS , SmithTO , AshcroftGP , MyintPK . A systematic review of tranexamic acid in hip fracture surgery. British Journal of Clinical Pharmacology2016;82:1458-70."><b>Farrow 2016</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0006" title="Haj-YounesB , SivakumarBS , WangM , AnVV , LorentzosP , AdieS . Tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Surgery2020;28(1):1-6."><b>Haj‐Younes 2020</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0007" title="JiangW , ShangL . Tranexamic acid can reduce blood loss in patients undergoing intertrochanteric fracture surgery: a meta-analysis. Medicine (Baltimore)2019;98(11):e14564."><b>Jiang 2019</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89."><b>Liu 2022</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0010" title="LuoX , HuangH , TangX . Efficacy and safety of tranexamic acid for reducing blood loss in elderly patients with intertrochanteric fracture treated with intramedullary fixation surgery: a meta-analysis of randomized controlled trials. Acta Orthopaedica et Traumatologica Turcica2020;54(1):4-14."><b>Luo 2020</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300."><b>Masouros 2022</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0012" title="QiYM , WangHP , LiYJ , MaBB , XieT , WangC , et al. The efficacy and safety of intravenous tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. Journal of Orthopaedic Translation2019;19:1-11."><b>Qi 2019</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0018" title="WangW , YuJ . Tranexamic acid reduces blood loss in intertrochanteric fractures: a meta-analysis from randomized controlled trials. Medicine (Baltimore)2017;96(52):e9396."><b>Wang 2017a</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0019" title="XiaoC , ZhangS , LongN , YuW , JiangY . Is intravenous tranexamic acid effective and safe during hip fracture surgery? An updated meta-analysis of randomized controlled trials. Archives of Orthopaedic and Trauma Surgery2019;139:893-902."><b>Xiao 2019</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0020" title="XingF , ChenW , LongC , HuangFG , WangGL , XiangZ . Postoperative outcomes of tranexamic acid use in geriatric trauma patients treated with proximal femoral intramedullary nails: a systematic review and meta-analysis. Orthopaedics &amp; Traumatology: Surgery &amp; Research2020;106(1):117-26."><b>Xing 2020</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0022" title="YuXB , WangJW , WangXY , XieLZ , ChenCH , ZhengWH . The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials. Journal of Thrombosis and Thrombolysis2020;50(2):243-57."><b>Yu 2020</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0023" title="ZhangP , HeJS , FangYC , ChenPT , LiangY , WangJC . Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis. A meta-analysis. Medicine2017;96(21):1-8."><b>Zhang 2017</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0024" title="ZhangP , BaiJ , HeJ , LiangY , ChenP , WangJ . A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery. Clinical Interventions in Aging2018;13:1579-91."><b>Zhang 2018</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0025" title="ZhouXD , LiJ , FanGM , HuangY , XuNW . Efficacy and safety of tranexamic acid in elderly patients with intertrochanteric fracture: an updated meta-analysis. World Journal of Clinical Cases2019;7(11):1302-14."><b>Zhou 2019a</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><a href="./references#CD013737-bbs2-0026" title="ZhuQ , YuC , ChenX , XuX , ChenY , LiuC , et al. Efficacy and safety of tranexamic acid for blood salvage in intertrochanteric fracture surgery: a meta-analysis. Clinical and Applied Thrombosis/Hemostasis2018;24(8):1189-98."><b>Zhu 2018</b> </a> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="18"> <div class="table-footnote"> <p>Scores from the 16 questions in the AMSTAR 2 critical appraisal tool (see <a href="./appendices#CD013737-sec-0085">Appendix 2</a>). N: no; PY: partial yes; Y: yes </p> <p><sup>a</sup>Funnel plot not performed, but we noted that fewer than 10 trials were included<br/><sup>b</sup>Although citations for individual studies were not given, reasons for exclusion were enumerated<br/><sup>c</sup>No studies excluded at full‐text review<br/><sup>d</sup>Protocol did not clearly state a rationale for choosing to combine studies; however, we judged the studies to be sufficiently similar </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">AMSTAR 2 summary for reviews evaluating tranexamic acid</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013737-tbl-0008"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">AMSTAR 2 summary for reviews evaluating iron or iron with erythropoeitin (EPO)</span></div> <tbody> <tr> <td align="left" class="headercell" colspan="1" rowspan="1" valign="bottom"></td> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>1</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>2</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>3</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>4</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>5</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>6</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>7</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>8</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>9</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>10</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>11</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>12</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>13</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>14</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>15</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>16</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall confidence in the results of the review</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0003" title="ChenR , LiL , XiangZ , LiH , HouXL . Association of iron supplementation with risk of transfusion, hospital length of stay, and mortality in geriatric patients undergoing hip fracture surgeries: a meta-analysis. European Geriatric Medicine2021;12(1):5-15. [PMID: 32691389]">Chen 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0005" title="Gomez-RamirezS , Maldonado-RuizMA , Campos-GarriguesA , HerreraA , MunozM . Short-term perioperative iron in major orthopedic surgery: state of the art. Vox Sanguinis2019;114(1):3-16. [PMID: 30411362]">Gomez‐Ramirez 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0008" title="LinDM , LinES , TranMH . Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfusion Medicine Reviews2013;27(4):221-34. [PMID: 24135037]">Lin 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0013" title="SchackA , BerkforsAA , EkeloefS , GögenurI , BurcharthJ . The effect of perioperative iron therapy in acute major non-cardiac surgery on allogenic blood transfusion and postoperative haemoglobin levels: a systematic review and meta-analysis. World Journal of Surgery2019;43(7):1677-91. [PMID: 30824959]">Schack 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0015" title="ShinHW , ParkJJ , KimHJ , YouHS , ChoiSU , LeeMJ . Efficacy of perioperative intravenous iron therapy for transfusion in orthopedic surgery: a systematic review and meta-analysis. PLoS One2019;14(5):e0215427. [PMID: 31059515]">Shin 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0016" title="SinclairR , MoppettGI . Perioperative iron administration in patients with fractured hips. PROSPERO: International prospective register of systematic reviews. Available from www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420201711972020.">Sinclair 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0017" title="SmithA , MoonT , PakT , ParkB , UrmanRD . Preoperative anemia treatment with intravenous iron in patients undergoing major orthopedic surgery: a systematic review. Geriatric Orthopaedic Surgery &amp; Rehabilitation2020;11:2151459320935094. [PMID: 32637197]">Smith 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013737-bbs2-0021" title="YangY , LiH , LiB , WangY , JiangS , JiangL . Efficacy and safety of iron supplementation for the elderly patients undergoing hip or knee surgery: a meta-analysis of randomized controlled trials. The Journal of Surgical Research2011;171(2):e201-7. [PMID: 21962806]">Yang 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PY</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Y</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="18"> <div class="table-footnote"> <p>Scores from the 16 questions in the AMSTAR 2 critical appraisal tool (see <a href="./appendices#CD013737-sec-0085">Appendix 2</a>). N: no; N/A: not applicable, as no meta‐analysis was conducted; PY: partial yes; Y: yes </p> <p><sup>a</sup>Although citations for individual studies were not given, reasons for exclusion were enumerated<br/><sup>b</sup>Funnel plot not performed, but we noted that anaylsis included fewer than 10 trials </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">AMSTAR 2 summary for reviews evaluating iron or iron with erythropoeitin (EPO)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013737-tbl-0009"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Summary of findings table: tranexamic acid versus control for reducing blood cell transfusion in adults undergoing hip fracture surgery</span></div> <tbody> <tr> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Tranexamic acid versus control for reducing blood cell transfusion in adults undergoing hip fracture surgery</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> people undergoing surgery for hip fracture </p> <p><b>Setting:</b> hospital settings </p> <p><b>Intervention:</b> tranexamic acid, given at any dose by any route of administration; studies included in these reviews gave tranexamic acid intravenously, topically, or both </p> <p><b>Comparison:</b> placebo or no treatment </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Number of participants (studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence (GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with control</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with TXA</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Number of people requiring ABT</b><sup>a</sup> </p> <p><i>during perioperative period</i> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.56</b> </p> <p>(0.46 to 0.68)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2148 participants (21 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Moderate<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>451 per 1000<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>257 per 1000</b> </p> <p>(207 to 307)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Volume of transfused allogeneic blood (measured as units of PRC)</b><sup>d</sup> </p> <p><i>during perioperative period</i> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean volume of transfused PRC in the control group ranged from <b>0.53 to 2.4 units</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.53 units lower</b> </p> <p>(0.27 lower to 0.80 lower)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>813 participants (7 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate<sup>e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Postoperative delirium</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b><sup>a</sup> </p> <p>DVT</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.16</b> </p> <p>(0.74 to 1.81)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(22 studies)<sup>g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Moderate<sup>h</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Effects of other adverse events were:</p> <p>PE: RR 1.01, 95% CI 0.36 to 2.86; 9 studies</p> <p>MI: RR 1.00, 95% CI 0.23 to 4.33; 8 studies</p> <p>CVA: RR 1.45, 95% CI 0.56 to 3.70; 8 studies</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79 per 1000<sup>f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>92 per 1000</b> </p> <p>(58 to 142)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Activities of daily living</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Health‐related quality of life</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All‐cause mortality</b><sup>a</sup> </p> <p><i>within 1 month of surgery</i> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.01</b> </p> <p>(0.70 to 1.46)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(10 studies)<sup>g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Moderate<sup>h</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Time point was not reported; we assumed from other information that this effect estimate includes data from &lt; 3 months and ≥ 3 months </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67 per 1000<sup>i</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>67 per 1000</b> </p> <p>(47 to 98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>ABT:</b> allogenic blood transfusion; <b>CI:</b> confidence interval; <b>CVA:</b> cerebrovascular accident; <b>DVT:</b> deep vein thrombosis; <b>MI:</b> myocardial infarction; <b>PE:</b> pulmonary embolism; <b>PRC:</b> packed red blood cells; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>The data for this outcome were reported in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>, which did not include a summary of findings table. We judged the certainty of the evidence based on the information presented in the published report. We did not re‐analyse the data, or re‐assess any risk of bias judgements in the published report.<br/><sup>b</sup>Derived from the pooled estimate of the control groups in the included studies in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a><br/><sup>c</sup>Downgraded by one level for publication bias. Review authors noted evidence of publication bias from funnel plot investigation and Eggers test (P = 0.001)<br/><sup>d</sup>The data for this outcome were reported in <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>, which did not include a summary of findings table. We judged the certainty of the evidence based on the information presented in the published report. We did not re‐analyse the data, or re‐assess any risk of bias judgements in the published report.<br/><sup>e</sup>Downgraded by one level for inconsistency, owing to statistical heterogeneity (I² = 78%)<br/><sup>f</sup>We were unable to determine a pooled estimate of the control group in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a>, because these data were not reported by the study authors; therefore, we derived the control group risk of DVT from <a href="./references#CD013737-bbs2-0011" title="MasourosP , AntoniouG , NikolaouVS . Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials. Injury2022;53(2):294-300.">Masouros 2022</a>.<br/><sup>g</sup>Number of participants included in this effect estimate was not reported in <a href="./references#CD013737-bbs2-0009" title="LiuW , DengS , LiangJ . Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. Archives of Orthopaedic and Trauma Surgery2022;142(10):2769-89.">Liu 2022</a><br/><sup>h</sup>Downgraded by one level for imprecision, owing to wide CI that includes both benefit and harm<br/><sup>i</sup>Risk in the control group taken from the National Hip Fracture Database (NHFD) for England, Wales and Northern Island for 2016 </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Summary of findings table: tranexamic acid versus control for reducing blood cell transfusion in adults undergoing hip fracture surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013737-tbl-0010"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Summary of findings table: iron versus control for reducing blood cell transfusion in adults undergoing hip fracture surgery</span></div> <tbody> <tr> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Iron versus control for reducing blood cell transfusion in adults undergoing hip fracture surgery</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> people undergoing surgery for hip fracture </p> <p><b>Setting:</b> hospitals </p> <p><b>Intervention:</b> iron or iron with EPO, given at any dose for any duration; studies in the review used intravenous administration, starting preoperatively </p> <p><b>Comparison:</b> placebo control or standard care treatment </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Number of participants (studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence (GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with control</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with iron</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Number of people requiring ABT</b><sup>a</sup> </p> <p><i>during perioperative period</i> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.90</b> </p> <p>(0.73 to 1.11)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>403 participants (2 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Low<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>475 per 1000<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>428 per 1000</b> </p> <p>(347 to 527)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Volume of transfused allogeneic blood (measured as units of PRC)</b><sup>a</sup> </p> <p><i>during perioperative period</i> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean volume of transfused PRC in the control group ranged from <b>0.87 to 1.28 units</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.07 fewer units</b> </p> <p>(0.31 fewer to 0.17 more)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>403 participants (2 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Postoperative delirium</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>303 participants (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No effect estimate reported; however, review authors reported that 25 participants in the iron group had delirium compared to 26 participants in the control group. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b><sup>a</sup> </p> <p>Infection</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.99</b> </p> <p>0.55 to 1.80</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>403 participants (2 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Low<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>110 per 1000<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>111 per 1000</b> </p> <p>(61 to 198)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Activities of daily living</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No effect estimate or data reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Health‐related quality of life</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No effect estimate or data reported. Review authors reported that there were no significant differences between groups </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All‐cause mortality</b><sup>a</sup> </p> <p><i>1‐month follow‐up</i> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.06</b> </p> <p>(0.53 to 2.13)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>403 participants (2 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Low<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70 per 1000<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>70 per 1000</b> </p> <p>(37 to 149)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>ABT:</b> allogenic blood transfusion; <b>CI:</b> confidence interval; <b>EPO:</b> erythropoietin; <b>PRC:</b> packed red blood cells; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>The data for this outcome were reported in <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a>, which did not include a summary of findings table. We judged the certainty of the evidence based on the information presented in the published report. We did not re‐analyse the data or re‐assess any risk of bias judgements in the published report.<br/><sup>b</sup>Derived from the pooled estimate in the control groups in <a href="./references#CD013737-bbs2-0014" title="ShahA , PalmerAJ , FisherSA , RahmanSM , BrunskillS , DoreeC , et al. What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis. Perioperative Medicine2018;7:30. [PMID: 30559962]">Shah 2018</a><br/><sup>c</sup>We downgraded the evidence by two levels for imprecision, because the effect estimate was imprecise, and because the evidence was derived from a few participants in only two studies. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Summary of findings table: iron versus control for reducing blood cell transfusion in adults undergoing hip fracture surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013737.pub2/full#CD013737-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013737.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD013737-note-0012">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD013737-note-0019">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013737-note-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013737-note-0017">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD013737-note-0015">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD013737-note-0018">Polski</a> </li> <li class="section-language"> <a class="" href="th#CD013737-note-0014">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013737-note-0011">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD013737-note-0013">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013737\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013737\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013737\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013737\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013737\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013737\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013737\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013737\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013737\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013737\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013737\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013737\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013737\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013737\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013737\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013737\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013737\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013737\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013737.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013737.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013737.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013737.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013737.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727365688"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013737.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727365692"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013737.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eaa46ba899377',t:'MTc0MDcyNzM2Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 